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ABSTRACT 
A NOVEL APPROACH TO ASSESS MINIMALLY INVASIVE SURGICAL DEVICE 
FAILURE UTILIZING ADVERSE EVENT OUTCOME SEVERITY AND DESIGN 
COMPLEXITY 
 
Marie K. Riggs 
October 27th, 2017 
Medical device failure and misuse have the potential to cause serious injury and 
death.  Given the intricate nature of the instruments utilized specifically in minimally 
invasive surgery (MIS), users and manufacturers of surgical devices share a responsibility 
in preventing user error and device failure.  A novel approach was presented for the 
evaluation of minimally invasive device failures, which involved assessing the severity of 
adverse event outcomes associated with the failures modes and investigating aspects of 
the devices’ design that may contribute to failure.  The goals of this research were to 1) 
characterize the design attributes, failure modes, and adverse events associated with 
minimally invasive surgical devices and 2) describe the relationship between minimally 
invasive surgical device design complexity and the severity of adverse events.  The types 
of failure modes, phases of operation in which failure occurs, severity of adverse event 
outcomes, and design complexity associated with four minimally invasive surgical 
devices were determined.   
An association was shown to exist between phases of surgical device operation 
and the severity of outcomes that occur in each phase (p < 0.05).  Across both device 
types, the majority of failure occurred during execution of the devices’ main function, 
 vi 
which involved securing and transecting tissue.  The least amount of failures occurred 
during the results and post-op phase of operation; however, the failures that occurred 
during this phase resulted in the highest average outcome severity.  The endoscopic 
staplers assessed resulted in overall higher average outcome severities relative to that of 
the tissue sealers.   
The methods employed are the first to evaluate medical device design, function, 
and failure outcomes from a complexity perspective.  While statistical conclusions 
regarding the overall research goal could not be drawn, heuristic methods support 
development of the approach presented.  The work herein assists the enhancement of risk 
awareness and prevention techniques and serves as a contribution to filling the 
knowledge gap regarding device use and failure outcomes.  Bridging the gap between 
surgeons and engineers is crucial to the successful implementation and evaluation of new 
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1.1 Specific Aims 
 
 The progression of medical devices contributes to countless saved lives by 
enabling the alleviation of pain, conquering of disability, and sustainment of life.  
However, device failure and misuse have the potential to cause serious injury and death.  
The Institute of Medicine (IOM) estimated that 1.3 million serious injuries to Americans 
are caused by medical devices each year (Rados 2003).  Further, it was stated that more 
deaths occur due to medical errors occurring in hospitals than from AIDS, breast cancer, 
or motor vehicle accidents in a given year (Rados 2003).  More than 2,000 device-related 
deaths and more than 200,000 reports of device-related injuries and malfunctions are 
reported to the FDA every year (Mouzoon and Carome 2012).  Many adverse events are 
attributed to user error; though, the rising trends in the number of recalls indicate that 
manufacturing error and design flaws are also contributing factors.  In the fiscal year 
2011, there were 1201 recalls for moderate- and high-risk devices, which is more than 
double the number of recalls in 2007 (Mouzoon and Carome 2012).  This substantial 
increase was not paralleled by an increase in the number of new product applications 
submitted to the FDA, which gives reason for investigation into manufacturing and 
design defects (Mouzoon and Carome 2012).  
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Rapid technological advancement has allowed the development of highly 
complex, intricate medical devices, which is especially notable in the evolution of 
devices used for minimally invasive surgery (MIS) (Janetschek, Bagheri et al. 2003, 
Feldman, Fuchshuber et al. 2012, Chekan and Whelan 2014).  MIS has become more 
applicable to an increasing number and variety of procedures and in many cases has 
become the preferred technique over open procedures (Belli, Fantini et al. 2006, Hu, Gu 
et al. 2009, Zingg, McQuinn et al. 2009, Biere, van Berge Henegouwen et al. 2012, 
Swanson, Meyers et al. 2012).  Numerous commendable user and patient benefits are 
associated with MIS, yet evidence of a knowledge gap in surgeons’ understanding of 
surgical devices has the potential to negatively impact the clinical outcome of operations 
(McColl, Karmali et al. 2009, Feldman, Fuchshuber et al. 2012, Feldman, Brunt et al. 
2013, Chekan and Whelan 2014, Madani, Watanabe et al. 2016).   For example, a study 
survey given to a target test audience demonstrated the consequences of rapid device 
advancement as it revealed only 28% of respondents considered themselves “experts” in 
the area of surgical energy-based devices used in MIS (Feldman, Brunt et al. 2013).  A 
knowledge gap in users’ understanding of devices combined with the potential for device 
failure is of great concern as it can result in detrimental effects on patient and procedural 
outcomes.  
At any stage of a minimally invasive procedure user or device failure has the 
potential to cause catastrophic consequences, such as severe hemorrhage and conversion 
to open surgery, which puts patients’ lives at risk.  General surgical errors account for 
approximately half of all adverse events and up to 13% of hospital deaths (McCrory, 
LaGrange et al. 2014).  Investigation into device class-specific adverse events reveals that 
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the rate of injuries from surgical energy has been estimated as one to two per 1,000 
operations (Nduka, Super et al. 1994, Overbey, Townsend et al. 2015).  This rate of 
injury is relatively low; however, considering more than 50 million inpatient procedures 
are performed in the United States each year, continuous and additional efforts are 
necessary in order to reduce these adverse outcomes in the operation setting (Overbey, 
Townsend et al. 2015).   
Given the intricate nature of MIS and the instruments utilized, users and 
manufacturers of surgical devices share a responsibility in preventing user error and 
device failure.  In an investigation into casual factors for medication and medical device 
related adverse clinical incidents, medical equipment breakage and failure was found to 
be the most common precursor event for medical device related incidents (46%), and 
22.5% of medical device related incidents occurred intraoperatively (Mitchell, 
Williamson et al. 2015).  Complexity of a surgical device’s design has the potential to 
inhibit a user’s understanding of proper operation and techniques for failure prevention; it 
could also impact proper device functionality.  Understanding the complexity of surgical 
devices can provide valuable insight into specific mechanisms of failure and a means to 
implement countermeasures against undesired outcomes in the surgical setting. Further, 
risk awareness and prevention techniques can be enhanced via an assessment of the 
severity of adverse event outcomes that result from failure.  
 The long term goal was to facilitate intraoperative safety and prevent patient 
injury and death caused by adverse events associated with minimally invasive surgical 
devices.  The specific goals of this research were to 1) characterize the design attributes, 
failure modes, and adverse event outcomes associated with minimally invasive surgical 
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devices and 2) describe the relationship between minimally invasive surgical device 
design complexity and the severity of adverse events.  The research presented supplies 
users and manufacturers with insight regarding phases of operation and mechanisms 
responsible for the failures related to surgical devices in addition to the nature of the 
associated adverse event outcomes.  The following specific aims were established as 
steps to achieve the research goal: 
 
1. Describe the types of failure modes shown to be associated with endoscopic 
staplers and energy-based tissue sealers used in MIS based on reported adverse 
events. 
2. Describe the severity of adverse event outcomes that are associated with the 
failure modes of endoscopic staplers and energy-based tissue sealers. 
3. Characterize the design complexity of endoscopic staplers and energy-based 
tissue sealers used in MIS using device component decomposition and functional 
modeling. 
4. Describe the relationship between minimally invasive surgical device design 
complexity and the severity of adverse event outcomes associated with 
endoscopic staplers and energy-based tissue sealers. 
H1: As minimally invasive surgical device design complexity increases, the 
severity of adverse event outcomes associated with the device also increases. 
5. Develop a tool to predict the likelihood of severe adverse events associated with 
minimally invasive surgical devices based on design complexity. 
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The specific aims were addressed by carrying out the following research 
components.  The first component involved characterizing the nature and frequency of 
failure modes associated with two relatively diverse classes of minimally invasive 
surgical devices.  Characterization was achieved through data collection and analysis of 
reports retrieved from the United States (US) Food and Drug Administration (FDA) 
Manufacturer and User Facility Device Experience (MAUDE) database, which was 
outlined in Chapter II.  The next component assessed the severity of the adverse event 
outcomes associated with the failure modes via application of the Common Terminology 
Criteria for Adverse Events (CTCAE) v4.0 grading scale as described in Chapter III.  
Chapter IV presents the third component, which consisted of reverse engineering four 
minimally invasive surgical devices and determining a design complexity score based on 
an existing complexity measure.  Chapter V discusses the final component of this 
research, which was to utilize the average outcome severity and complexity score 
associated with each surgical device in order to determine the relationship between the 
two variables.  An extension of this component involved exploring the viability of an 
outcome severity predictive tool based on complexity by performing ordinal regression, 
which would be applied in the early design stages to mitigate potential design-related 
adverse events. 
Chapter VI concludes with a summary of results and discussion.  Through testing 
of the hypothesis, the variables investigated associated with complexity and outcome 
severity can potentially enhance engineers’ abilities to prevent or reduce the severity of 
surgical device failure mode outcomes.  A novel approach to assessing minimally 
invasive device failures and adverse event outcomes was presented, which included 
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evaluating medical device design, function, and failure outcomes from a design 
complexity perspective. 
 
1.2 Background and Significance 
 
1.2.1 Minimally Invasive Surgical Devices 
 
1.2.1.1 Minimally Invasive Surgical Device Overview 
A medical device is defined as an instrument used for diagnosis, treatment, or 
prevention of a disease, injury, or other condition that is not a drug, biologic or food 
(Rados 2003).  Types of medical devices range from simplistic tongue depressors to 
complex surgical tools.  Significant medical device innovation has emerged and 
contributes specifically to minimally invasive surgical techniques.  Minimally invasive 
surgery (MIS) has been applied to an increasing number and variety of procedures and in 
many cases has become the preferred technique over open procedures (Belli, Fantini et al. 
2006, Hu, Gu et al. 2009, Zingg, McQuinn et al. 2009, Biere, van Berge Henegouwen et 
al. 2012, Swanson, Meyers et al. 2012).  MIS has transformed many medical procedures 
and offers various advantages compared to conventional surgery, such as reduced 
postoperative pain, faster recovery, reduction in intraoperative bleeding, and reduced 
postoperative complications (Belli, Fantini et al. 2006, Hu, Gu et al. 2009, Zingg, 
McQuinn et al. 2009, Handy, Asaph et al. 2010, Biere, van Berge Henegouwen et al. 
2012, Irwin and Wong 2012).  The goal of medical treatment is further realized with the 
application of MIS, which is “to minimize harm to patients and maximize the natural 
self-healing power for fighting against the disease” (Wang 2015).  The medical devices 
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and accompanying tools for such procedures allow a decrease in the size of incisions 
required for operation, which in turn spares the surrounding tissue (Irwin and Wong 
2012).   
Procedurally innovative endoscopic approaches have been enabled through the 
improved design of surgical instrumentation.  Miniaturization of surgical instruments, 
such as forceps, cutting tools, electronic sensors, drug delivery systems, and lighting 
technology, facilitates access to regions of the body that once had to be opened entirely.  
This research focuses on the following types of devices for MIS: endoscopic staplers and 
energy-based tissue sealers. 
 
1.2.1.2 Endoscopic Stapler Overview 
The use of endoscopic stapling devices is increasingly being applied to more 
wide-ranging open and MIS procedures (Deng, Meng et al. 2002, Janetschek, Bagheri et 
al. 2003, Belli, Fantini et al. 2006, Robert, Poncet et al. 2011, Hassouna and Manikandan 
2012, Kwazneski, Six et al. 2012).  Endoscopic staplers deploy either purely mechanical 
or powered mechanisms to simultaneously staple and transect target tissue during the 
firing sequence.  Stapling occurs as individual straight metal staples are released from the 
cartridge, travel through the compressed tissue, and typically bent into a “B” shape upon 
contact with a hard anvil pocket on the opposite side (Mery, Shafi et al. 2008).  
Alterations of the pocket design and resulting staple shape have been initiated on more 
recent device designs in attempt to improve hemostasis.  Stable anastomosis relies on the 
integrity of the staple line, which directly relates to the amount of tissue compression 
(Chekan and Whelan 2014).  Intrinsic biomechanical properties of tissue vary along with 
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the tissue types and thickness. Tissue properties determine both the proper compressive 
force and optimal compression time before firing the device (Chekan and Whelan 2014).  
Device performance depends heavily on the proper shape formation of staples, integrity 
of the staple line, smooth division of target tissue, and proper overall mechanical function 
through all stages of device use.  
Endoscopic staplers are one of many instruments that have been developed and 
approved for use in open surgery and MIS.  For various procedures, endoscopic staplers 
are often used to execute the most difficult and anxiety-provoking portions of the 
operation, such as ligation and division of vascular structures (Deng, Meng et al. 2002).  
These devices are utilized in procedures such as lobectomy, nephrectomy, gastrectomy, 
gastric bypass, appendectomy, hepatectomy, and video-assisted thoracic surgery (VATS), 
to name a few.  The successful creation of an anastomosis from an optimal staple line can 
be achieved by applying the proper size cartridge and corresponding staple height based 
on the tissue’s thickness and mechanical properties.  Performance of endoscopic staplers 
relies on an optimal compression force that allows for proper tissue approximation, yet 
spares tissue from shearing or injury (Mery, Shafi et al. 2008).   
 
1.2.1.3 Energy-Based Tissue Sealer Overview 
The energy-based devices of interest seal vessels and transect tissue through 
utilization of bipolar and ultrasonic technology.  Devices within this category are relied 
upon to create a hemostatic seal as a result of denaturation of collagen and elastin in 
vessel walls (Aytan, Nazik et al. 2014).  Two electrodes are contained within a bipolar 
electrosurgical device, between which the tissue is grasped.  Current passes through the 
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tissue between these electrodes causing distribution of thermal energy and coagulation of 
vessel walls.  Advanced bipolar devices deliver pulses of electrical energy, which allows 
the tissue to cool throughout activation in attempt to reduce tissue sticking on the 
electrode.  Such devices also rely on computer-controlled feedback response systems in 
order to adjust the current and voltage based on tissue impedance and temperature (Lyons 
and Law 2013).  Tissue impendence and temperature is regulated via computer-controlled 
feedback response systems, and positive temperature coefficient (PTC) technology may 
be incorporated to minimize undesired thermal spread surrounding the application site.  
The electrodes of bipolar devices are efficient for sealing vessels, and a cutting device, 
such as a retractable blade, is built within to allow a mechanism for transection of tissue.  
Controlling the frequency, intensity, and duration of electrosurgical energy delivered to 
the tissue provides surgeons with the option to cauterize, coagulate, and/or reduce 
bleeding (Johnson, Couture et al. 2007).  
Ultrasonic devices result in a similar tissue effect as produced by bipolar devices, 
yet it is achieved via ultrasonic vibrations.  Electrical energy is converted to mechanical 
and thermal energy by means of the vibrations in order to both seal and transect vessels.  
Bipolar and ultrasonic devices involve conversion of electrical energy into mechanical 
and thermal energy, yet the methods vary as described.  To achieve the necessary tissue 
effects, bipolar devices convert energy via intracellular frictional effects, whereas the 
frictional force generated by ultrasonic devices results in extracellular heating of tissue 
followed by intracellular heating (Lyons and Law 2013).  The effectiveness of these 
devices relies on the pressure applied to the vessel and the gap distance between the 
electrodes; such mechanical properties must be constantly maintained at the proper 
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setting based on the vessel thickness (Johnson, Couture et al. 2007).  The energy-based 
devices are utilized in various laparoscopic procedures that include, but not limited to, 
colectomy, hysterectomy, liver resection, lobectomy, and pancreatectomy.  
 
1.2.2 Clinical Variables and User Knowledge Gap 
 
1.2.2.1 Clinical Knowledge Gap 
The technological advancements that contribute to the evolution of devices for 
MIS lead to the development of new and modified surgical techniques.  A consequence 
of the rapid rate of the technological advancement is a lack in surgeons’ knowledge of 
surgical devices, which has been referred to as a “knowledge gap” in surgeons’ 
understanding of how devices interact with tissue.  Since many surgeons are not aware of 
the tissue handling characteristics and limitations of new or reengineered devices, the 
knowledge gap can impact the clinical outcome of operations (Feldman, Fuchshuber et al. 
2012, Feldman, Brunt et al. 2013, Sankaranarayanan, Resapu et al. 2013, Chekan and 
Whelan 2014).  Adverse events have been shown to be attributed to both user error as 
well as device-related errors.  Therefore, continuous training and education for surgeons 
and device design improvements by manufacturers are imperative (Zingg, McQuinn et al. 
2009, Madani, Watanabe et al. 2014, Wang 2015, Madani, Watanabe et al. 2016, 
Watanabe, Kurashima et al. 2016).  
In a study of laparoscopic linear cutting stapler failure, less than 0.3% of the 
incidences were primarily related to device failure when cases of user error were 
excluded and the use of multiple staplers and cartridges was included (Deng, Meng et al. 
2002).  In a study by Chen et al., the incidence of primary device failure was estimated to 
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be less than 0.2% (Chan, Bishoff et al. 2000).  These outcomes demonstrate the criticality 
of surgeon experience, knowledge, and vigilance.   
Despite the training programs offered by manufacturers and the instructions for 
device use, more resources are necessary (Parker 2010).  McColl et al. studied the 
baseline knowledge of endoscopic staplers possessed by surgical residents and found a 
deficiency of knowledge, especially in junior residents (McColl, Karmali et al. 2009).  
Manufacturer-offered courses that detail the function and operation of special surgical 
instrumentation are widely available for attending physicians; however, trainees are 
typically not offered such courses.  Surgeons are often relied upon to train the residents 
about each specialized surgical device in an operating room setting, which can result in 
an increase in procedure time and costs (Bridges and Diamond 1999, Lavernia, Sierra et 
al. 2000, Farnworth, Lemay et al. 2001).  Educational techniques must evolve for 
physicians and residents in response to technological advancements of surgical 
instrumentation in order to fill the knowledge gap and prevent adverse operative 
outcomes. 
Surgical energy devices are a common tool used by surgeons and in many cases 
are used on a daily basis (Watanabe, Kurashima et al. 2016).  Surveys results given to a 
target test audience revealed that only 28% of respondents considered themselves 
“experts” in the area of surgical energy-based devices (Feldman, Brunt et al. 2013). 
Additionally, of 48 Society of American and Gastrointestinal and Endoscopic Surgeons 
(SAGES) leaders who took a pretest examination of energy use in surgery, the median 
percent of correct answers was 59% (Feldman, Fuchshuber et al. 2012).  The test 
revealed that 13% did not know that thermal injury can spread outside of the bipolar 
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instrument jaws, and 31% could not identify the device that would be the least likely to 
interfere with a pacemaker (Feldman, Fuchshuber et al. 2012).  After informing the 
participants of the correct answers, a different post-test completed by 25 of the 
participants resulted in a median of 90% correct answers, revealing the potential of a 
formal curriculum to help fill the knowledge gap (Feldman, Fuchshuber et al. 2012).  A 
standard curriculum is typically not available outside of the training offered by the device 
manufacturers.  
Due to the potential knowledge gap suggested in regards to surgical energy-based 
devices, SAGES created a curriculum called the Fundamental Use of Surgical Energy 
(FUSE) to address the safety and usage concerns (Feldman, Fuchshuber et al. 2012, 
Feldman, Brunt et al. 2013).  FUSE was launched in 2012 and includes content such as 
fundamentals of electrosurgery, monopolar devices, bipolar devices, endoscopic devices, 
and ultrasonic energy systems.  Initial studies have shown that a formal curriculum in 
specific surgical medical devices, such as FUSE, can decrease the knowledge gap and 
consequentially reduce complications (Feldman, Brunt et al. 2013, Overbey, Townsend et 
al. 2015, Madani, Watanabe et al. 2016, Watanabe, Kurashima et al. 2016).  Yet, 
combined efforts from medical, design, technology, and manufacturing domains are 
necessary. 
Five strategies have been identified using a system approach by Dankelman and 
Grimbergen aimed at the reduction of MIS errors: (1) reduce complexity, (2) standardize 
procedures, (3) implement checklists, (4) improve the quality and standardization of 
instruments and equipment and (5) training (Dankelman and Grimbergen 2005).  The 
overall approach calls for the elimination of unnecessary and inefficient interactions and 
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processes in addition to a standardization of procedures and equipment (Flin, O'Connor et 
al. 2008).  Errors within complex systems can be due to a confliction between the work 
system and operator/user capabilities (or lack thereof) (van Det, Meijerink et al. 2009).  
Also, in order to reduce complexity, a method must be applied in order to identify and 
quantify it. 
 
1.2.2.2 Endoscopic Stapling Variables 
Surgeons are faced with multiple complex variables upon implementation of their 
choice of stapling technique.  Examples of the variables associated with endoscopic 
stapling devices include staple height associated with cartridge or reload selection, 
compression time, buttress usage, overlapping staple lines, and tissue properties.  
Intrinsic biomechanical properties of tissue vary along with the tissue types and 
thickness.  Performance of endoscopic staplers relies on an optimal compression force 
that allows for proper tissue approximation, yet spares tissue from shearing or injury 
(Mery, Shafi et al. 2008).  Mery et al. profiled endoscopic staplers through a series of 
leak pressure tests and found staple height was an important determinant of leak pressure, 
overlap did not affect leak pressure, and buttressing improved all types of staple lines 
(Mery, Shafi et al. 2008).  Buttressing refers to thin sheets that are placed on one or both 
sides of the target tissue in attempt to supply additional support and hemostasis (Mery, 
Shafi et al. 2008).  Less bleeding from staple lines has been associated with buttressing, 
yet it can cause visualization issues and interference with repeated staple firing 
(Angrisani, Lorenzo et al. 2004).  
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Overlapping staple lines has been shown to attribute to adverse event outcomes 
and can result in dulling of the blade and incomplete staple lines accompanied by a 
difficulty in firing (Mery, Shafi et al. 2008).  Though, certain procedures call for 
overlapping staple lines in order to complete a transection, such as the creation of a 
gastric pouch during gastric bypass.  That is yet another factor that the surgeon must 
consider during his/her choice of endoscopic stapling technique.  
A user’s choice of stapler and staple height depend heavily on the tissue type.  
Body tissue ranges in thickness and the dimensions vary based on age, anatomical 
location, sex, disease state, structure, and patient medications (Chekan and Whelan 
2014).  Tissue consists of both solid and liquid, and its intrinsic properties must be 
considered, such as protein content and metabolic factors (Chekan and Whelan 2014).  
Firing should be initiated on elongated tissue with a decreased quantity of fluid, which is 
achieved by optimal compression times.  When choosing a stapler, the user must consider 
these tissue-specific properties, which also includes vascularity of the structure, tension, 
and likelihood of variable tissue thickness (Chekan and Whelan 2014). 
Many adverse events are attributed to user error; even so, manufacturers have a 
responsibility to recognize and address any overwhelming confusion or challenges faced 
by surgeons during use.  Also, the number of recalls associated with endoscopic staplers 
indicates device error shares responsibility (Deng, Meng et al. 2002, Kwazneski, Six et 
al. 2012).  Filling the knowledge gap requires consistent reporting of adverse events to 
increase awareness, providing up-to-date educational techniques for physicians and 
residents, and ensuring the development of safe, reliable, and user-friendly devices. 
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1.2.2.3 Energy-Based Tissue Sealing Variables 
Energy-based devices in particular have increased in the rate of technological 
evolution and complexity.  Delicate, intricate procedures combined with the 
incorporation of electrical energy and heat generation create high-pressure environments 
in operating rooms.  In addition to the wide range of device options and features, such an 
operational setting can induce devastating complications.  According to the Emergency 
Care Research Institute (ECRI), surgical burns and fires are listed in the top 10 health 
technology hazards for 2012 (Feldman, Fuchshuber et al. 2012).  
The hazards of electrosurgery must be monitored by the surgeon and staff.  
Surgical smoke produced during tissue diathermy can be potentially hazardous to staff 
and patients.  Based on chemical analysis, 5% of the surgical smoke consists of 
potentially harmful content, such as hydrocarbons and nitriles (Gallagher, Dhinsa et al. 
2011).  The most common source of ignition for fires and explosions in the operating 
room is electrosurgical devices; nearby cloth, paper, flammable liquid, or gaseous 
anesthetics in an oxygen-rich environment can be ignited (Wang and Advincula 2007).  A 
surgeon must be well-aware of the other medical devices that may be implanted in a 
patient prior to applying an electrosurgical technique; interference with certain types of 
pacemakers have the potential to lead to cardiac arrest (Gallagher, Dhinsa et al. 2011).  
New tissue sealing technologies that utilize ultrasonic and bipolar technology 
have significantly limited the risks involved in conventional monopolar surgery.  
Nonetheless, electrosurgical caution and knowledge still remain a necessity for clinical 
safety.  In addition to having an understanding of electrical basics, surgeons must be 
well-versed in instructions for use specific to their device and generator brand of choice.  
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Informed judgment is required in order apply devices to the proper size vessels 
considering advanced bipolar and ultrasonic devices have the ability to seal and transect 
vessels up to 7mm in diameter (Lyons and Law 2013).  Heat production during 
application must also be monitored in order to minimize the risk of lateral thermal spread.  
Users must be aware of the audible generator tones occurring during application to 
indicate tissue status in addition to monitoring the effects to both the target and 
surrounding structures.   
New technology, especially that within the generators used to power the devices, 
eliminates many procedure variables.  For example, adaptive technology monitors the 
thermal state of the device blade in addition to the amount of tissue that remains in the 
jaws.  By monitoring these factors, the tissue response generator queues a decrease in 
delivered power in order to prevent excess thermal injury (Broughton, Welling et al. 
2013).  Despite the elimination of some user-controlled variables, interfaces between 
technology, surgeons, and patients can still induce a heightened level of stress in the 
clinical setting, especially when electrical energy is involved. 
 
1.2.3 Medical Device Regulation and Reporting 
 
1.2.3.1 Medical Device Regulation 
 Congress granted the FDA the authority to regulate medical devices in 1976, 
while drugs have been mandated to prove to be safe and effective since 1938 due to the 
Federal Food, Drug, and Cosmetic Act (Burditt 1995).  It wasn’t until morbid 
consequences of the Dalkon Shield intrauterine device unfolded, including reports of 209 
second-trimester abortions and 11 maternal deaths, that Congress took action by enacting 
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the Medical Device Amendments of 1976 (Monsein 1997).  Consequences and evidence 
of inadequate post market surveillance in addition to lack of manufacturer adverse event 
reporting triggered Congress to enact the Safe Medical Devices Act of 1990 and the 
Medical Device Amendments of 1992 (Monsein 1997, Maisel 2004).  As a result, clinical 
facilities were required to report serious injuries or deaths related to medical devices.  
Additionally, manufacturers were enforced to report device malfunctions to the FDA that 
cause or potentially cause patient injury (Maisel 2004).  
 Despite the actions by Congress, concerns still existed in regards to the FDA 
approval processes.  The premarket approval (PMA) process was introduced by the 1976 
law specifically for devices.  PMA submissions require the following: “valid scientific 
evidence” provided by extensive testing that “provide(s) reasonable assurance that the 
device is safe and effective for its intended use” (Yock, Zenios et al. 2015).  This 
rigorous process is applied rightfully to medical devices that “support or sustain human 
life, are of substantial importance in preventing impairment of human health, or which 
present a potential, unreasonable risk of illness or injury” (Maisel 2005). The 510(k) 
provision, an alternative regulatory standard, emerged in 1976 in addition to the PMA 
due to the significant number of existing devices in the market.  The intention of the 
510(k) provision was to provide a less burdensome and less expensive path for newer 
versions of existing devices to enter the market by requiring only a demonstration that the 
device was “substantially equivalent” in materials, purpose, and mechanism of action to 
another device that was already marketed.  
 The FDA classifies devices based on their risk profile.  The lowest and 
intermediate risk devices are classified as Class I and Class II, respectively.  Class III 
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devices pose the greatest potential risk.  Adopted from Biodesign: A Process of 
Innovating Medical Technologies, Table 1 displays a detailed outline of each device class 
(Yock, Zenios et al. 2015).  
 
Table 1. FDA device classification (Yock, Zenios et al. 2015). 






potential harm to 
patient and are 
typically simple in 
design. 
 Registration of the 
establishment with FDA. 
 Medical device listing. 
 General FDA labeling 
requirements. 
 Compliance with quality 








but more complicated 
in design than Class I; 
must demonstrate that 
the devices will 
perform as expected 
and not cause injury or 
harm to users. 
 Special labeling 
requirements. 
 Mandatory performance 
standards. 
 Design controls. 











therapeutic, or life 
sustaining high risk 
devices. 
 Generally approved by 
PMA regulatory pathway; 
some eligible for 510(k) 
clearance. 
 Valid scientific evidence 
to demonstrate safety and 
effectiveness before use 
in humans. 
 
 Approximately 75% of Class I and less than 10% of Class II devices do not 
require FDA clearance to be marketed (Yock, Zenios et al. 2015).  All class III devices 
are required to obtain FDA clearance.  Of all medical devices, about half fall in Class I 
classification, while 45-50% are in Class II, and 5-10% in Class III (Yock, Zenios et al. 
2015).  More than 100,000 medical devices are regulated by the FDA, which are 
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organized into 1,700 different categories of technology.    The categories are managed by 
the Office of Device Evaluation (ODE), which consists of seven divisions with 33 
branches based on medical specialties (CDHR 2017).  A device is referred to as cleared 
and to have achieved premarket notification when it passes 510(k) clearance, whereas a 
Class III device that completes the PMA route is approved by the FDA.    
 The 510(k) provision was initially intended for Class I and many Class II devices 
that did not require significant scientific study.   However, the technological evolution 
quickly increased device complexity, and the FDA lacked necessary resources to modify 
performance standards for these evolving devices or pass more devices through the 
rigorous PMA pathway (Zuckerman, Brown et al. 2011).  Further, Congress passed the 
Medical Device User Free and Modernization Act of 2002 (MDUFMA) which sparked a 
shift in the regulatory standard.  Recently, 510(k) provision has been used by the FDA as 
the leading mechanism for new device clearance, while only 1% of medical devices have 
been reviewed using the PMA process (Zuckerman, Brown et al. 2011).  The 
Government Accountability Office (GAO) reviewed the 510(k) process and published a 
report in 2009 revealing that 66% of recent Class III submissions that were “implantable, 
life sustaining, or of significant risk” were cleared via the 510(k) process (GAO 2009).  
By law, all Class III devices should have been subjected to the more thorough PMA 
process. 
 The 510(k) process as applied by the FDA has been under critical observation by 
media, organizations, and Congress.  A 2011 study by Zuckerman et al. investigated how 
the approval and clearance processes were used for medical devices that had been 
recalled for life-threatening problems (Zuckerman, Brown et al. 2011).  Of 113 recalls 
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between 2005-2009 examined by Zuckerman et al., 7% were exempt from FDA 
regulation, 19% were approved via the PMA process, and 71% were cleared through the 
510(k) process (Zuckerman, Brown et al. 2011).  Further, 12% of the recalled devices 
that had undergone 510(k) clearance were marketed for “risky or life-sustaining Class III 
indications,” and, as such, should have been legally mandated for review under PMA 
regulations (Zuckerman, Brown et al. 2011).  The study revealed differences in the 
approval criteria for high risk and life sustaining devices and the recall criteria that deems 
a device life threatening. 
 Issues likely stem from the FDA’s efforts in balancing the approval of safe and 
effective devices while also promoting innovation in the medical device industry.  Some 
criticism of the FDA is directed towards device approval processes being too quick and 
not rigorous enough, while other criticism is geared towards delay of the entry of 
important new medical devices (Challoner 2011, Yock, Zenios et al. 2015).  The Institute 
of Medicine (IOM) committee released a report in 2011 suggesting a shift away from the 
510(k) process as soon as possible and development of a new framework (Challoner 
2011).  Clearly regulatory process reform is necessary, and the FDA has recently taken 
steps indicating acknowledgement and implementation of changes intended to improve 
the criteria and assessments associated with the 510(k) process (Monsein 1997, Maisel 
2004, Maisel 2005, Zuckerman, Brown et al. 2011, Yock, Zenios et al. 2015, CDHR 
2017, FDA 2017). 
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1.2.3.2 Medical Device Reporting and Recalls 
Medical device reporting (MDR) is carried out by manufacturers, importers, and 
user facilities and is the primary means by which the FDA collects medical device 
adverse event reports (Yock, Zenios et al. 2015).  The FDA’s MAUDE database contains 
a significant number of medical device-related incidents and is a useful tool for 
identifying the nature and frequency of such incidents.  Efficient searches of the database 
must be approached systematically as described in the study by Gupta and Pidgeon 
(Gupta and Pidgeon 2016).  The FDA’s MAUDE database reports include identifying 
factors such as report number, event date, report date, manufacturer, product code, and 
brand name.  The reports typically contain an event description with details regarding the 
adverse event and may include a manufacturer narrative with details regarding a follow 
up analysis of the device involved.   
Any device malfunction that causes or could cause significant injury is required to 
be reported to the FDA by the manufacturer.  Device user facilities are required to report 
a suspected medical device-related death to the FDA and manufacturer.  User facilities 
must also report serious injuries related to a medical device to the manufacturer or to the 
FDA if the manufacturer is unknown (FDA 2017).  User facilities are not required to 
report a device malfunction.  Healthcare professionals, consumers, and patients are 
encouraged to voluntarily report adverse events related to medical devices in addition to 
user errors, quality issues, and therapeutic failures (FDA 2017).  To improve safety in the 
market, it has been suggested to make detailed public reporting of medical device 
malfunctions and device reliability mandatory; however, some physicians disagree 
claiming that such extensive notification is too onerous and increases physician liability 
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(Maisel 2005). Mandatory and accurate reporting would supply superior information to 
patients and physicians enabling them to make more informed decisions regarding their 
choice of medical device.  MDR provides a means to derive useful failure mode data 
directly related to surgical medical device use.   
The most serious medical device recalls posted by the FDA include products with 
a “reasonable chance that they would cause serious health problems or death” (FDA 
2017). Recalls occur due to one or both of the following: a defective medical device or 
when a device could put a user’s health at risk.  Either a correction or removal recall 
takes place depending on the action location.  A correction recall “addresses a problem 
with a medical device in the place where it is used or sold,” and a removal recall 
“addresses a problem with a medical device by removing it from where it is used or sold” 
(FDA 2017). Typically, a company recalls a medical device voluntarily if the product is 
shown to violate FDA law.  If necessary, a company can be required by the FDA to recall 
a device.  Product recalls can be accessed via the FDA Medical Device Recalls database 
and include information such as recall firm, center classification year, number of recalls, 
product name, and recall reason. 
 
1.2.3.3 Limitations of Medical Device Reporting 
 Device user facilities are required to report device-related death and serious 
injury; however, there are no requirements as to the level of report detail submitted to the 
FDA.  The event descriptions provided within adverse event reports may or may not 
provide enough information to derive a specific failure mode, which hinders a complete 
investigation into user and device failures.  There is some general consensus among users 
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in regards to the terminology used to report an adverse event, yet an overall definition 
and application of terms and types of failure modes still lacks.  This research relied on the 
level of detail of adverse event reports and collected terms from the literature in order to 
compile the most universal terms for reporting a failure mode relative to the particular 
device.  In regards to the FDA regulatory processes, there is no doubt that concerns from 
outside parties exist in terms of the acceptance criteria.  While this research does not 
provide suggestions for regulatory reform, it does provide assistance to designers in 
identifying the design complexity and potential surgical device failures that could be of 
value to consider in the early design stages.  Consequentially, such assistance helps 
ensure the effectiveness and safety of a device’s final design in addition to the steps 
required for FDA approval or clearance.  
 
1.2.4 Surgical Device Failure Mode Studies 
 
1.2.4.1 Endoscopic Stapler Failure Mode Studies 
 Endoscopic staplers are generally reliable, yet difficulties have been noted in 
every step of use.  Recall that endoscopic staplers simultaneously staple and cut interior 
tissue as discussed in Section 1.2.1.2.  Problems can occur in various stages of use as 
identified by Deng et al. including removal from packaging, application to tissue, firing 
staples, cutting tissue, removal from tissue and/or port, and resulting staple line (Deng, 
Meng et al. 2002).  Issues with packaging potentially compromise the sterility of the 
device or reload and may damage critical components for proper function.  Improper 
anastomosis may result from any complications encountered during the firing sequence.  
 24 
Difficulty in releasing the device after firing can lead to various undesirable outcomes 
such as unintended tissue damage and loss.   
Deng et al. found that abnormal firing of the stapler and improper staple 
formation to be the most common and fatal aspects of device error (Deng, Meng et al. 
2002).  A study on hemostasis in laparoscopic renal surgery indicated that endoscopic 
staplers had the highest risk of malfunctioning (Hassouna and Manikandan 2012).  
Further, it was stated that the two most common mechanisms of failure found in the 
investigation were inadequate staple lines and device failure to release from tissue, which 
result in a relatively high percentage of severe hemorrhage and open conversion during 
laparoscopic renal surgery (Hassouna and Manikandan 2012).  These consequences 
heavily affect staple line integrity, which is an essential aspect of endoscopic stapling 
given that failure many times causes intra-operative and post-operative leaks, thus 
compromising a patient’s recovery, health, and safety. 
 A study that investigated MAUDE reports of endovascular gastrointestinal 
anastomosis (Endo-GIA) malfunctions during laparoscopic nephrectomy indicated the 
most common mechanism of failure was malformed or leaking staple line after firing 
(Mansour, El-Nashar et al. 2014).  The study analyzed 65 Endo-GIA device failures 
during renal vascular control in laparoscopic nephrectomy identified in the FDA 
MAUDE database.  Malformed or a leaking staple line after firing accounted for 60% of 
the cases.  10.8% were attributed to device failure to release from tissue, and device 
handle breakage during firing occurred in 2 of the cases.   
 One of the most concerning complications occurs upon firing a used stapler or 
cartridge.  There are lockout mechanisms on many endoscopic staplers that are meant to 
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prevent the ability to fire a used device; however, this lockout mechanism, also referred 
to as a safety interlock, can be overcome with excessive force applied by an 
inexperienced surgeon (Deng, Meng et al. 2002).  Studies have shown that preventable 
user error accounts for a majority of adverse event associated with endoscopic staplers 
(Chan, Bishoff et al. 2000, Deng, Meng et al. 2002). However, a study that surveyed 44 
minimally invasive program directors indicated that the two most common malfunctions 
were staples partially firing and the stapler misfiring and not releasing, which are 
potentially device specific versus user error (Kwazneski, Six et al. 2012).  The recalls 
identified by Brown and Woo also suggest stapler errors arise from design and 
manufacturing issues versus solely user error (Brown and Woo 2004).   
 Various failure mode types that contribute to adverse events can be difficult to 
classify as either user or device error.  Consider events that involve malformed staples.  
Such an outcome could be due to firing the device on too thick of tissue; yet, this could 
also be an outcome of improper device function.  The results of such investigations 
emphasize the importance of diligent and accurate reporting of adverse outcomes related 
to use of endoscopic stapling devices during MIS in order to determine the source of 
complication. 
 
1.2.4.2 Energy-Based Tissue Sealer Failure Mode Studies 
 A thorough understanding of energy-based device complications is essential in 
order to decrease the likelihood of preventable injuries and deaths.  The rate of injuries 
from surgical energy has been estimated as one to two per 1,000 operations (Nduka, 
Super et al. 1994, Overbey, Townsend et al. 2015).  The rate of injury is relatively low; 
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however, considering more than 50 million inpatient procedures are performed in the 
United States each year, continuous and additional efforts are necessary in order to 
reduce adverse event outcomes in the operation setting.  An array of clinical hazards has 
been linked to electrosurgical devices overall.  The most common source of ignition for 
fires and explosions in the operating room is electrosurgical devices; nearby cloth, paper, 
flammable liquid, or gaseous anesthetics in an oxygen-rich environment can be ignited 
(Wang and Advincula 2007).  Insulation failure can create alternate pathways for current 
flow, and adjacent organ injury is possible with a high enough current density.  Tissue 
burns and operation fires can also be attributed to insulation failure.   
 Patterns of injuries and deaths resulting from energy-based devices in general 
have been identified as thermal burn, hemorrhage, mechanical failure, and fire.  Injury 
mechanisms of failure modes include inadvertent application, dispersive electrode failure, 
capacitive coupling, residual heat, insulation failure, and direct application.  
Electrosurgical failures are typically associated with monopolar devices and earlier 
bipolar devices.  Many of these complications have been mitigated by the implementation 
of advanced technologies, yet adverse outcomes can still occur.  In a study by Overbey et 
al., ultrasonic energy accounted for 19% of the mechanical failures.  Advanced bipolar 
devices accounted for 48% of broken devices indicated in the analysis, and 37% of the 
retained object reports were associated with ultrasonic energy (Overbey, Townsend et al. 
2015).  Residual heat injury has been most commonly associated with ultrasonic devices, 
in which injury occurs from a heated electrode after completion of the activation cycle; 
21% of thermal burns due to residual heat were attributed to ultrasonic energy (Overbey, 
Townsend et al. 2015).  Ultrasonic and advanced bipolar devices were most commonly 
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associated with bleeding events, which is likely due to the nature of their specific 
function in a surgical procedure (Overbey, Townsend et al. 2015).  Another disadvantage 
and potential hazard of ultrasonic energy is the formation of aerosolized fatty droplets 
during activation on tissue, which can interfere with endoscopic visualization (Alkatout, 
Schollmeyer et al. 2012).  Also, despite lower operating temperatures, ultrasonic energy 
has been correlated with substantial and undesirable tissue heating (Person, Vivas et al. 
2008).    
 
1.2.4.3 Limitations of Failure Mode Studies 
Studies have described failure modes of endoscopic staplers and energy-based 
devices via query of the FDA MAUDE database.  However, these studies’ assessments of 
failure modes are predominantly approached from a clinical standpoint versus a design or 
engineering perspective.  The few studies that mention device or component failure are 
vague and do not discuss the particular mechanism of failure that would assist designers 
and engineers in developing new devices or implementing modifications for design 
improvement.  The manufacturers of surgical devices conduct extensive tests and 
research related to device failure modes; however, this information is not made accessible 
by the general public or device users.  Published information related specifically to 
device design complexity in relation to failure mode outcomes can aid the decisions of 
clinical facilities, users, and, in some cases, patients in regards to procedural approaches 
that involve such surgical devices. 
The studies aimed at investigation into the FDA MAUDE database typically 
include a very broad range of device types and technologies.  While that approach 
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provides very useful general information for users, it does not allow for an in-depth 
discussion of specific device-related failures.  This research investigated the specific user 
and device failure modes derived from adverse event reports directly associated with 
endoscopic staplers and energy-based tissue sealers. 
Any mechanical device, such as the surgical medical devices discussed herein, 
possesses the potential to malfunction (Deng, Meng et al. 2002).  Device failure at any 
stage of use during MIS has the potential to cause severe hemorrhage and conversion to 
open surgery.  A comprehensive understanding of device failure is crucial in order to 
identify user error and device-related failures.  Such an understanding helps to reduce and 
eliminate user and device error and, therefore, improves the safety, efficiency, and 
usability of a device (Gupta and Pidgeon 2016).  The rate of adverse events reported 
regarding endoscopic stapler and energy-based device malfunction has been shown to be 
relatively low when compared to their overall frequency of use (Chan, Bishoff et al. 
2000, Deng, Meng et al. 2002, Brown and Woo 2004, Overbey, Townsend et al. 2015). 
However, thorough and on-going investigation is paramount due to potential catastrophic 
consequences of device failure.   
 
1.2.5 Severity Grading Methods 
 
1.2.5.1 Overview of Current Methods 
 Classification and severity grading of adverse event outcomes is necessary for a 
common assessment and evaluation of procedural concerns that are both user and surgical 
instrument related.  Various methods for grading surgical complications have been 
developed, such as the T92 and its derivatives.  Strasberg et al. proposed a modification 
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to the grading system, known as the Accordion Classification system, used to determine 
the severity of postoperative complications (Strasberg, Linehan et al. 2009).  The 
Accordion Classification shows promise towards a common severity grading system for 
surgical complications by providing a more understandable and accessible method, yet 
further modifications are still required to cover an even wider range of procedure 
incidents.  The Abbreviated Injury Scale (AIS) ranks the severity of injury as an 
anatomical scoring system (Copes, Champion et al. 1990).  The scoring system ranks on 
a scale of 1 to 6.  The Injury Severity Score (ISS) and the New Injury Severity Score  
(NISS) focus on injury associated with a particular region of the body, such as head, face, 
chest, etc. (Baker, O'Neill et al. 1974).  Other injury severity scoring methods exist, some 
of which are applied specifically to intraoperative surgical complications (Bruce, Russell 
et al. 2001, Dindo, Demartines et al. 2004, Dekutoski, Norvell et al. 2010, Porembka, 
Hall et al. 2010).  
 The International Classification of Diseases (ICD) aims to identify, classify, and 
document mortality statistics.  Reported causes of death are translated into medical codes 
using the latest revision of the ICD, which to date would be the ICD-10 (CDC 2016).  
The ICD codes have been utilized for a variety of other purposes within the medical field, 
including the characterization of injury severity and the likelihood of death and 
medically-caused injuries.  Samore et al. compared detections methods for medical 
device-related hazards and adverse events in hospitalized patients (Samore, Evans et al. 
2004).  The use of ICD-9 codes was useful in the surveillance of adverse events due to 
the consistent application across various institutions, yet it was not adequate to serve as a 
surveillance standard (Samore, Evans et al. 2004).  While the ICD-9 codes appeared 
 30 
beneficial for surveillance of device-related adverse events that resulted in 
hospitalization, it was not as useful for the adverse events that took place during 
hospitalization.   
 The Government of New South Wales (NSW) in Australia utilizes Severity 
Assessment Codes (SACs) in the NSW Health Incident Management Process (NSW 
2014, Mitchell, Williamson et al. 2015).  This process outlines the required steps for each 
level of SAC for application to adverse clinical incidents in public hospitals.  The clinical 
incidents are defined as “any unplanned event which causes, or has the potential to cause, 
harm to a patient” and are reported to an Incident Information Management System 
(IIMS) (NSW 2014).  Clinical incidents are classified SACs, with SAC1 being the most 
serious and SAC4 being the least severe. 
 As defined by the National Cancer Institute (NCI), an adverse event is “any 
unfavorable and unintended sign (including an abnormal laboratory finding), symptom, 
or disease temporarily associated with the use of a medical treatment or procedure that 
may or may not be considered related to the medical treatment or procedure” (NIH 2003).  
NCI developed the Common Toxicity Criteria (CTC) system in 1983.  The CTC system 
went through various revisions, and the most recent version was developed in order to 
move away from the term “toxicity.”  The Common Terminology Criteria for Adverse 
Events v3.0 (CTCAE v3.0) emerged to fulfill this purpose and, upon release in 2003, 
represented the “first comprehensive, multimodality grading system to include both acute 
and later effects” (Trotti, Colevas et al. 2003). Implementation of such a system assists 
adverse event report standardization, comparison, and completion.  The CTCAE v3.0 is 
organized by organ system categories and incorporates a 1-5 point grading scale (NIH 
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2003). Grading refers to the severity of the adverse event, and the CTCAE v3.0 includes 
unique clinical descriptions for each severity. 
 Grading is specific to the adverse event depending on the category.  Applicable to 
this research are the following adverse event categories listed in the CTCAE v3.0: intra-
operative injury and hemorrhage/bleeding associate with surgery, intraoperative or 
postoperative.  The grading criteria for these categories are shown in Table 2. 
 
Table 2. CTCAE v3.0 category-specific grading (NIH 2003). 
Adverse 
Event 
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 A fourth version of the CTCAE was published in 2009 which modified various 
categories and grades that were provided in the third version.  The expansion of the 
grading descriptions is shown in Table 3.  Instrumental activities of daily living (ADL) 
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refer to preparing meals, shopping for groceries or clothes, using the telephone, managing 
money, etc. (NIH 2009).  Self-care ADL refer to bathing, dressing and undressing, 
feeding self, using the toilet, taking medication, and not bedridden.  The CTCAE versions 
have been commonly used in clinical trials to document toxic effects caused by cancer 
treatments (Liu, Zhu et al. 2012).  
 
Table 3. CTCAE v4.0 grading (NIH 2009). 
Grade Description 
1 Mild; asymptomatic or mild symptoms; clinical or diagnostic 
observations only; intervention not indicated. 
2 Moderate; minimal, local or noninvasive intervention indicated; 
limiting age-appropriate instrumental ADL. 
3 Severe or medically significant but not immediately life-threatening; 
hospitalization or prolongation of hospitalization indicated; disabling; 
limiting self-care ADL. 
4 Life-threatening consequences; urgent intervention indicated. 
5 Death related to AE. 
 
1.2.5.2 Limitations of Severity Grading Methods  
 Methods exist for both surveillance and severity grading of adverse events, yet 
many are not sufficient for the objectives of this research.  The Accordion Classification 
Grading System was developed for surgical complications encountered postoperatively 
versus intraoperative.  While the use of classification could be applicable to 
intraoperative complications, this may present threshold difficulties due to the range of 
possible events and variables in such situations (Strasberg, Linehan et al. 2009).  The 
ICD codes work well for the surveillance of medical device-related adverse events, 
particularly for those events that result in patient hospitalization.  However, it has been 
noted to be less useful for adverse events encountered during hospitalization, which is the 
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primary concern for investigating procedural adverse events (Samore, Evans et al. 2004).  
Further, the ICD surveillance system only allows broad classifications of adverse events 
by device type, whereas more specific classifications are desirable (Samore, Evans et al. 
2004).  The CTCAE grading method was deemed the most appropriate grading method 
for intraoperative and post-operative surgical complications associated with adverse 
events provided the descriptions listed for each grade.  Specifically, the CTCAE v4.0 
grading descriptions can be applied in order to assess the severity of adverse event 
outcomes associated with intraoperative minimally invasive surgical device use and 
postoperative outcomes. 
 
1.2.6 Functional Modeling 
   
The roots of flow-based functional modeling can be traced back to the field of 
Value Analysis (Rodenacker 1971, Miles 1972).  From these early representations of 
functions in Value Analysis, researchers have continued work to effectively and 
accurately describe functionality (Roth 1981, Koller 1985, Hundal 1990, Little, Wood et 
al. 1997, Szykman, Racz et al. 1999, Stone and Wood 2000, Hirtz, Stone et al. 2002, 
Pahl, Beitz et al. 2007).  In engineering design, a functional model is often a description 
of a product in terms of the elementary functions and flows that are required to achieve 
the product’s overall function or purpose.  A graphical form of a functional model is 
represented by a collection of sub-functions connected by the flows on which they 
operate (Kurfman, Stone et al. 2000).  The structure is a way for a designer to see what 
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type of functions are performed without being distracted by any particular form the 
system and components may take.    
Flow-based functional models stemming from the Pahl and Beitz methodology 
are perhaps the more common forms of functional models in engineering design (Pahl 
and Beitz 2013).  Models are generated at two levels of abstraction: a black box model 
and a sub-functional model. Black box functional models are stand-alone functional 
models abstracting a high-level transformation intended for the product to complete and 
are generated based on the system design requirements.  A functional model decomposes 
the overall functional black box into specific flow transformations.  Flow transformations 
define the operations required of the system such that the identified input flows become 
the identified output flows through the operation of the system.  Material flows are bold 
arrows; energy flows are thin arrows; and signals are dashed arrows.   
Stone et al. developed the general framework for functional modeling (Stone and 
Wood 2000) and Nagel et al. developed an algorithmic approach to teaching functionality 
(Nagel, Bohm et al. 2012).  The Nagel et al. approach uses a series of grammar rules to 
assemble function chains from a list of enumerated functions desired of the final product.  
Function chains are then aggregated into a complete functional model which represents a 
system or product. Creating a functional model consists of three primary steps; black box 
model, chains, and the aggregated functional model. Nagel et al. provide an example of a 
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black box model, chains, and an aggregated functional model shown in Figures 1, 2, and 
3, respectively (Nagel, Bohm et al. 2015). 
 
 




Figure 2. Functional modeling chains (Nagel, Bohm et al. 2015). 
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Figure 3. Functional model (Nagel, Bohm et al. 2015). 
 
 
1.2.7 Design Complexity 
 
1.2.7.1 Surgical Device Design Complexity  
 The design of surgical devices has evolved to include more than the basic 
mechanical mechanisms for creating a proper anastomosis.  Designing devices for 
surgical procedures presents many challenges and must address efficiency, accuracy, and 
ease of use.  Modularity should also be considered for surgical devices in particular due 
to the flexibility provided for product variations and technology development without 
requiring overall design changes (Hölttä and Otto 2005).  The evolution of both 
technology and user demands potentially affects the complexity of medical devices.  
Consideration of an objective measure of complexity aids systematic reduction of 
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unnecessary design elements and enables quantitative comparisons of design solutions 
(Ameri, Summers et al. 2008).  
Mitchell et al. conducted a study to examine non-fatal adverse clinical incidents 
through use of a human factors classification framework (Mitchell, Williamson et al. 
2015).  Casual factors for medication and medical device related adverse clinical 
incidents were identified.  Medical equipment breakage/failure was found to be the most 
common precursor event for medical device related incidents (46.0%), and 22.5% of 
medical device related incidents occurred intraoperatively (Mitchell, Williamson et al. 
2015).  Further, Mitchell et al. suggested that medical device failure or breakage can be 
an indication of design flaws, inadequate maintenance of devices, and lack of device 
examination before use (Mitchell, Williamson et al. 2015).  While the study assessed 
human factors related to a wide range of clinical incidents involving both medication and 
medical devices, it demonstrated the need to address design related aspects of medical 
devices.  Complexity of a device’s function and design is a factor that should be 
considered when addressing both user and device based failures and adverse event 
outcomes.   
 Complexity of a surgical device’s design has the potential to inhibit a user’s 
understanding of proper use and techniques for preventing failure; it could also impact 
proper device functionality.  Identifying specific ways by which the differences in design 
complexity of surgical devices influence the occurrence and severity of failure modes is 
necessary in order to prevent further complication by contributing to user and designer 
knowledge.  Assessment of these differences can be achieved through an investigation of 
the most utilized device brands within surgical device classes.  Quantifying complexity 
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allows the determination of optimal complexity levels, which, in turn, can maximize 
product performance.  Understanding the complexity of surgical devices potentially 
provides valuable insight into specific mechanisms of failure and a means to implement 
countermeasures against undesired outcomes in the surgical setting. 
 Complexity is defined in many ways, at different levels of abstraction, and at 
different stages of design (Braha and Maimon 1998, Maier and Rechtin 2000, Blackenfelt 
2001, Hölttä and Otto 2005, Summers and Shah 2010, Jacobs 2013), which render it 
highly contextual and subjective.  The issue of generality is frequently exhibited in 
literature when considering complexity because each methodology defines complexity to 
exist only within its realm of investigation.  Complexity may be necessary for product 
success in certain cases, though, traditionally is viewed as unfavorable.  It can also be 
viewed as a hindrance if unnecessary functions or attributes are added to a product.  Such 
unnecessary functions or attributes could lead to more involved design efforts, greater 
manufacturing or assembly work, and higher production costs.  Developing product 
requirements or customer needs is an effective way to explicate significant product 
functions and mitigate useless ones.   
 Various complexity assessment methods have been developed for one or more of 
the following: design problem, design process, and design product. In terms of the design 
product, complexity can be studied from structural, functional, and behavioral 
perspectives.  The measurement of information applies to the structural complexity, 
which is a function of the information content as represented, whereas the probability of 
successfully satisfying all design requirements applies to the functional complexity 
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(Ameri, Summers et al. 2008).  Understanding the functional complexity of a product can 
be beneficial in the early stages of design as an indicator of post design complexity.   
The ability to identify complex systems, sub-systems, and components allows 
design teams to consider less complex alternatives earlier in the design process.  As 
designers and managers seek to mitigate complexity, having early indicators are 
paramount to keeping project costs low.  Quantifying complexity allows the 
determination of optimal complexity levels, which, in turn, can maximize product 
performance.  When considering complexity in a product development domain, it is 
generally considered to have an adverse effect on product performance, quality, and 
manufacturability (ElMaraghy, ElMaraghy et al. 2012).  However, it is unclear exactly 
what complexity is and how it can be measured on a general scale. 
 
1.2.7.2 Generalized Complexity Index 
   Considering complexity is related to a product’s design variables, the Generalized 
Complexity Index (GCI) developed by Jacobs is a method suggested to be applicable to 
design products (Jacobs 2013).  The GCI requires scrutiny of three factors; 1.) 
multiplicity, 2.) diversity, and 3.) interconnectedness.  Multiplicity is defined as the 
number of variants or versions of a product or the number of suppliers if evaluating at the 
supply chain level (Closs, Jacobs et al. 2008, Bozarth, Warsing et al. 2009, Closs, Nyaga 
et al. 2010).  Diversity refers to the degree of dissimilarity seen across the elements and 
can be quantified by comparing the number of unique elements to the total number of 
elements within a system.  Interconnectedness is a ratio of the number of connections 
within a system and the total number of possible connections.  The degree of 
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interconnectedness can be illustrated and derived through the use of a Design Structure 
Matrix (DSM) (Otto 2001, Otto and Wood 2001, Hommes and Berry 2003, English and 
Bloebaum 2008, Pahl and Beitz 2013). For the GCI, Jacobs prescribes a simple 
mathematical formula to calculate complexity, and Table 4 provides an explanation of the 
variables.  The GCI is calculated using: 
 








Table 4. Description of variables in the generalized complexity index. 
Variable Description 
V Number of Variants 
U Number of unique elements 
T Total number of elements 
A Number of connections 
M 
Maximum number of 
connections 
 
 A DSM is a compact and visual representation of a system, project, or artifact in 
the form of a square matrix (Eppinger and Browning 2012).  DSMs have been used in 
aerospace, manufacturing, and software engineering industries as well as research and 
academia (Makins and Miller 2000, Ahmadi, Roemer et al. 2001, Sullivan, Griswold et 
al. 2001, Guenov and Barker 2005, Farid and McFarlane 2006, Lambe and Martins 
2012).  Example DSM applications are estimation of product development time, 
definition of complex system interactions, and determining system modularity 
(Carrascosa, Eppinger et al. 1998, Sullivan, Griswold et al. 2001, Eppinger and Browning 
2012).  DSMs are widely used because of their ease of readability even when mapping 
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becomes complex.  DSMs are constructed by listing system elements in a square matrix 
then noting the interactions between elements with a value.  Whole numbers, dots, or 
even probabilities are utilized to signify element interactions.  Previous investigation 
reveals that while the GCI may be suited for application to supply chains, it does not 
accurately represent the complexity of a product (Mountain, Bohm et al. 2016, Riggs, 
Bohm et al. 2016).  
 
1.2.7.3 Connectivity Algorithm 
  Ameri et al. investigated methods and measures of engineering design complexity 
(Ameri, Summers et al. 2008). In their research, the common aspects required for 
complexity measures in design were identified as size, coupling between two elements, 
and solvability.  Size refers to numerous elemental counts including functional 
requirements, constraints applied, number of design variables, etc. Complexity as 
coupling is represented as the degree of decomposability of the bipartite entity-
relationship graph corresponding to the representation of interest, whether design 
problem, product, or process (Ameri, Summers et al. 2008, Summers and Shah 2010).  
The solvability refers to whether the design product may be predicted to satisfy the 
design problem.  Ameri et al. proposed and validated measures via a set of experiments; 
size and coupling complexities of consumer products were studied based on a function 
structure, connectivity graph, and parametric associativity graph (Ameri, Summers et al. 
2008).  Sizing and coupling were concluded to be independent entities and coupling 
complexity is less dependent on representation than size complexity (Ameri, Summers et 
al. 2008).     
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 Coupling complexity accounts for a measure derived from the connections 
between variables at multiple levels represented in a graph-based format (Summers and 
Shah 2010).  A connectivity algorithm has been proposed in the literature to measure the 
connectivity of an entity-relationship graph via removal of relationships between entities 
until the graph is decomposed into individual entities (Ameri, Summers et al. 2008).  
Graphs are repeatedly separated into sub-graphs until single nodes remain.  Adopted from 
a study by Ameri et al., Table 5 outlines the connectivity complexity algorithm (Ameri, 
Summers et al. 2008).  Once the algorithm has been applied, a decomposability score 
results, which measures how difficult it is to take the product or system apart piece by 
piece.  Complexity increases with the more steps, relationship sets, or relationships per 
separated element that are required to decompose the product or system entirely.  
 
Table 5. Connectivity algorithm (Ameri, Summers et al. 2008).  
Connectivity Algorithm 
1. Eliminate Unary Relations 
2. Initialize values: level = 1; total = 0; 
3. For each graph to be searched 
a) Initialize set size = 1 
b) For all combinations of relations in a set size 
i. Remove set size relations from graph 
ii. Check for separation 
iii. If separated graphs, mark the relation set removed 
c) If no relation set removed, increment set size and return to 3b 
d) For all relations sets marked, find the combination of sets that remove the 
most relations without duplicate removal (number of sets) 
e) Calculate score: level * set level * number of sets + total 
f) Submit each distinct graph to 3 
 
 The connectivity algorithm may be appropriately applied using the following 
graph-based formats: bipartite product representations derived from function structures, 
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connectivity graphs, parametric associativity graphs, or DSMs.  The level of 
interconnectedness of functions in a product is revealed within the function structure, 
whereas the existence and type of component connections within a product are well 
represented by connectivity graphs (Summers and Shah 2010).  A bipartite graph should 
be used first for the algorithm to represent a product considering that fundamentally the 
coupling complexity is a measure of the level of a product’s decomposability (Mohinder, 
Gill et al. 2016).  Conversely, a parametric associativity graph narrows in on the manner 
in which components are connected together through their parameters, for example, 
component material and geometric dimensions.  Utilizing the algorithm for various 
representations provides different views, indicating the importance of consistent graph 




While there are numerous studies aimed at improving surgeons understanding of 
surgical devices via implementing education tools (McColl, Karmali et al. 2009, 
Feldman, Brunt et al. 2013, Madani, Watanabe et al. 2014), little to no research has been 
carried out that assists engineers in early identification of specific design variables that 
are potentially detrimental to the device’s or user’s performance in the surgical setting.  A 
multidisciplinary approach to MIS is required in order to implement improved systems, 
methods, tools, and instruction in order to mitigate errors and prevent patient harm 
(Cuschieri 2006).  The specific aims carried out in support of the overall research goal 
provide users and manufacturers with insight regarding the phases of operation and 
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mechanisms responsible for the failures related to surgical devices.  The outcomes of 
reports retrieved from the FDA MAUDE database were examined in conjunction with a 
complexity assessment for specific classes of surgical devices to investigate the effect of 
a device complexity assessment on the severity of adverse event outcomes.  A universally 
accepted complexity score has not yet been developed; however, by applying the existing 
connectivity algorithm to surgical devices, a comparative complexity measure can be 
determined and utilized.   
Investigation of minimally invasive surgical device failure modes via query of the 
FDA’s MAUDE has been deemed valuable to trainee and experienced physicians (Deng, 
Meng et al. 2002, Brown and Woo 2004, Fuller, Ashar et al. 2005, Mansour, El-Nashar et 
al. 2014, Overbey, Townsend et al. 2015), while a complexity assessment aids designers 
in objective and quantifiable comparisons of design optimization, alternative design 
solutions, and cost estimation (Ameri, Summers et al. 2008). Given the existing evidence 
showing that many surgeons are not aware of the tissue handling characteristics and 
limitations of new or reengineered devices is reason for concern; such a knowledge gap 
can compromise patient safety (Mery, Shafi et al. 2008, Feldman, Fuchshuber et al. 2012, 
Feldman, Brunt et al. 2013, Chekan and Whelan 2014, Overbey, Townsend et al. 2015, 
Madani, Watanabe et al. 2016, Madani, Watanabe et al. 2016).  By investigating devices 
that utilize available and advancing technologies from various manufacturers, this 
research examined a broad range of operationally diverse classes of surgical devices.  As 
a result, the approach presented is applicable to an array of surgical practices and 
contributes knowledge and awareness to a widespread audience that encompasses users 
and designers.  Thorough and on-going investigation into device complexity and adverse 
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event outcomes is essential to ensuring patient safety and preventing serious injury and 
death.  The research contributions herein supplement efforts to bridge the gap between 
surgeons and engineers to ensure the successful implementation and evaluation of new 





SURGICAL DEVICE FAILURE MODES 
 
2.1 Failure Mode Study Overview 
 
The use of endoscopic staplers and energy-based tissue sealers is increasing along 
with their application to more wide-ranging procedures due to design and procedural 
evolution.  Enhanced features and safety of surgical devices encourages such increases in 
use and application; therefore, it is necessary to characterize the nature and frequency of 
the failures associated with these devices so as to better understand the mechanisms of 
failure.  The approach presented contributes to user and designer knowledge allowing for 
potential improvements as devices and surgical procedures advance.  This chapter 
addresses Specific Aim 1, which was to describe the types of failure modes shown to be 
associated with endoscopic staplers and energy-based tissue sealers used in MIS based on 
reported adverse events.  
The FDA MAUDE database was queried for product codes and terms specific to 
the devices of interest.  A random sample of reports was utilized in determining the types 
and frequencies of failure modes associated with each device.  The failure modes were 
grouped by phase of device operation.  The literature reveals that user error is said to 
account for the majority of failure as discussed in Section 1.2.4; however, device-based 
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failures are also prevalent and important to identify (Deng, Meng et al. 2002).  Therefore, 
recalls associated with each device were also retrieved as another means to identify the 
presence of device related issues.   The data reported reveals prevalence of both user and 
device-based errors, which further supports an investigation into adverse events from 
both a clinical and design perspective.  
 
2.2 Failure Mode Study Methods 
 
2.2.1 FDA Database Query 
 
   The FDA MAUDE database classifies reports using the following event types: 
malfunction, injury, and death.  The FDA defines an adverse event as “any undesirable 
experience associated with the use of a medical product in a patient” (FDA 2016).  An 
adverse event has also been defined as “any unfavorable and unintended sign (including 
abnormal laboratory finding), symptom, or disease temporally associated with the use of 
a medical treatment or procedure that may or may not be considered related to the 
medical treatment or procedure”.   These definitions were utilized, and an adverse event 
was considered to be an undesirable and unintended outcome as the result of a procedure 
involving a surgical device that specifically resulted in an injury or morbid outcome.  
Therefore, the events categorized as a death and injury by the reporting facility in the 
FDA database were retrieved for analysis while reports involving a malfunction event 
type were excluded.   
 
 48 
2.2.1.1 Endoscopic Stapler FDA Database Query 
Reports involving endoscopic staplers were retrieved from the FDA MAUDE 
database between January 1, 2006 and January 1, 2016 under the product codes listed in 
Table 6.  
 
Table 6.  FDA product code search for endoscopic staplers. 
Product Code Device 
GAG Stapler, surgical 
GDW Staple, implantable 
 
 The inquiry was optimized by searching for the following manufacturer and brand 
names of interest: ETS manufactured by Ethicon Endo-Surgery Inc. and the Endo GIA 
manufactured by Covidien Ltd.  Ethicon is a subsidiary of Johnson & Johnson.  The 
specific device of interest manufactured by Ethicon is classified as an Endocutter, which 
is a class of products in the surgery franchise that attributed to its market growth in 2015 
(JnJ 2016).  Due to the various transfers of ownership of the Endo GIA stapler, the device 
was also listed under US Surgical, Tyco Healthcare, and AutoSuture; therefore only the 
brand name Endo GIA was utilized for report retrieval.  The reports were downloaded 
from the FDA website and filtered in Excel for relevant terms that indicated an adverse 
event associated with the endoscopic staplers of interest.   
 
2.2.1.2 Energy-Based Tissue Sealer FDA Database Query 
 The FDA MAUDE database was queried for the target energy-based devices 
which are identified as laparoscopic tissue sealers that utilize either ultrasonic 
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technology, bipolar technology, or both.    The product codes to be included in the search 
are shown in Table 7. 
 
Table 7.  FDA product code search for bipolar and ultrasonic devices. 
Product Code Device 
GEI 
Electrosurgical, cutting & 
coagulation & accessories 
LFL Instrument, ultrasonic surgical 
  
The choice of product codes utilized in this research was driven by a query of the 
MAUDE for electrosurgical cutting and coagulation devices and accessories by Overbey 
et al. (Overbey, Townsend et al. 2015).  Their query revealed that 87% of the reports 
were classified under GEI, 10% were reported under LFL, and 3% were reported under 
the remaining product codes in the category.  The keywords used for the search under 
these product codes include the most utilized vessel sealing technologies in the field 
(Lyons and Law 2013).  The companies involved in the manufacture of such devices 
includes, but is not limited to, Covidien Ltd. (Medtronic), Ethicon Endo-Surgery, and 
Olympus.  Covidien manufactures a vessel sealer and divider known under the brand 
LigaSureTM and an ultrasonic device under the brand Sonicision.  Ethicon manufactures 
both an advanced bipolar tissue sealer and an ultrasonic device branded under the names 
Enseal® and Harmonic Ace®, respectively.  Olympus currently supplies the 
Thunderbeat, the world’s first and only full-integrated bipolar and ultrasonic technology 
for tissue management to date (Olympus 2012, Obonna and Mishra 2014).   
The energy-based tissue sealers retrieved for this analysis were the Thunderbeat 
manufactured by Olympus and the Harmonic Ace manufactured by Ethicon Endo-
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Surgery, Inc.  Reports for the Ethicon Harmonic Ace were retrieved from the FDA’s 
MAUDE database between January 1, 2006 and January 1, 2016.  Due to the relatively 
recent release date of the Olympus Thunderbeat, the entire sample of reports involving 
death and injury related to the Thunderbeat was retrieved up to what was available in the 
database on April 19th, 2017.   
 
2.2.1.3 Failure Mode Study Sample 
Table 8 shows the number of adverse event reports (death and injury) retrieved 
from the FDA database for each device of interest.   
 
Table 8.  Number of death and injury reports downloaded from MAUDE database. 
Device No. Death Reports No. Injury Reports 
Ethicon ETS 32 647 
Covidien Endo GIA 38 2039 
Ethicon Harmonic Ace 10 280 
Olympus Thunderbeat 8 77 
 
Reports with event descriptions that did not provide sufficient explanation of the 
adverse event were excluded from the random sample analysis.  In addition, irrelevant 
device reports, duplicate reports, and reports with unspecified event types were excluded 
from the overall analysis.   Sample size was chosen according to the rule-of-thumb for 
regression and correlations and verified using GPower (Green 1991, Voorhis and Morgan 
2007, Austin and Steyerberg 2015).  All reports were selected at random, and a 
proportionate number of death and injury reports relative to the total number were 
selected to attain 100 cases for each device.  The reports were sorted from smallest to 
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largest based on a random number generated for each report using Excel.  The sample 
included the total population of Thunderbeat reports and 100 reports associated with each 
of the remaining devices.  The final sample is shown in Table 9. 
 







Ethicon ETS 5 95 100 
Covidien Endo GIA 2 98 100 
Ethicon Harmonic Ace 3 97 100 
Olympus Thunderbeat 8 75 83 
 
2.2.2 Failure Mode Study Data Analysis 
 
 
2.2.2.1 Failure Mode Data Analysis 
Failure modes and the phase in which failure occurred were identified for each 
adverse event report.  Endoscopic stapler user and anatomical failure modes have been 
identified in the literature (Deng, Meng et al. 2002, Brown and Woo 2004, Mery, Shafi et 
al. 2008, Robert, Poncet et al. 2011, Kwazneski, Six et al. 2012) and has been expanded 
upon through analysis of the adverse event reports retrieved (Riggs, Bohm et al. 2016).  
The user and device-based failure mode taxonomy associated with laparoscopic vessel 
sealing technology from the literature review was applied (Tucker and Voyles 1995, Hay 
2005, Massarweh, Cosgriff et al. 2006, Wang and Advincula 2007, Gallagher, Dhinsa et 
al. , Alkatout, Schollmeyer et al. 2012, Lyons and Law 2013, Overbey, Townsend et al. 
2015).  It should be noted that in some cases when a failure mode was not explicitly 
stated, the failure mode was inferred based on the context provided in the event 
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description and manufacturer narrative.  Manufacturer narrative excerpts were included 
in the results to denote the type of content and inferences that can be acquired. 
The majority of anatomical and user errors were derived from the reporting 
facility’s narrative while the mechanical and electrical device-based failures were 
typically stated more explicitly in the manufacturer narrative of the event description 
within the reports.  In general, the number of reporting facility and user narratives 
outweigh the appearances of manufacturer narratives (Riggs, Bohm et al. 2016).  In many 
cases this unbalance was due to device disposal after use and failure of the user facility to 
return device to the manufacturer. 
All failure modes described within an event description were accounted for; 
therefore, the potential for more than one failure mode recorded for a single report was 
possible.  The number of reports with such occurrences was stated. 
The frequency of failure modes was specified for each device.  Failure modes 
were grouped by the phase of operation in which failure occurred.  The phases of 
operation were identified based on the description of the adverse event in the reports.  
The phases of operation associated with tissue sealing devices included transition, 
activation, and post-op.  The phases of operation associated with endoscopic staplers 
included reload, articulation, application, firing, cutting, removal, and staple line.  
Proportions were determined per failure mode relative to the total number of failure 
modes identified per device.  A proportion of the number of failure modes that occurred 
in each phase of operation was also reported.  The proportions were determined relative 
to the total number of failure modes per device versus the total sample per device because 
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some reports involved more than one failure mode.  Proportion percentages were reported 
to the nearest tenth decimal place. 
 
2.2.2.2 Medical Device Recalls  
Recalls associated with each device were retrieved from the FDA’s Medical 
Device Recall database as another means to identify the presence of device related issues.  
The brand names were used in the recall query for all devices.  Recall reports were 
organized by date, recall number, quantity in commerce, manufacturer reason for recall, 
and FDA determined cause.  Consistencies in the reasons for recalls and device failures 
resulting in adverse events were identified for each device.  
 
2.3 Failure Mode Study Results 
 
2.3.1 Manufacturer Narrative Excerpts 
 
The following excerpts were taken directly from manufacturer narratives within 
adverse event reports that resulted in an injury (FDA 2017): 
 
Manufacturer Narrative – Ethicon ETS 
“Evaluation summary: the analysis results found that the device was received 
with the firing mechanism damaged and with a cartridge loaded in the device. The 
cartridge was received fully loaded with staples. No functional test could be performed 
with the device. The device was disassembled to verify the condition of the internal 
components and the firing trigger teeth were found broken. The returned cartridge was 
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loaded into a test device and it fired, cut and formed all the staples as intended. Although 
no conclusion could be reached on how the device got damaged, it is possible that the 
device was fired on thicker tissue then intended causing the device to fail. It should be 
noted that at least a 100% inspection takes place during manufacturing to ensure the 
device meets the require specifications; in addition, a sample of the batch is inspected at 
fgqa. The manufacturing records were reviewed and no anomalies were found during the 
manufacturing process.” 
 
Manufacturer Narrative – Ethicon Harmonic Ace 
“Should the information be provided later, a supplemental medwatch will be sent. 
The device was returned with the distal tip of the blade broken off and returned with the 
device. The remaining blade portion was scratched. The device was activated with the 
generator and an error code 5 was displayed. Probable causes of blade damage, 
including breakage, are external contact during pre-op or general use, blade contact 
with other devices, staples or clips during the procedure or using any means other than 
the blade wrench to attach or detach the blade. Once minor blade damage has occurred, 
subsequent activations may increase damage severity and result in an error code 5 or 
blade "lockout" later in the procedure, and continued usage can result in a broken 
blade.” 
 
Manufacturer Narrative – Olympus Thunderbeat 
“Since the subject device was discarded by the user, the device was not returned 
to olympus medical systems corp. (omsc), therefore omsc could not evaluate the 
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referenced device. Since the manufacture record of the subject device was unknown, the 
manufacture record that dated back the past six months from the delivery date to the user 
was reviewed, with no irregularities noted. Omsc could not determine the root cause 
conclusively. Based on the characteristic of the device, it is known that the temperature of 
the distal end of the device is high after activation and it caused thermal damage by 
contacting the device with the tissue. The instruction manual of the device already 
cautions; the grasping section and probe tip become hot due to extended ultrasonic 
output. Do not let it come in contact with tissues other than the target tissue.” 
 
The examples demonstrate the importance of medical device reporting and the 
subsequent user and manufacturer follow up given the type of information that the 
manufacturer narratives provide.    
 
2.3.2 Endoscopic Stapler Failure Modes and Recalls 
 
The types, frequency, and proportion of failure modes for the Ethicon ETS and 
Covidien Endo GIA staplers are shown in Tables 10 and 11, respectively.  The frequency 
and proportion of failure modes per each phase of operation in which the failure occurred 






Table 10.  Endoscopic stapler phases and failure modes for ETS (n=111 failures derived 








Reload 10 (9.0%) 
Reload fell out of or off of device 7 (6.3%) 
Reload malfunction 3 (2.7%) 
Articulation 2 (1.8%) Articulation malfunction 2 (1.8%) 
Application 2 (1.8%) Failure to open/close for application on tissue 2 (1.8%) 
Firing 60 (54.1%) 
Malformed staples/Failure to form staples 17 (15.3%) 
Failure to fire (at all/completely/properly) 9 (8.1%) 
General misfire (nonspecific) 14 (12.6%) 
Failure to deploy staples (at all/on both sides) 20 (18%) 
Cutting 3 (2.7%) 
Unintentionally nicked tissue 0 (0.0%) 
Failure to cut (at all/completely/properly) 3 (2.7%) 
Removal 21 (18.9%) 
Failure to release 20 (18.0%) 
Difficult release 1 (0.9%) 
Staple line 13 (11.7%) 
Staple line failure 6 (5.4%) 









Table 11.  Endoscopic stapler phases and failure modes for the Endo GIA (n=113 failures 








Reload 6 (5.3%) 
Reload fell out of or off of device 3 (2.7%) 
Reload malfunction 3 (2.7%) 
Articulation 0 (0.0%) Articulation malfunction 0 (0.0%) 
Application 4 (3.5%) Failure to open/close for application on tissue 4 (3.5%) 
Firing 58 (51.3%) 
Malformed staples/Failure to form staples 30 (26.5%) 
Failure to fire (at all/completely/properly) 11 (9.7%) 
General misfire (nonspecific) 5 (4.4%) 
Failure to deploy staples (at all/on both sides) 12 (10.6%) 
Cutting 6 (5.3%) 
Unintentionally nicked tissue 2 (1.8%) 
Failure to cut (at all/completely/properly) 4 (3.5%) 
Removal 23 (20.4%) 
Failure to release 22 (19.5%) 
Difficult release 1 (0.9%) 
Staple line 16 (14.2%) 
Staple line failure 6 (5.3%) 
Staple line leak post-op 10 (8.8%) 
 
 The number of reports for the ETS and Endo GIA staplers that involved more 
than one failure mode was 11 and 13, respectively.  It should be noted that a multitude of 
events that reported firing phase issues also reported issues with removal for the same 





Figure 4.  Proportion of failures per phase and device brand (ETS n=113, Endo GIA 
n=111). 
 
The recalls associated with the Ethicon ETS stapler during the study period are 





























Table 12.  Ethicon ETS recalls. 
Date Posted Recall No. 
Quantity in 
Commerce 






Quality control identified a 
component issue where the pinion 
gear in the device could fail under 
extreme use cases. If this condition 
occurs, staples will be formed past 
the cut line and the device can be 
opened and removed from the 
patient. The firing stroke may be 
interrupted and the knife may not 
fully return to the home position 
potentially exposing the healthcare 




Jul-24-2015 Z-2229-2015 3 
EXP did not register as a medical 
device establishment, list the 
devices being recalled, or establish 
its own quality system and instead 
relied on the fact that its vendors 
were registered and had their own 
quality systems. 
Other 
Sep-12-2011 Z-3187-2011 27,582 
Ethicon Endo-Surgery initiated a 
voluntary global recall for specific 
production lots of ENDOPATH 
ETS Compact Flex 45mm 
articulating linear cutters because 
the possibility exists that damage to 
the blister pack may have 






The mechanism that connects the 
articulation joint to the device shaft 
may cause the jaws of the cutters to 
remain closed and clamped down on 
tissue after the device is fired. If the 
jaws of the device remain clamped 
down on the tissue, there is a risk 
the surgery will need to be modified 
to remove the device. This may lead 
to an increase in procedure time, 






A defective articulation band may 
result in improper staple formation 






The recalls associated with Endo GIA reloads and handles during the study period 
are shown in Table 13. The recalls associated with both endoscopic staplers were 
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classified as Class II, which the FDA defines as a “situation in which use of or exposure 
to a violative product may cause temporary or medically reversible adverse health 
consequences or where the probability of serious adverse health consequences is remote” 





















Table 13.  Covidien Endo GIA recalls. 
Date Posted Recall No. 
Quantity in 
Commerce 






Z-0819-2016 364,768 Staplers fail to fire or 
partially fire and reports of 
the instrument articulating 





Z-0822-2016 2,711 kits 
Apr-05-2013 Z-1063-2013 6,751 
Single Use Loading Unit 
contained two staples 
loaded in each cartridge 
pocket and may result in 
difficulty firing and 
removing the device from 
the application site, which 





Duet TRS may have the 
potential to injure adjacent 
anatomical structures which 











Mar-19-2012 Z-1227-2012 1,158 
Missing component results 




Duet TRS Straight and 
Articulating Single Use 
(SULU) Loading Staplers 
used in thoracic surgery 














Sterility of the device is 
compromised due to a 












2.3.3 Energy-Based Tissue Sealer Failure Modes and Recalls 
 
The types, frequency, and proportion of failure modes for the Olympus 
Thunderbeat and Ethicon Harmonic Ace tissue sealers are shown in Tables 14 and 15, 
respectively.  The frequency and proportion of failure modes per each phase of operation 
in which the failure occurred is also listed in the tables.  
 
Table 14.  Tissue sealer phases and failure modes for the Olympus Thunderbeat (n=81 





Failure Mode Frequency 
(Proportions) 
Activation 36 (44.4%) 
Unspecific error resulting in bleeding 1 (1.2%) 
Broken device - blade or probe 11 (13.6%) 
Broken device - tissue pad 7 (8.6%) 
Failure to seal/failure to seal properly 6 (7.4%) 
Direct application 7 (8.6%) 
Thermal spread 2 (2.5%) 
Insulation Failure 2 (2.5%) 
Transition  30 (37.0%) 
Residual heat 23 (28.4%) 
Broken device – blade or probe 1 (1.2%) 
Broken device – tissue pad 0 (0.0%) 
Inadvertent application 5 (6.2%) 
Installation error; electric shock 1 (1.2%) 
Post-op 15 (18.5%) 
Seal failure with bleeding/leakage 15 (18.5%) 
Tissue injury detected after device use 0 (0.0%) 
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Table 15.  Tissue sealer phases and failure modes for the Ethicon Harmonic Ace (n=102 
failures derived from 100 reports). 
 
The activation phase consists of intentional grasping, cutting, and/or sealing of 
tissue.  The transition phase refers to device preparation, insertion, removal, and internal 
and external transitions during surgery.  Post-op refers to failures that occur after the 
surgery has been completed.  Two Thunderbeat reports did not contain sufficient 
descriptions to identify the specific failure modes; though, it was inferred that both 
occurred post-op.   Two Harmonic reports contained more than one type of failure mode.   
The proportion of failures for each phase is shown per device in Figure 5. 
Phase Frequency 
(Proportions) 
Failure Mode Frequency 
(Proportions) 
Activation 47 (46.1%) 
Unspecific error resulting in bleeding 4 (3.9%) 
Broken device - blade or probe 10 (9.8%) 
Broken device - tissue pad 14 (13.7%) 
Failure to seal/failure to seal properly 16 (15.7%) 
Direct application 3 (2.9%) 
Thermal spread 0 (0.0%) 
Insulation Failure 0 (0.0%) 
Transition  24 (23.5%) 
Residual heat 16 (15.7%) 
Broken device – blade or probe 3 (2.9%) 
Broken device – tissue pad 4 (3.9%) 
Inadvertent application 1 (1.0%) 
Installation error; electric shock 0 (0.0%) 
Post-op 31 (30.4%) 
Seal failure with bleeding/leakage 29 (28.4%) 
Tissue injury detected after device use 2 (2.0%) 
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Figure 5.  Proportion of failures per phase and device brand (Thunderbeat n=81, 
Harmonic n=102). 
 
The recall associated with the Olympus Thunderbeat during the study period are 


































Table 16.  Olympus Thunderbeat recall. 








Dec-05-2013 Z-0432-2014 8,709 
Complaints of damage to 





breaking, or deformation 
of the components of the 
probe tip or jaw. 
Use error 
 
The recalls associated with the Ethicon Harmonic Ace tissue sealer during the study 
period are shown in Table 17. 
 
Table 17.  Ethicon Harmonic Ace recalls. 
Date Posted Recall No. 
Quantity in 
Commerce 





Nov-16-2015 Z-0278-2016 441,490 
Complaints of holes in 
Tyvek which can 
compromise the sterile 






12,467 - both sizes 
 
Internal labeling review 
found that the [Instructions 
for Use] IFU for the 
Harmonic Ace incorrectly 
instructs the user on how to 




12,467 - both sizes 
 
July-01-2013 Z-1644-2013 3 
The seal which maintains a 
sterile barrier for 
reprocessed medical devices 
became compromised to the 
point where product may 




The recalls associated with both tissue sealers were classified as Class II.   
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2.4 Failure Mode Study Discussion 
 
The objective of Specific Aim 1 was to describe the types of failure modes shown 
to be associated with endoscopic staplers and energy-based tissues sealing devices used 
in MIS based on reported adverse events.  The proportions of failure modes and phases in 
which failure occurred were calculated relative to the total number of failures identified 
per each device.    
 
2.4.1 Endoscopic Stapler Failure Mode Discussion 
 
The phases in which failure occurred most frequently were firing (ETS – 54.1%, 
Endo GIA – 51.3%), removal (ETS – 18.9%, Endo GIA – 20.4%), and staple line (ETS – 
11.7%, Endo GIA – 14.2%).  Failures associated with the endoscopic staplers occurred 
most frequently during the firing phase.  Within the firing phase, the most common 
failure modes associated with endoscopic staplers were the failure to deploy staples at all 
or on both sides (ETS – 18.0%, Endo GIA – 10.6%) and malformed staples or the failure 
to form staples (ETS – 15.3%, Endo GIA – 26.5%).  Of the failures during firing, the 
Endo GIA resulted in more malformed staples or failure to form staples compared to the 
ETS, while the ETS resulted in more failures to deploy staples at all or on both sides of 
tissue.  Overall, malformed staples or a failure to form staples contributed to the most 
adverse events occurring during firing.  The most common failure mode within the 
removal phase was the failure of the device to release from tissue after firing.  18.0% of 
Ethicon ETS and 19.5% of Covidien Endo GIA failures involved the failure to release.  
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Issues encountered with the staple line involved staple line failure (ETS – 5.4%, Endo 
GIA – 5.3%) and staple line leaks post-op (ETS – 6.3%, Endo GIA – 8.8%).   
The most common phases in which failure occurred and the most common 
failures modes within each phase identified in this study were consistent with those 
recognized throughout the scientific literature (Deng, Meng et al. 2002, Champion and 
Williams 2003, Hamilton, Sims et al. 2003, Marshall, Srivastava et al. 2003, Brown and 
Woo 2004, Hassouna and Manikandan 2012, Mansour, El-Nashar et al. 2014).  Brown 
and Woo reviewed 112 FDA MAUDE death reports in their investigation of fatalities 
associated with surgical staplers.  The authors found the failure to fire properly, ruptured 
staple lines, and failure to form staples to be the most common types of stapler issues that 
resulted in fatalities (Brown and Woo 2004).  Deng et al. reviewed approximately 460 
urologic laparoscopic cases in order to characterize the problems with linear cutting 
staplers and concluded that the most common and morbid aspects of stapling device 
failure were abnormal firing of the stapler and improper staple formation (malformed 
staples) (Deng, Meng et al. 2002).  An investigation into Endo-GIA malfunctions during 
laparoscopic nephrectomy that were reported to the FDA MAUDE database showed the 
most common mechanisms of failure involved malformed or leaking staple line after 
firing and failure of the device to release from tissue (Mansour, El-Nashar et al. 2014).  
Similarly, the two most common mechanisms of endoscopic stapler failure during 
laparoscopic renal surgery were determined to be inadequate staple lines and failure to 
release from tissue, which resulted in a high percentage of severe hemorrhage and 
conversions to open surgery (Hassouna and Manikandan 2012).  Outcomes of gastric 
bypass surgery have shown staple line failures and anastomotic leaks to be a major cause 
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of patient morbidity and death (Champion and Williams 2003, Hamilton, Sims et al. 
2003, Marshall, Srivastava et al. 2003).  While the most common types of endoscopic 
failure were shown to vary per procedural application in the reviews discussed, the 
phases of operation in which failure most frequently occurred were consistent with the 
top three identified in this study: firing, removal, and staple line. 
The ETS stapler was associated with the most reload failures (9.0%), some of 
which the reload fell completely out of the device and into the patient (6.3%).  This type 
of failure can lead to serious consequences such as the cutting of tissue without 
simultaneous deployment of staples, which was reported with user experience during 
laparoscopic Roux-en-Y gastric bypass (Champion and Williams 2003).  Despite 
similarity in the specific function executed, variations in failure frequency between the 
devices are potentially due to the differences in reloading mechanisms inherent to each 
device’s design. The ETS stapler is supplied as a full stapler that requires insertion of 
individual reloads, also referred to as cartridges, into the elongate channel.  After the ETS 
stapler is fired, it requires a new reload in order to be used again in the same procedure.  
The reload is inserted into place via a snap fit type of mechanism.  The Endo GIA also 
involves two separate components, yet it is supplied as a handle with a shaft portion that 
connects to a separate reload portion via an interlocking mechanism.  Replacing an Endo 
GIA reload provides new jaws, distal articulation components, and knife for the next fire 
during the same procedure.  These differences are discussed further in Section 4.3.1. 
Endoscopic staplers resulted in more reports that involved failure in two phases 
relative to tissue sealers.  It should be noted that a multitude of events that reported firing 
phase issues also reported issues with removal for the same device incident (n=7).  Such a 
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trend suggests that the failures associated with the firing sequence, whether device or user 
related, may result in a failure during removal.  Removal was the second most common 
phase of operation in which failure occurred and consisted mainly of stapler failure to 
release from tissue after firing.  When a device fails to release, the surgeon must deploy 
unfavorable tactics, which includes manually cutting adjacent tissue or creating another 
port for application of another stapling device in order to remove the malfunctioning 
device (Kwazneski, Six et al. 2012).  Kwazneki II et al. found that of the 44 minimally 
invasive program directors that completed their survery, 66% of survey participants 
experienced an incident where a linear stapler would not release after application, 25% of 
survey participants noted having to significantly alter the planned procedure due to a 
device failure, and 30% of survey participants stated that they did not receive useful 
feedback from the manufacturer despite making contact (Kwazneski, Six et al. 2012). 
In a 2004 review of surgical stapler-associated fatalities and adverse events 
reported to the FDA, it was found that similar failures identified in the death reports were 
also responsible for the majority of adverse events that did not  result in a death (i.e. 
injury and malfunctions) (Brown and Woo 2004).  Such a finding suggests that if device 
malfunctions are either prevented or handled properly when they occur then, as a result, 
death and injuries can be prevented.  The final outcome, whether injury or death, can 
relate back to a user’s familiarity with device performance and failure in addition to their 
response to an adverse event (Mansour, El-Nashar et al. 2014).  Specifically, the methods 
deployed in reaction to a failure may affect whether or not a malfunction causes an injury 
or death.  Also, preventative techniques play an important role in the severity of 
outcomes of adverse events (Baker, Foote et al. 2004, Fuller, Paull et al. 2014, Mansour, 
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El-Nashar et al. 2014), which is emphasized further in the assessment of failure mode 
outcome severity in Chapter II.  
Determining whether an endoscopic staler failure is user or device related is 
difficult and cannot always be derived from the report event descriptions.  Consider the 
failure mode involving the failure of the device to properly form staples.  Malformed 
staples can result from improper contact of the unformed staples with the anvil pockets.  
Specifically, Chekan and Whelan list tissue and staple related causes of malformed 
staples as they relate to the staple legs (Chekan and Whelan 2014).  The tissue 
characteristics affecting the formation of staples include tissue thickness and viscosity, 
while the staple properties include the staple thickness, height, bending characteristics, 
and type of metal (Chekan and Whelan 2014).  Additionally, firing over clips, or a similar 
obstruction, can result in malformed staples, a failure to form staples, and/or the failure of 
a device to release from tissue after firing (Mansour, El-Nashar et al. 2014, Riggs, Bohm 
et al. 2016).  While this is specific to a user error, instances involving firing over a clip 
may not be adequately described (i.e. presence of the clip was not included in the adverse 
event report).  The device could also cause malformed staples due to a manufacturing 
defect, such as stapler misalignment (Fuller, Paull et al. 2014).  Typically, the event 
descriptions within the FDA MAUDE database reports are not specific enough to identify 
the root cause of failure mode that results in an adverse event outcome.      
Recalls involving the endoscopic staplers were retrieved over a period ranging 
from 2003 to 2016.  A total of 36 recall numbers were retrieved in the search, of which 
30 were related to the Covidien Endo GIA and 6 were related to the Ethicon ETS.  Of the 
five manufacturer reasons for recall associated with the Ethicon ETS stapler recalls, three 
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are consistent with adverse event outcomes.  The recall reason that states “the mechanism 
that connects the articulation joint to the device shaft may cause the jaws of the cutters to 
remain closed and clamped down on tissue after the device is fired; if the jaws of the 
device remain clamped down on tissue, there is a risk that the surgery will need to be 
modified to remove the device; this may lead to an increase in procedure time, tissue 
manipulation, and a change in t…” accounted for one recall (Z-0361-2011) and a total 
quantity in commerce of 4,113.  This recall reason was consistent with the failure of the 
device to release from tissue after it is fired as identified in this study.  The recall reason 
stating “a defective articulation band may result in improper staple formation with 
possible hematosis” accounted for one recall (Z-0212-04) and a total quantity in 
commerce of 16,962.  This recall reason was consistent with the following failure modes 
identified: articulation malfunction, malformed staples, and failure to form staples. 
One recall associated with the Ethicon ETS stapler did not relate to a specific 
failure mode identified herein but demonstrated the potential for device related issues to 
cause adverse event outcomes.  The recall reason stating “quality control identified a 
component issue where the pinion gear of the device could fail under extreme use cases; 
if this condition occurs, staples can be formed past the cut line and the device can be 
opened and removed from the patient; the firing stroke may be interrupted and the knife 
may not fully return to the home position potentially exposing the healthcare professional 
to a sharp injury” accounted for two recalls (Z-0295-2017, Z-0296-2017) and a total 
quantity in commerce of 318.  This recall reason did not specifically state a failure mode 
identified herein.  Though, it did mention a specific device related failure that can cause 
improper functioning and injury.  Further, the failure of the knife to return to its home 
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position has the potential to affect the removal of the device from tissue given that the 
knife must be pulled back to its original position enough in order for the jaws to open and 
release. 
Of the six manufacturer reasons for recall associated with the Covidien Endo GIA 
stapler recalls, five were consistent with adverse event outcomes.  The recall reason 
stating “staplers fail to fire or partially fire and reports of the instrument articulating lever 
disengaging during use” accounted for four recalls (Z-0819-2016, Z-0820-2016, Z08-21-
2016, Z-0822-2016) and a total quantity in commerce of 1,797,442.  This recall reason 
was consistent with the following failures mode identified herein: articulation 
malfunction, failure to fire (at all/completely/properly), and failure to deploy staples (at 
all/on both sides).  The recall reason stating “single use loading unit contained two 
staples loaded in each cartridge pocket and may result in difficulty firing and removing 
the device from the application site, which may require medical intervention” accounted 
for one recall (Z-1063-2013) and a total quantity in commerce of 6,751.  This recall 
reason was consistent with the following failure modes identified: failure to fire properly, 
failure to release, and difficult release.  The recall reason stating “missing component 
results in the stapler not firing” accounted for one recall (Z-1227-2012) and a total 
quantity in commerce of 1,158.  This recall reason was consistent with the failure to fire.    
Recalls associated with the Covidien Endo GIA were identified that did not relate 
to a specific failure mode identified herein but demonstrate the potential for device 
related issues to cause adverse event outcomes.  The recall reason stating “duet TRS may 
have the potential to injure adjacent anatomical structure which may result in life 
threatening post-operative complications” accounted for eight recalls (Z-2432-2012, Z-
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2433-2012, Z-2434-2012, Z-2435-2012, Z-2436-2012, Z-2437-2012, Z-2438-2012, Z-
2439-2012) and a total quantity in commerce of 1,078,939.  The recall reason was not 
specific as to what aspect of the device could potentially cause injury to adjacent tissue 
and did not directly relate to the failure modes identified.  However, it is an important 
recall reason to recognize given the magnitude of the quantity recalled and it highlights 
the potential for device related causes of adverse event outcomes.  The recall reason that 
states “duet TRS straight and articulating single use (SULU) loading staplers used in 
thoracic surgery may result in serious injury or death” accounted for eight recalls (Z-
0991-2012, Z-0992-2012, Z-0993-2012, Z-0994-2012, Z-0995-2012, Z-0996-2012, Z-
0997-2012, Z-0998-2012) and a total quantity in commerce of 671,977.  This was another 
recall reason that did not directly relate to a specific failure mode identified herein.  The 
recall reason was not specific as to what feature of the device is responsible for a 
potential serious injury or death, yet it also demonstrates the possibility of adverse event 
outcomes due to device related issues.   
Overall, a total quantity in commerce of 3,577,660 were recalled for reasons 
associated with endoscopic stapler device related issues that could potentially cause 
adverse event outcomes.  Of this total, the Covidien Endo GIA recalls (3,556,267) 
involved a higher quantity in commerce than the Ethicon ETS recalls (4,113).  The 
reasons for endoscopic stapler product recall as identified by the FDA were consistent 
with the failure modes and failure mode consequences identified in the adverse event 
reports.  Specifically, the recall reasons coincide with two of the most frequent failure 
modes for endoscopic staplers which were malformed staples/failure to form staples and 
failure to release from tissue.  In addition, the reasons for recall include the potential of 
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post-operative complications and serious injury or death, which was consistent with the 
nature of the failure outcomes identified in the adverse event reports.   
The number of recalls associated with the endoscopic staplers that correspond to 
the adverse event outcomes indicate that device failure shares responsibility, which is 
consistent with previous findings in the literature (Brown and Woo 2004, Kwazneski, Six 
et al. 2012, Fuller, Paull et al. 2014).  Kwazneski et al. state that both the number of 
recalls and the number of endoscopic stapling problems experienced by users suggests a 
redesign and remanufacture of the staplers could positively impact the safety profile of 
the devices (Kwazneski, Six et al. 2012).  Further, it is likely that all issues associated 
with these devices are underreported to the FDA, which results in an underestimation of 
the extent of the failures and the corresponding root causes (Brown and Woo 2004).   
Fuller et al. assessed 25 stapling-related root causes from the Veterans Health 
Administration (VHA) and mapped them to the following: 10 were environment issues 
(40%), seven were user issues (28%), five were task issues (20%), and three were 
equipment issues (12%) (Fuller, Paull et al. 2014).  Environmental issues include a lack 
of surgical team educational opportunities, overscheduling of cases, and lack of a 
standardized procedure to attain blood products in an emergency.  User issues included 
firing a misaligned stapler and lack of familiarity of the device.  Poor visualization of the 
target tissue and friable tissue characteristics were cited to be task issues.  Finally, 
equipment issues were defined as misalignment of the stapler and misfire (Fuller, Paull et 
al. 2014).  This brings attention to factors other than solely user and device related issues.  
Fuller et al. also provided an extensive list of recommendations in order to prevent or aid 
in recovery from endoscopic stapler adverse events.  Recommendations are listed for 
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before surgery, during surgery, and after an adverse event and include the following 
examples for each stage, respectively (Fuller, Paull et al. 2014):  
 
 “Implement directed systematic training on surgical devices for all 
members of the surgical team to increase familiarity with the device, its 
approved use scenarios, and known characteristics of device malfunction.  
 Utilize a standard procedure for tracking information about the stapler 
during the procedure, including number of firings, loadings, and 
reloadings. 
 If stapler malfunction is noted when the stapler is still locked on tissue, 
clamp or litigate the vessel before releasing the stapler.” 
 
The recommendations can assist users with various aspects of endoscopic stapling 
devices and also improve the reporting of adverse events to the FDA by suggesting 
implementation of a standardized procedure for investigations of device misfires (Fuller, 
Paull et al. 2014).  Such practices may also assist in determining the root cause of failure, 
whether user, environment, task, or device related. 
 
2.4.2 Energy-Based Tissue Sealer Failure Mode Discussion 
 
The majority of tissue sealing device failures occurred during the activation phase 
of operation for both devices (Thunderbeat – 44.4%, Harmonic Ace – 46.1%).  The most 
common failure mode during Thunderbeat activation was a broken probe (13.6%), 
whereas the most common failure mode during Harmonic Ace activation was the failure 
 76 
to seal or seal properly (15.7%).  The second most common phases of operation in which 
failure occurred for the Thunderbeat and Harmonic Ace were transition (37%) and post-
op (30.4%), respectively.  Within the transition phase, residual heat was the most 
common failure mode associated with the Thunderbeat (28.4%).  The most common 
failure mode that occurred post-op associated with the Harmonic Ace was seal failure 
with bleeding or leakage (28.4%).  The phase of operation associated with the 
Thunderbeat in which the least amount of failures occurred was the post-op phase 
(18.5%).  The transition phase involved the least amount of failures associated with the 
Harmonic Ace (23.5%). 
Upon assessing the devices separately, the most common failure mode associated 
with the Thunderbeat was residual heat (28.4%), whereas seal failure with bleeding or 
leakage was the most common failure mode associated with the Harmonic Ace (28.4%).   
The second most common failure mode associated with the Thunderbeat was seal failure 
with bleeding and leakage (18.5%).  The second most common failure mode associated 
with the Harmonic Ace was tied between residual heat (15.7%) and failure to seal or seal 
properly (15.7%).   Overall, the top two failure modes associated with both devices were 
residual heat and seal failure with bleeding or leakage.   
Tissue sealing device failures induced by a broken device were more associated 
with the activation phase relative to the transition phase.  The proportion of broken 
device failures involving the blade or probe was higher for both devices in the activation 
phase (Thunderbeat – 13.6%, Harmonic Ace – 9.8%) versus the transition phase 
(Thunderbeat – 1.2%, Harmonic Ace – 2.9%).  Similarly, the proportion of broken device 
failures that involved the tissue pad were higher in the activation phase (Thunderbeat – 
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8.6%, Harmonic Ace – 13.7%) versus the transition phase (Thunderbeat – 0.0%, 
Harmonic Ace – 3.9%).  Of the broken device failures that occurred during activation, the 
Thunderbeat failures were more associated with the blade or probe component (13.6%), 
while the Harmonic Ace was more associated with the tissue pad (13.7%).    The tissue 
pad and blade responsible for these failures are both essential components of the jaw 
portion that grasp and secure the tissue during activation.  Proper delivery of thermal and 
mechanical energy to the tissue relies on these components.  Per manufacturer notice and 
instruction, wear and separation of the tissue pad can be due to activation of the device 
while there is no tissue present in the grasping section.  The user must avoid contact 
between the tissue pad and grasping section during activation to preserve the integrity of 
the distal tip components.  Grasping tissue thicker than the specific range for the devices 
can also result in damage of the tissue pad and blade.  The device must not come into 
contact with staples, clips, or other surgical instruments during activation. 
The most common failure during transition was residual heat, which refers to 
injury caused by a heated electrode or blade after the completion of the activation cycle.  
Residual heat causes burns to surrounding internal organs (n=20), external patient skin 
(n=10), and operating staff (n=9) when not handled cautiously during and after 
activation.  The probe tip of the device and a portion of the distal end of the shaft 
becomes heated during and after prolonged activation.  The Harmonic Ace and 
Thunderbeat reports resulted in the same number of residual heat injuries involving the 
patient’s internal organs (n=10 for each device) and external skin (n=5 for each device).  
Eight residual heat injuries associated with the Thunderbeat device involved the 
operating staff, whereas only one of these incidents was associated with the Harmonic 
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device.  For both devices, seal failure with bleeding or leakage was the most common 
failure mode in the post-op phase of operation (Thunderbeat – 18.5%, Harmonic Ace – 
28.4%).   
The failure modes related to the Ethicon Harmonic Ace (ultrasonic energy source) 
and the Olympus Thunderbeat (ultrasonic and bipolar energy source) are in large part 
specific to their energy sources.  This finding has been documented in scientific literature 
(Tucker and Voyles 1995, Overbey, Townsend et al. 2015). Overbey et al. analyzed 
reports from the FDA MAUDE and identified the common mechanisms leading to injury 
and death associated with various types of surgical energy-based device.  The types of 
devices assessed in their investigation included traditional bipolar instruments, plasma 
beam monopolar devices, advanced bipolar devices, ultrasonic devices, 
radiofrequency/microwave ablation devices, and the monopolar “Bovie” instrument 
(Overbey, Townsend et al. 2015).  While their proportions cannot be directly related to 
the proportions herein due to the range of device types assessed, the types of failures and 
outcomes shown to be associated with bipolar and ultrasonic energy devices were similar 
to those identified.  Overbey et al. indicated that advanced bipolar tissue sealing device 
adverse event outcomes reported to the FDA MAUDE database mostly involved bleeding 
and thermal burns due to direct application (Overbey, Townsend et al. 2015).  In addition, 
ultrasonic energy device adverse event outcomes were also most commonly associated 
with bleeding as a result of failure.  Mechanical failure and thermal burn due to residual 
heat were associated with ultrasonic devices.  These findings are consistent with the data 
presented herein considering that both tissue sealers assessed utilize ultrasonic energy.   
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The bleeding associated with tissue sealing devices is concerning; however, it 
should be put into perspective when comparing devices across a range of applications 
since this failure consequence is inherent to the very function these devices carry out, 
which is to seal and transect vessels.  While the specific failure modes were not identified 
by Overbey et al., the adverse event outcomes that involve bleeding are likely due to seal 
failure that involves bleeding or leakage, which was one of the top two failure modes 
identified across the Thunderbeat and Harmonic Ace reports.   
Residual heat was identified by Overbey et al. as a mechanism of injury 
associated with ultrasonic energy, which is also supported elsewhere in scientific 
literature (Govekar, Robinson et al. 2011, Overbey, Townsend et al. 2015).  Residual heat 
was one of the most common failure modes associated with the tissue sealers assessed in 
this study.  Ultrasonic tissue transection is carried out via mechanical friction between the 
oscillating shaft of the device and the tissue.  Inherent to this mechanism is an increase in 
temperature that is proportional to the time of activation.  That is, the longer the device is 
active, the greater the distal tip temperature.  Therefore, injury due to both residual heat 
and lateral thermal spread remain a concern (Lyons and Law 2013).  The consequences 
of lateral thermal spread is a risk across all laparoscopic energy sources (Lyons and Law 
2013).  Ultrasonic and bipolar energy devices have evolved to include temperature 
regulation and control, yet the 2013 study by Lyons et al. states that the effectiveness and 
benefits of some of the various methods have yet to be proven in clinical trials (Lyons 
and Law 2013).  These methods include adaptive technology that regulates energy 
delivery during activation and an audible feedback to the user indicating the device status 
through the activation stages via audible tone changes (Lyons and Law 2013). 
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Relative to electrosurgical techniques that deliver energy through tissue, the 
advantages to devices utilizing ultrasonic energy include less tissue necrosis and charring, 
less smoke generation, and reduced lateral thermal spread (Entezari, Hoffmann et al. 
2007, Lamberton, Hsi et al. 2008).  In general, lateral thermal spread associated with 
ultrasonic energy has been shown to be relatively less (Hruby, Marruffo et al. 2007, 
Noble, Smart et al. 2011).  However, a device’s residual temperature of the device tip 
after activation is less with bipolar technology (Govekar, Robinson et al. 2011, Lyons and 
Law 2013).  It is important to note that the extent of the effects of lateral thermal spread 
and residual heat associated with laparoscopic sealing technologies relies heavily on the 
operator.  User experience and knowledge is critical, especially considering many of the 
failure modes are preventable.  Instructions for ultrasonic device use indicate the 
possibility of residual heat and further emphasize the caution that must be implemented 
after activation.  It is not advised to grasp other tissue immediately after an activation 
cycle.  Care must be taken when handling the device after activation when inside a 
patient to avoid injury and burns to tissue.  The surgical staff must also use caution when 
the device is handled outside of the patient, as the heated tip can still cause injury to skin 
(even through surgical gloves) if contact occurs.  Users must be aware of the available 
features of their devices of choice in order to properly follow the instructions; for 
example, if the equipment generates audible tones indicating the stages of device 
activation, the user must be aware of what each tone indicates and signals regarding the 
state of the tissue. 
The prevalence of failures caused by operator error should be addressed by both 
users and manufacturers of the devices.  Direct application (in which the active electrode/ 
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probe directly causes unintended thermal injury to adjacent tissue during activation), 
inadvertent application, and injury from residual heat are typically caused by well-
functioning devices that are being handled incorrectly at the time of injury (Alkatout, 
Schollmeyer et al. 2012, Jones, Brunt et al. 2015).  The level of understanding held by the 
user relating to all aspects of their choice of tissue sealing devices must be considered 
when assessing adverse events, especially their knowledge related to the generation of 
current and heat via electrical and mechanical energy.  Users have a responsibility to 
adhere to instructions for use and warnings provided; however, device manufacturers 
have a separate responsibility to investigate, acknowledge, and address operational 
aspects of the device that inhibit proper use.  The findings of this study support the need 
for a standardized curriculum for users to fill the knowledge gap related to surgical 
energy-based devices (Tucker and Voyles 1995, Harrell and Kopps 1998, Feldman, 
Fuchshuber et al. 2012, Feldman, Brunt et al. 2013, Watanabe, Kurashima et al. 2016). 
Surgeons are tasked with determining the most appropriate device to use for a 
specific procedure and tissue type.  It can be difficult for a user to make a properly 
informed and objective decision regarding the most appropriate laparoscopic energy 
source provided that some studies published in medical literature are sponsored by device 
manufacturers (Lyons and Law 2013).  In addition, directly comparing vessel sealing data 
from different studies is not generally advised given the study conditions vary so widely 
(Lyons and Law 2013).  Not only do surgeons have to choose between the sealing 
technologies available, but they also have to pick between the various device brands.  
Each of the options can come with varying user experiences, sealing performance, and 
risks.  The difficulties that come with choosing a device due to the range of options 
 82 
available emphasizes the need for user experience, reliable knowledge sources, and 
continued education as the technology in this field rapidly continues to develop. 
Several scientific studies indicated the need for a standardized curriculum in the 
safe use of energy in the operating room (Feldman, Fuchshuber et al. 2012, Watanabe, 
Kurashima et al. 2016).  The Fundamental Safe Use of Energy (FUSE) program was 
developed to address the training, knowledge, and assessment gaps in the instances where 
a lack of a standardized curriculum related to surgical energy devices may contribute to a 
risk for injury (Feldman, Fuchshuber et al. 2012).  Feldman et al. distributed surveys to 
target audiences to identify the areas that required the most focus in the development of 
the assessment component of the FUSE program (Feldman, Fuchshuber et al. 2012, 
Feldman, Brunt et al. 2013).  Of fifty surveys completed from a target audience that 
consisted mostly experienced surgeons, only 28% considered themselves as “experts” in 
the safe use of the devices that they use regularly (Feldman, Brunt et al. 2013).  A 
separate survey to a target audience that included Society of American Gastrointestinal 
and Endoscopic Surgeons (SAGES) leaders indicated a knowledge gap in 
“electrosurgical nomenclature, generator settings, responses to operating room fires, and 
interactions with other implantable devices.”  A pretest given as part of a pilot 
postgraduate course for the FUSE program indicated that surgeons held a minimal 
understanding of the devices that they use regularly and also train others to use (Feldman, 
Fuchshuber et al. 2012).  Improvement in participant test scores resulted after completion 
of the pilot FUSE postgraduate course, which demonstrated the need for such a 
comprehensive curriculum and certification process to educate users about the risks and 
complications associated with energy use in the operating room.    
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One recall involved the Thunderbeat device (Z-0432-2014), and the reason for 
recall stated “complaints of damage to various models of Thunderbeat hand instruments 
during surgical procedures, including cracking, breaking, or deformation of the 
components of the probe tip or jaw.”  This reason for recall provided by the manufacturer 
accounted for a quantity in commerce of 8,709 and was directly related to the adverse 
event outcomes identified in the adverse event reports.  Specifically, the recall was 
consistent with the broken device failures involving the tissue pad and probe tip.  The 
recall was determined by the FDA to be caused by “use error,” which is consistent with 
the possible causes of a broken device described in the adverse event reports.  One of the 
four Harmonic Ace recalls was related to device design (Z-0278-2016), however the 
specific reason provided by the manufacturer was not consistent with the failure modes 
identified in the adverse event reports given it involves packaging issues.  The following 
excerpts were taken from manufacturer narratives that described the possible causes for a 
broken device (FDA 2017): 
 
Manufacturer Narrative – Thunderbeat 
 “…the exact cause of the reported event could not be conclusively determined at 
this time.  This type of probe damage is most likely related to the operator’s technique.  
The instruction manual contains several warning statements in an effort to prevent 
damage to the probe. ‘Do not activate output in seal and cut mode while grasping section 
is closed without contacting tissue or vessel.  Do not activate output while applying the 
probe tip to the tissue with a strong force.  Do not activate output while grasping thick 
and hard tissue.  Otherwise, vari[o]us forms of damage in the probe tip and/or the tissue 
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pad such as premature wear, breakage, deformation, exposure of metal, and/or falling 
inside the body cavity, and/or partial separating may occur.’” 
 
Manufacturer Narrative – Harmonic Ace 
“…probable causes of blade damage, including breakage, are external contact 
during pre-op or general use, blade contact with other devices, staples or clips during the 
procedure or using any means other than the blade wrench to attach or detach the blade.  
Once minor blade damage has occurred, subsequent activations may increase damage 
severity and result in an error code 5 or blade ‘lockout’ later in the procedure, and 
continued usage can result in a broken blade…” 
 
Manufacturer Narrative – Harmonic Ace 
“The analysis results found that the device was returned with the tissue pad 
melted and partially detached.  Based on the condition of the tissue pad, it appears 
possible that the clamp of the device may have been closed and the instrument activated 
without tissue present…Our instruction insert states ‘care should be taken not to apply 
pressure between the instrument blade and tissue pad without having tissue between 
them.  This can result in possible damage to the instrument.’” 
 
In these cases, the broken device is suggested as a direct result of improper use.  
However, based on the context provided within the event descriptions it is not always 
possible to conclude the root cause of the failure. 
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2.4.3 Manufacturer Narratives and Event Descriptions  
 
Prevention of user error and device failure requires consistent reporting of adverse 
events to improve awareness, educational techniques for use, and the development of 
safe, reliable, user-friendly devices.  The FDA MAUDE database is intended for the 
quick detection and correction of medical device issues, yet various factors need to be 
improved for the database to be effective as a medical professional and manufacturer 
resource.  It is important to note the differences in terminology provided by the reporting 
users and facilities for the two types of devices.  Failure modes tended to be more 
explicitly described in the reports associated with endoscopic staplers as compared to 
tissue sealers.  Additionally, the stapler failure terminology was more consistent across 
the reports and adhered more to the terminology frequently referred to in the scientific 
literature.   In contrast, the tissue sealer reports were more difficult to interpret due to the 
lack of consistency in failure terminology and overall lack of standardized terminology to 
clearly describe the cause of failure.   The discrepancy may be attributed to the 
knowledge gap in users’ understanding of electrosurgical outcomes overall as mentioned 
in multiple knowledge gap studies and discussed previously in Section1.2.2.1  (Feldman, 
Fuchshuber et al. 2012, Feldman, Brunt et al. 2013, Madani, Watanabe et al. 2014, 
Watanabe, Kurashima et al. 2016). It is not always possible to decipher whether a failure 
was caused by the user or device malfunction.  A standardized curriculum, such as the 
FUSE program, must be well implemented for physicians and residents in response to 
technological advancements of surgical instrumentation to fill the knowledge gap and 
prevent adverse operative outcomes (Chekan, Whelan et al. 2013, Feldman, Brunt et al. 
2013, Madani, Watanabe et al. 2014). 
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Manufacturers have a responsibility to recognize and address the challenges faced 
by surgeons during use, and medical device reporting is one source to identify these 
challenges. The manufacturer narrative included in many adverse event reports is 
essential to identifying the root cause of failure, which enables manufacturers to 
implement design changes to prevent further device failure and user errors associated 
with device operation.  Certain component failures may actually be due to user errors 
such as deploying a stapler on too thick of tissue for the cartridge or reload chosen.  
Identifying which components failed and the reason for such failure can further heighten 
a manufacturer’s understanding of user error, device failure mechanisms, and the 
potential association between the two. 
By responding to adverse events and providing a manufacture narrative for each 
reported event, manufacturers are able to reemphasize instructions and warnings while 
gaining a valuable understanding of the issues users encounter in the operating room.  
On-going investigation is necessary to characterize the nature and frequency of issues 
associated with medical devices in order to prevent adverse events and enhance user and 
manufacturer awareness of potential risks and complications as the technology and 
procedures continue to advance. 
 
2.5 Failure Mode Study Limitations and Future Work  
 
The FDA’s MAUDE database is a voluntary database, and it is likely that the 
number of incidence is underreported.  Event descriptions within the reports were not all 
adequate to allow for phase or failure mode identification in some cases.  Furthermore, 
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manufacturer narratives were not provided in the Covidien Endo GIA reports, from 
which valuable insight regarding specific failures can be derived.  The accuracy and 
completeness of the adverse events reports cannot be established or confirmed.  It should 
be noted that in some cases when a failure mode was not explicitly stated, the failure 
mode was inferred based on the context provided in the event descriptions and 
manufacture narrative.   Therefore, it is possible that misclassification of failure modes 
could have occurred leading to an improper overall assessment of failure modes.   
The overall use associated with surgical stapling devices is unknown as well as 
the use per device brand.  Without quantifying the total usage of devices, the incidence 
rate of adverse events and corresponding failure modes remains undetermined.  The total 
number of uses of the devices is not recorded and not all complications resulting in 
adverse events are reported to the FDA MAUDE (Brown and Woo 2004, Overbey, 
Townsend et al. 2015).   
  To ensure reports involved a scenario that qualifies as an adverse event, only the 
events categorized as a death or injury by the reporting facility in the FDA MAUDE 
database were analyzed.  Therefore malfunctions were not accounted for which are 
associated with additional device failure modes (Riggs, Bohm et al. 2016).  From a 
manufacturer perspective, further investigation that involves malfunction event types 
could provide valuable insight as it relates to design and a comprehensive device error 
overview.  It is important to note that even though the reports are classified by the event 
type, the reporting facility classifications are not always accurate.  Based on this work 
and a previous review of endoscopic stapler FDA reports, there is evidence that many 
reports involving injury have been classified as malfunction and reports that involve 
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purely malfunction have been classified as an injury event type (Riggs, Bohm et al. 
2016).  It is important to be aware of this in future work especially if adverse events that 
are consistent with the accompanying definition are required (i.e. only injury and death 
outcomes).    
Due to limitations in the allotted resources and budget for obtaining surgical 
medical devices, only two devices from two device classes were assessed.  There are 
other available brands in the device classes whose adverse event reports should be 
investigated to provide a more comprehensive assessment.  The Thunderbeat is a 
relatively new device and was limited in the total sample of adverse event reports 
available in the FDA MAUDE database.  On-going investigation into this particular 
device is suggested as its overall use increases.  The endoscopic staplers investigated 
operate via strictly mechanical mechanisms.  Though not covered specifically, powered 
surgical stapling devices are gaining in popularity, which has also been demonstrated by 
the increasing appearance of adverse events related to these devices in the MAUDE 
database as mentioned in a previous review (Riggs, Bohm et al. 2016).  In many cases for 
these devices, the phases of operation in which failure occur would be similar to those 
identified due to the general features and functional requirements.  However, future 
studies should be conducted observing the specific failure modes of powered surgical 
stapling devices as their presence in the operating room increases. 
This work also aimed to investigate the relationship between the device design 
complexity and failure mode types associated with endoscopic staplers and energy-based 
tissue sealers.  However, the types of failure modes were not consistent across the two 
types of minimally invasive surgical devices assessed.  Therefore, a statistical method 
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could not be employed for this sample provided that the frequencies of each specific 
failure type could not be grouped in similar categories for all four devices and 
corresponding complexity scores.  Further assessment of devices of the same type would 





SEVERITY OF ADVERSE EVENT OUTCOMES 
 
3.1 Adverse Event Outcome Severity Study Overview 
 
Identifying and describing failure modes associated with minimally invasive 
surgical devices is an essential step in improving patient safety.  Further, assessing the 
severity of the adverse outcomes associated with such failures is necessary given the 
broad range of possible patient consequences.  This chapter addresses Specific Aim 2, 
which was to contribute to provision of a comprehensive evaluation of adverse clinical 
events by describing the severity of adverse event outcomes that are associated with the 
failure modes of endoscopic staplers and energy-based tissue sealers.  The CTCAE v4.0 
grading scale was applied to the adverse event outcomes associated with the failure 
modes identified in Chapter II.  
Adverse events associated with medical device use are concerning due to the 
potential morbid patient consequences, especially for those that occur during MIS.  
Recall from Section 1.2.4 that while various studies have broadly focused on assessing 
the failure modes of medical devices as revealed in FDA MAUDE database reports, none 
have investigated the severity associated with the failure mode outcomes specific to 
intraoperative device use.  This is the first study to apply an adverse event severity 
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grading method to the failure mode outcomes derived from FDA MAUDE database 
reports associated with intraoperative minimally invasive surgical device use.   
Failures during MIS are particularly of concern given the lack of direct 
accessibility during device use.  Issues with device use during MIS increase the 
possibility of requiring a conversion to an open procedure, procedural delays, prolonged 
hospital stays, and heightened patient risk.  Therefore, it is necessary to not only assess 
the types of failures, but also the severity associated with the outcomes.  The severity 
assessment supplies users with a better understanding of failures and corresponding 
adverse event outcomes in the operation setting.  It is important to be aware of the types 
of various failures modes, their relative frequencies, and their associated outcome 
severity.  The work presented is an essential step in the development of an approach for 
prevention of outcome severities that specifically result in severe, life-threatening, or 
morbid outcomes on the CTCAE v4.0 grading scale.   
 
3.2 Adverse Event Outcome Severity Methods 
 
3.2.1 Severity Grading  
 
The severity of user and device-based failure mode outcomes associated with 
endoscopic staplers and tissue sealers was investigated.  The sample of FDA MAUDE 
reports used in assessing the type and frequency of failure modes (Section 2.2.1.3) was 
also used for the severity assessment.  CTCAE v4.0 grading descriptions were employed 
in order to assign a severity grade to each adverse event outcome identified through 
analysis of the event descriptions (NIH 2009).   
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In accordance with the CTCAE v4.0 grading outlined in Table 3 in Section 
1.2.5.1, a severity of 1 indicates a mild consequence that involves clinical or diagnostic 
observations only when no intervention is indicated.  For example, a minor burn from the 
residual heat of a tissue sealer would be classified as mild if it did not require any type of 
intervention, such as a form of a topical treatment.  A severity of 2 indicates a moderate 
event that required local or noninvasive intervention.  Following from the previous 
example, if a burn occurred from residual heat that required topical treatment it would be 
classified as a moderate outcome of severity 2.  In regards to endoscopic staplers, a 
moderate outcome example would include unanticipated tissue loss (resection) that did 
not involve tissue damage or further adverse consequences.   
An outcome with a severity of 3 is medically significant but not immediately life-
threatening.  Severe events can involve prolonged hospitalization or procedural delays.  
Additionally, severe outcomes relative to these devices are those that involve blood loss 
(that does not require transfusion), tissue damage, conversion to open surgery, or 
reoperation due to the adverse event.  If a blood transfusion is required it is considered 
life threatening, which would be a severity of 4.  A death related to the adverse event is a 
severity of 5. 
All failure modes described within an event description were accounted for, and 
one severity grade was applied per outcome.  Therefore, in the cases where two failure 
modes were identified in one report’s event description, the severity grade of a single 
outcome was applied to both failure modes for this analysis. 
 
3.2.1 Adverse Event Outcome Severity Data Analysis 
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Severity grade frequencies, proportions, and averages were used to compare 
severity per phase of operation, failure mode, device brand, and device type.  Average 
outcome severity was calculated for each phase of operation and failure mode.  Phase of 
operation proportions were calculated relative to the total number of failures and 
corresponding severities for each device type unless indicated otherwise.  The percentage 
of failure outcomes that resulted in a severity of 3 or higher were also reported per phase 
of operation and device type in order to identify the occurrence of medically significant 
outcomes.  All proportions were rounded to the nearest tenth decimal place.  To enable 
further analysis, common phases of operation across both device types were determined 
to be transition, main function, and results/post-op.  The endoscopic stapler phases of 
operation utilized in Chapter II were regrouped according to the common phases of 
operation categories for severity frequencies.  Specifically, the reload, application, 
articulation, and removal phases for endoscopic staplers were grouped into the transition 
phase, the main function consisted of the firing and cutting phases, and the results/post-
op phase involved the staple line.  The tissue sealer transition, activation, and post-op 
phases correspond to the transition, main function, and results/post-op common phases, 
respectively.   
Frequencies of each severity grade were determined per common phase of 
operation and analyzed for association.  The cross tabulation table resulted in a cell 
frequency of less than five; therefore, Fisher’s Exact Test was used to indicate association 




3.3 Adverse Event Outcome Severity Results 
 
3.3.1 Severity of Failure Mode Outcomes Associated with Endoscopic Staplers 
 
Failure mode frequencies were grouped using the severity of the associated 
adverse event outcomes.  The severities were averaged per phase of operation and failure 
mode.  The severities associated with the Ethicon ETS endoscopic stapler failure modes 
are shown in Table 18. 
 
Table 18.  Severity of failure mode outcomes associated with the ETS endoscopic stapler 








1 2 3 4 5 
Reload 3.60 
Reload fell out of or off of device   4 1 2 3.71 
Reload malfunction   2 1  3.33 
Articulation 3.00 Articulation malfunction   2   3.00 
Application 3.00 Failure to open/close for application on tissue   2   3.00 
Firing 3.27 
Malformed staples/Failure to form staples   15 1 1 3.18 
Failure to fire (at all/completely/properly)  1 5 3  3.22 
General misfire (nonspecific)  1 11 2  3.07 
Failure to deploy staples (at all/on both sides)   11 8 1 3.50 
Cutting 2.67 
Unintentionally nicked tissue      - 
Failure to cut (at all/completely/properly)  1 2   2.67 
Removal 2.43 
Failure to release  13 6 1  2.40 
Difficult release   1   3.00 
Staple line 3.46 
Staple line failure   4 2  3.33 
Staple line leak post-op   4 2 1 3.57 
 
The outcome severities associated with the Covidien Endo GIA endoscopic 
stapler failure modes are shown in Table 19. 
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Table 19.  Severity of failure mode outcomes associated with the Endo GIA endoscopic 








1 2 3 4 5 
Reload 2.83 
Reload fell out of or off of device  1 2   2.67 
Reload malfunction  1 1 1  3.00 
Articulation - Articulation malfunction      - 
Application 3.25 Failure to open/close for application on tissue   3 1  3.25 
Firing 2.90 
Malformed staples/Failure to form staples  7 22 1  2.80 
Failure to fire (at all/completely/properly)  5 4 2  2.73 
General misfire (nonspecific) 1 1 3   2.40 
Failure to deploy staples (at all/on both sides)  1 4 7  3.50 
Cutting 3.12 
Unintentionally nicked tissue    1 1 4.50 
Failure to cut (at all/completely/properly)  2 2   2.50 
Removal 2.78 
Failure to release  6 16   2.73 
Difficult release    1  4.00 
Staple line 3.5 
Staple line failure   1 4 1 4.00 
Staple line leak post-op   8 2  3.20 
 
Table 20 includes the total number and proportion of failures that occurred and 
average outcome severity per the assigned common phase of operation for each 
endoscopic stapler.  The average severities take into account the outcome severity of each 
failure mode occurrence within each phase of operation. 
 
Table 20.  Endoscopic stapler failure frequencies (proportions) and average severity of 













Transition 35 (31.5%) 2.83 33 (29.2%) 2.85 
Main Function 63 (56.8%) 3.24 64 (56.6%) 2.92 
Result/Post-op 13 (11.7%) 3.46 16 (14.2%) 3.50 
 
 96 
Endoscopic stapler outcome severity frequencies and proportions relative to the 
total number of failures assessed are shown in Table 21 per common phase of operation. 
 




Transition Main Function Results/Post-op Total 
1 - 1 (0.4%) - 1 (0.4%) 
2 21 (9.4%) 19 (8.5%) - 40 (17.9%) 
3 39 (17.4%) 79 (35.3%) 17 (7.6%) 135 (60.3%) 
4 6 (2.7%) 25 (11.2%) 10 (4.5%) 41 (18.3%) 
5 2 (0.9%) 3 (1.3%) 2 (0.9%) 7 (3.1%) 
Total 68 (30.4%) 127 (56.7%) 29 (12.9%) 224 (100%) 
 
The average severity of adverse event outcomes associated with each common 
phase of operation for endoscopic staplers is shown per phase in Table 22 in addition to 
the overall percentage of failure outcomes that resulted in a severity of 3 or higher.  The 
percentages are relative to the total number of outcomes across all phases of operation. 
 
Table 22.  Endoscopic stapler average severity per phase of operation and overall 
percentage of failure outcomes with severity of 3 or higher.   
Phase of Operation Average Severity % with Severity ≥ 3 
Transition 2.84 21.0% 
Main Function 3.08 47.8% 
Result/Post-op 3.48 12.9% 
 
Table 23 provides the percentage of outcomes that resulted in a severity of 3 or 
higher relative to the number of outcomes per common phase of operation. 
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Table 23.  Endoscopic stapler percentage of outcomes with severity 3 or higher relative to 
the number of outcomes that occurred during each phase of operation.  
Phase of Operation % with Severity ≥ 3  
Transition 69.1% 
Main Function 84.3% 
Result/Post-op 100% 
 
The distribution of the severity outcome data per common phase of operation is 
shown in the boxplot in Figure 6. 
 
 
Figure 6.  Distribution of severity per phase of operation associated with endoscopic 
staplers. 
 
Fisher’s Exact Test was conducted in order to determine the association between 
the severity of adverse event outcomes and the phases of operation.  The cross tabulation 
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table (Table 24) shows the frequency counts and column percentages, and Fisher’s Exact 
Test results are shown in Table 25. 
 
Table 24.  Endoscopic stapler cross tabulation table. 
Phase 
Severity Count (%) 
1 2 3 4 5 Total 
Main Function 1 (100%) 19 (47.5%) 79 (58.5%) 25 (61.0%) 3 (42.9%) 127 (56.7%) 
Results/Post-op 0 (0.0%) 0 (0.0%) 17 (12.6%) 10 (24.4%) 2 (28.6%) 29 (12.9%) 
Transition 0 (0.0%) 21 (52.5%) 39 (28.9%) 6 (14.6%) 2 (28.6%) 68 (30.4%) 
Total 1 (100%) 40 (100%) 135 (100%) 41 (100%) 7 (100%) 224 (100%) 
 
Table 25. Chi-Squared tests SPSS output for endoscopic stapler outcome severity and 

















Pearson Chi-Square 22.370a 8 0.004 <0.01b 0.000 0.020 
Likelihood Ratio 26.399 8 0.001 <0.01b 0.000 0.020 
Fisher’s Exact Test 24.061   <0.01b 0.000 0.020 
N of Valid Cases 224      
a. 6 cells (40.0%) have expected count less than 5.  The minimum expected count 0.13. 
b. Based on 224 sampled tables with starting seed 1314643744. 
 
The Fisher’s Exact Test significance value indicates there was an association 
between the severity of the outcome and the phase in which the adverse event occurred (p 
< 0.05).  The severity of the outcomes in the various phases of endoscopic stapler 
operation was significantly different. 
 
3.3.2 Severity of Failure Mode Outcomes Associated with Tissue Sealers 
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Failure mode frequencies were grouped using the severity of the associated 
adverse event outcomes.  The severities were averaged per phase of operation and failure 
mode.  The outcome severities associated with the Thunderbeat device failure modes are 
shown in Table 26. 
 
Table 26.  Severity of failure modes associated with the Thunderbeat tissue sealer (n=81 








1 2 3 4 5 
Activation 2.36 
Unspecific error resulting in bleeding 
    1 5.00 
Broken device - blade or probe 6 5 
   1.45 
Broken device - tissue pad 2 2 3 
  2.14 
Failure to seal/failure to seal properly 2 
 4   2.33 
Direct application 
 1 4 1 1 3.29 
Thermal spread 
  2   3.00 
Insulation Failure 
  2   3.00 
Transition 2.37 
Residual heat 1 12 10 
  2.39 
Broken device - blade or probe 1 
    1.00 
Broken device - tissue pad 
     - 
Inadvertent application 
 1 4   2.80 
Installation error; electric shock 1 
    1.00 
Post-op 3.53 
Seal failure with bleeding/leakage 
  11  4 3.53 
Tissue injury detected after device use 
     - 
 
The outcome severities associated with the Harmonic device failure modes are 







Table 27.  Severity of failure mode outcomes associated with the Harmonic Ace tissue 








1 2 3 4 5 
Activation 2.40 
Unspecific error resulting in bleeding   2 1 1 3.75 
Broken device - blade or probe 1 3 6   2.50 
Broken device - tissue pad 12  2   1.29 
Failure to seal/failure to seal properly 1 3 10 2  2.81 
Direct application   2 1  3.33 
Thermal spread      - 
Insulation Failure      - 
Transition 2.08 
Residual heat 3 5 7  1 2.44 
Broken device - blade or probe 2 1    1.33 
Broken device - tissue pad 4     1.00 
Inadvertent application   1   3.00 
Installation error; electric shock      - 
Post-op 3.52 
Seal failure with bleeding/leakage  1 12 15 1 3.55 
Tissue injury detected after device use   2   3.00 
 
Two adverse event reports associated with the Thunderbeat device did not 
indicate a specific failure mode; however, it was indicated that the failures occurred post-
op and resulted in death (severity of 5).  These two reports are included in Table 28 
which lists the total number and proportion of failures that occurred and average outcome 
severity per the assigned common phase of operation for each tissue sealer. 
 














Transition 30 (36.1%) 2.37 24 (23.5%) 2.08 
Main Function 36 (43.4%) 2.36 47 (46.1%) 2.40 
Result/Post-op 17 (20.5%) 3.70 31 (30.4%) 3.52 
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Tissue sealer failure outcome severity frequencies and proportions relative to the 
total number of failures assessed are shown in Table 29 per common phase of operation. 
 
Table 29.  Tissue sealer failure outcome severity frequencies per phase of operation. 
Severity 
Frequency (%) 
Transition Main Function Results/Post-op Total 
1 12 (6.5%) 24 (13.0%) - 36 (19.5%) 
2 19 (10.3%) 14 (7.6%) 1 (0.5%) 34 (18.4%) 
3 22 (11.9%) 37 (20.0%) 25 (13.5%) 84 (45.4%) 
4 - 5 (2.7%) 15 (8.1%) 20 (10.8%) 
5 1 (0.5%) 3 (1.6%) 7 (3.8%) 11 (5.9%) 
Total 54 (29.2%) 83 (44.9%) 48 (25.9%) 185 (100%) 
 
The severity of adverse event outcomes associated with each common phase of 
operation for tissue sealers is shown per phase in Table 30 in addition to the overall 
percentage of failure outcomes that resulted in a severity of 3 or higher.  The percentages 
are relative to the total number of outcomes across all phases of operation. 
 
Table 30.  Tissue sealer average severity per phase of operation and overall percentage of 
failure outcomes with severity of 3 or higher.   
Phase of Operation Average Severity % with Severity ≥ 3 
Transition 2.24 12.4% 
Main Function 2.39 24.3% 
Result/Post-op 3.58 25.4% 
 
Table 31 shows the percentage of outcomes that resulted in a severity of 3 or higher 




Table 31.  Tissue sealer percentage of outcomes with severity 3 or higher relative to the 
number of outcomes that occurred during each phase of operation. 
Phase of Operation % with Severity ≥ 3 
Transition 42.6% 
Main Function 54.2% 
Result/Post-op 97.9% 
 
The distribution of severity outcome data per common phase of operation is 
shown in the boxplot in Figure 7. 
 
 
Figure 7.  Distribution of severity per phase of operation associated with tissue sealers. 
  
Fisher’s Exact Test was conducted in order to determine the association between 
the severity of adverse event outcomes and the common phases of operation.  The cross 
tabulation table (Table 32) shows the frequency counts and column percentages, and 
Fisher’s Exact Test results are shown in Table 33. 
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Table 32. Tissue sealer cross tabulation table. 
Phase 
Severity Count (%) 
1 2 3 4 5 Total 
Main Function 24 (66.7%) 14 (41.2%) 37 (44.0%) 5 (25%) 3 (27.3%) 83 (44.9%) 
Results/Post-op 0 (0.0%) 1 (2.9%) 25 (29.8%) 15 (75%) 7 (63.6%) 48 (25.9%) 
Transition 12 (33.3%) 19 (55.9%) 22 (26.2%) 0 (0.0%) 1 (0.1%) 54 (29.2%) 
Total 36 (100%) 34 (100%) 84 (100%) 20 (100%) 11 (100%) 185 (100%) 
 


















Pearson Chi-Square 63.896c 8 0.000 <0.01d 0.000 0.025 
Likelihood Ratio 74.087 8 0.000 <0.01d 0.000 0.025 
Fisher’s Exact Test 65.513   <0.01d 0.000 0.025 
N of Valid Cases 185      
c. 3 cells (6.7%) have expected count less than 5.  The minimum expected count 2.85 
d. Based on 185 sampled tables with starting seed 2000000. 
 
 The Fisher’s Exact Test significance value indicates there was an association 
between the severity of the outcome and the phase in which the adverse event occurred (p 
< 0.05).  The severity of the outcomes in the various phases of tissue sealer operation was 
significantly different. 
 
3.3.3 Severity of Failure Mode Outcomes Associated with Both Device Types 
 
The failure outcome severities associated with both device types were combined 
then grouped per common phase of operation. The combined outcome severity 
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frequencies and proportions relative to the total number of failures assessed are shown in 
Table 34 per phase of operation. 
 
Table 34.  Combined failure outcome severity frequencies and proportions. 
Severity 
Frequency (%) 
Transition Main Function Results/Post-op Total 
1 12 (2.9%) 25 (6.1%) - 37 (9.0%) 
2 40 (9.8%) 33 (8.1%) 1 (0.2%) 74 (18.1%) 
3 61 (14.9%) 116 (28.4%) 42 (10.3%) 219 (53.5%) 
4 6 (1.5%) 30 (7.3%) 25 (6.1%) 61 (14.9%) 
5 3 (0.7%) 6 (1.5%) 9 (2.2%) 18 (4.4%) 
Total 122 (29.8%) 210 (51.3%) 77 (18.8%) 409 (100%) 
 
The severity of adverse event outcomes associated with each common phase of 
operation for the surgical devices is shown per phase in Table 35 in addition to the 
overall percentage of failure outcomes that resulted in a severity of 3 or higher.  The 
percentages are relative to the total number of outcomes across all phases of operation. 
 
Table 35.  Surgical device average severity per phase of operation and overall percentage 
of failure outcomes with severity of 3 or higher.   
Phase of Operation Average Severity % with Severity ≥ 3  
Transition 2.57 17.1% 
Main Function 2.80 37.2% 
Result/Post-op 3.55 18.6% 
 
Table 36 provides the percentage of outcomes that resulted in a severity of 3 or 




Table 36.  Surgical device percentage of outcomes with severity 3 or higher relative to 
the number of outcomes that occurred during each phase of operation. 
Phase of Operation % with Severity ≥ 3  
Transition 57.4% 
Main Function 72.4% 
Result/Post-op 98.7% 
 
The percentage of failure outcomes that resulted in a severity of 3 or higher relative 
to the total number of outcomes per device type is shown in Table 37. 
 
Table 37.  Overall percentage of failure outcomes with severity of 3 or higher relative to 
the number of outcomes that occurred during each phase of operation. 
Device Type % with Severity ≥ 3 
Endoscopic Staplers 81.7% 
Tissue Sealers 62.2% 
Both Device Types 72.8% 
 
The distribution of the combined severity outcome data per common phase of 




Figure 8.  Distribution of severity per phase of operation. 
 
Fisher’s Exact Test was conducted in order to determine the association between 
the severity of adverse event outcomes and the phases of surgical device operation.  The 
cross tabulation table (Table 38) shows the frequency counts and column percentages, 
and Fisher’s Exact Test results are shown in Table 39. 
 
Table 38. Surgical device cross tabulation table. 
Phase 
Severity Count (%) 
1 2 3 4 5 Total 
Main Function 25 (67.6%) 33 (44.6%) 116 (53.0%) 30 (49.2%) 6 (33.3%) 210 (51.3%) 
Results/Post-op 0 (0.0%) 1 (1.4%) 42 (19.2%) 25 (41.0%) 9 (50%) 77 (18.8%) 
Transition 12 (32.4%) 40 (54.1%) 61 (27.9%) 6 (9.8%) 3 (16.7%) 122 (29.8%) 
Total 37 (100%) 74 (100%) 219 (100%) 61 (100%) 18 (100%) 409 (100%) 
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Pearson Chi-Square 72.189e 8 0.000 <0.01f 0.000 0.011 
Likelihood Ratio 81.048 8 0.000 <0.01f 0.000 0.011 
Fisher’s Exact Test 75.335   <0.01f 0.000 0.011 
N of Valid Cases 409      
e. 1 cell (6.7%) has expected count less than 5.  The minimum expected count is 3.39. 
f. Based on 409 sampled tables with starting seed 1502173562. 
 
The Fisher’s Exact Test significance value indicates there was an association 
between the severity of the outcome and the phase in which the adverse event occurred (p 
< 0.05).  Overall, the severity of the outcomes was significantly different per the various 
phases of surgical device operation. 
 
3.4 Adverse Event Outcome Severity Discussion 
 
The objective of Specific Aim 2 was to describe the severity of adverse event 
outcomes that are associated with the failure modes of endoscopic staplers and energy-
based tissue sealers.  The average outcome severity was determined for each failure mode 
and phase of operation that was identified in Chapter II.  The percentage of failure 
outcomes that resulted in a severity of 3 or higher was reported in order to assess the 
occurrence of medically significant adverse outcomes.  Severity frequencies and 
proportions were determined per phase of operation for the devices.  The frequencies of 
each severity grade were analyzed for association with the common phases of operation. 
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3.4.1 Endoscopic Stapler Adverse Event Outcome Severity 
 
 The Ethicon ETS stapler failure modes associated with the most severe outcomes 
involved the reload falling out of or off of the device (average severity of 3.71), staple 
line leak post-op (3.57), and the failure to deploy staples at all or on both sides (3.50).  
Only two failure modes resulted in an average outcome severity of less than 3, which 
were the failure to release (2.40) and the failure to cut (2.67).  These results do not reflect 
the frequency of each failure mode.  Recall from Section 2.3.2, the most common failure 
modes associated with the ETS stapler were the failure to deploy staples at all or on both 
sides (18%), failure to release (18%), and malformed staples or failure to form staples 
(15.3%).  The failure to deploy staples at all or on both sides was a common failure mode 
for this device and resulted in one of the highest average outcome severities.  The failure 
to release resulted in the lowest average outcome severity associated with the ETS stapler 
of 2.40.  Malformed staples or failure to form staples resulted in an average outcome 
severity of 3.18.  The reload falling out of or off the device and staple line leak post-op 
each accounted for 6.3% of the failures.   
 The Covidien Endo GIA failure modes associated with the most severe outcomes 
were the unintentional nicking of tissue (4.50), difficult release (4.00), and staple line 
failure (4.00).  Though, these failure modes accounted for a relatively low number of 
failures associated with the Endo GIA stapler as reported in Section 2.3.2.  
Unintentionally nicking tissue accounted for 1.8% of failures, a difficult release 
accounted for 0.9%, and staple line failure accounted for 5.3%.  The least severe 
outcomes associated with the Endo GIA stapler resulted from a general misfire 
(nonspecific) (2.40), the failure to cut (2.50), and the reload falling out of or off the 
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device (2.67).  The most common failure modes associated with the Endo GIA stapler 
were malformed staples or failure to form staples (26.5%), the failure to release (19.5%), 
and failure to deploy staples at all or on both sides (10.6%); these failure modes resulted 
in average outcome severities of 2.80, 2.73, and 3.50, respectively.   
 The failure to deploy staples at all or on both sides was a common failure mode 
for both the Ethicon ETS and the Covidien Endo GIA.  The average outcome severity 
was the same for both devices (3.50).  The average outcome severity falls between severe 
and life-threatening on the CTCAE v4.0 grading scale.  Therefore, considering the 
relative frequency and average outcome severity associated with this failure mode across 
both staplers, the failure to deploy staples at all or on both sides is noteworthy.  Given the 
nature of this failure mode, it is concerning that it occurred relatively frequently since the 
failure to deploy staples at all or both sides leaves the tissue susceptible to being cut 
without being simultaneously secured with staples.   
Cutting without applying staples accounted for 10.7% of the 84 adverse event 
reports retrieved from the FDA MAUDE database by Kwazneski et al. (Kwazneski, Six 
et al. 2012).  The 84 adverse event reports were retrieved using the keyword “misfire” 
and searching for both Ethicon and Covidien laparoscopic stapling devices (Kwazneski, 
Six et al. 2012).  The failure mode identified in the scientific literature is similar to the 
one herein except that it does not include failure to deploy on both sides of tissue.   A 
concerning consequence takes place when the knife is deployed yet only one side of 
staples is deployed, especially when staples are not deployed on the patient side of the 
tissue.  For this reason, there are preventative techniques that have been suggested for 
laparoscopic stapling given the potentially high outcome severity of this failure.  For 
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example, Deng et al. discuss a modification of a vascular ligation technique which first 
utilizes a device that only deploys staples, then proceeds to divide tissue only after it is 
secured (Deng, Meng et al. 2002).  Clamping or applying clips to tissue and structures 
that are prone to bleeding and leakage prior to deploying a stapling device may prevent or 
reduce the severity of an adverse event if a failure during firing occurs.   However, care 
should be taken when using any type of clip near the stapling site since contact with such 
an obstruction can disrupt the firing sequence of an endoscopic stapler (Mansour, El-
Nashar et al. 2014, Riggs, Bohm et al. 2016).   
 Malformed staples or the failure to form staples was a common failure for both 
staplers, but resulted in a relatively lower outcome severity (ETS – 3.18, Endo GIA – 
2.80).  Despite being low relative to other outcome severity averages, these average 
outcome severities are deemed severe and medically significant (severity grade of 3) if 
rounded to the nearest severity grade. The failure mode involves staples that are deployed 
from the device but are either not formed correctly or not formed at all.  Malformed 
staples are noted consistently as a concern in scientific literature and can be caused by a 
number of staple leg bending factors (Deng, Meng et al. 2002, Chekan and Whelan 2014, 
Fuller, Paull et al. 2014).  Examples of factors that affect staple leg bending include 
staple height, type of metal (bending characteristics), and tissue properties (thickness, 
viscosity, etc.) (Mery, Shafi et al. 2008, Chekan and Whelan 2014).  Chekan and Whelan 
provide examples of acceptable and unacceptable staple forms produced after firing 
staples into tissue (Chekan and Whelan 2014).  Malformed staples can result in failure of 
the staple line, tissue trauma, bleeding, or leakage immediately after firing (Mery, Shafi 
et al. 2008).  If malformed staples are not noticed and addressed promptly by the surgical 
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team, it can potentially cause detrimental consequences later in the surgery or post-
operatively.  Specifically, Chekan and Whelan state the unacceptable staple forms can 
“compromise integrity and strength of the staple line resulting in an increase rate of leaks 
and bleeding” (Chekan and Whelan 2014). 
 Device failure to release from tissue was another common failure mode for both 
staplers that resulted in a relatively low outcome severity (ETS – 2.40, Endo GIA – 2.73).  
The average outcome severities fall between a moderate (2) and severe (3) outcome.  The 
severity of these outcomes is likely dependent on the type of tissue that was fired upon 
and the procedure type.  When a device fails to release from tissue during a minimally 
invasive procedure the user typically must create another port and apply another stapling 
device in order to remove the malfunctioning device, which involves additional tissue 
resection (Kwazneski, Six et al. 2012, Riggs, Bohm et al. 2016).  Depending on the tissue 
type and procedural setup, additional tissue resection may or may not be an acceptable 
option.  Conversion to an open surgery is necessary in such cases and if visibility is 
hindered or the creation of another port is not an available option.        
The ETS stapler was associated with more reload failures than the Covidien Endo 
GIA (ETS – 9%, Endo GIA – 5.3%).  Further, the instances where the reload fell 
completely out of the ETS stapler resulted in more severe outcomes on average than that 
of the Covidien Endo GIA (ETS – 3.71, Endo GIA – 2.67).  This failure mode resulted in 
the highest average outcome severity of all failure modes associated with the ETS stapler, 
which is likely due to the nature of the outcome.  Adverse event outcomes are likely 
severe since the consequence of this failure involves the firing of a stapler on tissue 
without inserting staples (Champion and Williams 2003).  The user experiences reported 
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in the FDA MAUDE database have noted detrimental consequences as a result of this 
error, such as life-threatening blood loss (FDA 2017).  This failure mode could be due to 
the reload insertion process dictated by the very design of the device jaw.  This event can 
occur if the reload is not inserted properly or if it “pops” out of place prior to the firing.  
Further developments of this device have incorporated safety features to prevent the 
ability to fire without a reload present, but there is evidence that these prevention 
measures can be overridden and the surgeon and staff may not be familiar the features 
offered by the various devices available (Deng, Meng et al. 2002). 
 Similar trends are evident between both devices when assessing the number of 
failures and average severities per common phases of operation.  For both devices, the 
most failures occurred during the main function of the endoscopic stapler, which 
involved cutting and firing on tissue (ETS – 56.8%, Endo GIA – 56.6%).  The second 
most common phase of operation in which failure occurred was the transition phase, 
which involved the reload, articulation, application, and removal of the device (ETS – 
31.5%, Endo GIA – 29.2%).  The least common phase of operation in which failure 
occurred was the results and post-op phase, which involved the staple line (ETS – 11.7%, 
Endo GIA – 14.2%).  Though, the results and post-op phase resulted in the highest 
average outcome severity (ETS – 3.46, Endo GIA – 3.50) for both devices compared to 
the other two phases.  The transition phase resulted in the lowest average outcome 
severity (ETS – 2.83, Endo GIA – 2.85).   
The frequencies and severities of adverse event outcomes associated with both 
endoscopic staplers were combined and assessed.  Across all phases, a severe outcome 
(severity of 3) was the most common accounting for 60.3% of the outcomes assessed 
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(transition – 17.4%, main function – 35.3%, results/post-op – 7.6%).  Of all failures 
reported, 47.8% that occurred during the main function resulted in a severity of 3 or 
higher.  Of the failures reported, the proportion of the failures that resulted in a severity 
of 3 or higher for the transition phase and results and post-op phase were 21.0% and 
12.9%, respectively.  All failures associated with the result and post-op phase were of 
severity 3 or higher.  Across all phases, only one failure resulted in a mild outcome.  Of 
the failures that occurred during the main function, 84.3% resulted in an outcome severity 
of 3 or higher.  Of the failures that occurred during the transition phase, 69.1% resulted in 
an outcome severity of 3 or higher.  Therefore when assessing each phase of operation 
individually, the failures associated with the results and post-op phase resulted in the 
most severe outcomes.  Relative to the other phases, the main function phase resulted in 
the most dispersed severity outcomes on the 1-5 CTCAE v4.0 grading scale. 
The outcome severity of endoscopic stapler failures was significantly different per 
common phase of operation in which the failure occurred (p < 0.05), deeming the 
association between the phase of operation in which an adverse event occurred and the 
severity of the outcome noteworthy.  Due to the various factors involved in surgical 
stapling, such as staple height, tissue properties, accessibility, port placement, and so on, 
it can be difficult to narrow in on the root cause of an adverse event.  Therefore, 
providing information regarding the severities associated with phases of operation and 
the failure modes within each phase can supply users and designers of the devices with 
insight regarding the most critical and risky aspects of the surgery.  It is important for 
users to be aware of the types of severe outcomes that can result from device and user 
induced failures.   
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Educating users about the potential failures and outcome scenarios is one way to 
bring awareness to the issues and further encourage the implementation of the 
preventative techniques as suggested in the scientific literature (Baker, Foote et al. 2004, 
Fuller, Paull et al. 2014, Mansour, El-Nashar et al. 2014).  Users are encouraged to 
explore the available options for prevention, as many are specific to tissue types and 
procedures.  Also, each technique can bring about its own additional risks that must be 
carefully considered and weighed by the user.  For example, buttressing techniques are 
meant to make the staple line more uniform and provide additional support by placing 
thin sheets made of different material on one or both sides of the tissue to be stapled 
(Mery, Shafi et al. 2008).  Buttressing has been associated with less bleeding from staples 
lines (Shikora, Kim et al. 2003, Angrisani, Lorenzo et al. 2004); however, the long term 
effects on healing, among other factors, are unclear (Mery, Shafi et al. 2008).  Though 
relatively low compared to overall usage, endoscopic stapling device failures will occur.  
Therefore, it is even more important for users to be educated and trained in the most 
appropriate methods to implement in response to the issues that can arise in the surgical 
setting that are specific to endoscopic staplers. 
 
3.4.2 Energy-Based Tissue Sealer Adverse Event Outcome Severity 
 
 The most severe failure mode outcomes associated with the Olympus 
Thunderbeat were related to an unspecific error that resulted in bleeding (average 
outcome severity of 5.00), seal failure with bleeding/leakage (3.53), and direct 
application (3.29).  The outcome associated with the most severe failure mode involved 
death of the patient, yet the only details provided in the report indicated that bleeding 
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resulted from an error during the activation phase.  Further, recall from Section 2.3.3 that 
this failure mode only accounted for 1.2% of the total failures associated with the 
Thunderbeat.  The most common failure mode associated with this tissue sealer was 
residual heat, which accounted for 28.4% of its total failures and resulted in an average 
outcome severity of 2.39.  Seal failure with bleeding/leakage was the second most 
common failure mode associated with the Thunderbeat and resulted in one of the highest 
average outcome severities.  Direct application, which results in thermal injury to 
adjacent tissue due to the unintended contact with the active probe during activation, 
resulted in one of the most severe outcomes and accounted for 8.6% of the Thunderbeat 
failures. 
 Similar to the Thunderbeat, the most severe outcomes associated with the Ethicon 
Harmonic Ace were the result of an unspecific error that resulted in bleeding (3.75), seal 
failure with bleeding/leakage (3.55), and direct application (3.33).  The unspecific errors 
associated with bleeding accounted for 3.9% of the Harmonic Ace failures, and one 
outcome involved death of the patient.  The most common failure mode associated with 
this device was seal failure with bleeding/leakage, which accounted for over a quarter of 
its failures (28.4%) and also resulted in one of the highest average outcome severities.  
Direct application accounted for 2.9% of Harmonic Ace failures.  Residual heat and the 
failure to seal or seal properly were also common failure modes of this tissue sealer with 
each accounting for 15.7% of the failures and resulting in average outcome severities of 
2.44 and 2.81, respectively.         
 Seal failure with bleeding or leakage was a common failure mode that resulted in 
severe outcomes for both the Thunderbeat and Harmonic Ace devices.  Adverse event 
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outcomes associated with tissue sealers that utilize either ultrasonic or bipolar energy or 
both commonly involve bleeding as a result of failure (Overbey, Townsend et al. 2015).  
While concerning, it is important to emphasize the specific function of these devices, 
which involves sealing and transecting vessels.  Failures can be prone to association with 
bleeding and leakage outcomes due to the very nature of the surgical tasks these devices 
are relied upon to carry out.  Though, the patient risks are heightened for failures that 
occur post-operatively.  Thorough inspection of the seal prior to the completion of a 
procedure is necessary in order to prevent post-operative seal failure that may require 
reoperation.   Users must be aware of the sealing capabilities of their device(s) of choice 
given that various brands and types of tissue sealers specify the range of vessel diameters 
in which they are intended to seal.  Further, users must have the experience and 
judgement practices that allow proper assessment regarding the use of tissue sealers for 
various applications, tissue types, and tissue/vessel sizes.  
 Residual heat was a common failure mode associated with the tissue sealers and 
resulted in an average severity outcome between moderate (severity grade of 2) and 
severe (severity grade of 3) on the CTCAE v4.0 grading scale.  Across both devices, only 
one outcome resulted in death and no life-threatening outcomes occurred.  Specifically, 
the death was reportedly due to a post-operative leak that originated from a burn on the 
small bowel.  Burns to hollow structures, such as the bowel, are deemed to be of the 
highest risk given the potential for post-operative leakage and infection.  Burns due to 
residual heat were reported to have affected the patient’s internal and external organs in 
addition to the surgical team’s skin.  Each of the consequences can result in a range of 
outcome severities depending on the location and degree of the burn due to residual heat 
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of the device’s distal tip.  In a 2011 study, Govekar et al. determined that even 20 seconds 
after activation the tip of ultrasonic energy devices heated tissue more than 20°C from 
baseline temperature, which further emphasizes the need for cautious handling of devices 
that utilize ultrasonic technology after activation (Govekar, Robinson et al. 2011).     
 Assessing both the frequency of failures modes and their corresponding outcome 
severity is necessary to provide an inclusive perspective on adverse event outcomes.  
Various failure modes may be uncommon, yet result in severe outcomes when they do 
occur.  Failures involving direct application and an unspecific error that resulted in 
bleeding during activation were not the most common failures modes associated with the 
tissue sealing devices, yet their outcomes were among the most severe.  Unfortunately, 
various event descriptions were not specific enough to identify the error that resulted in 
bleeding; however, it is evident that bleeding during the activation phase is concerning 
due to the life-threatening and morbid outcomes that can result.  The outcome severities 
herein provide additional noteworthy information in the assessment of adverse event 
reports that frequencies and proportions alone cannot deliver.  A comprehensive 
evaluation of the adverse events associated with surgical devices should at least include 
the types of failures modes and their relative frequencies, the range of outcome severity 
associated with the failure modes, and average outcomes severities per failure mode and 
phase of operation.   
 The majority of failure occurred during the main function for both the 
Thunderbeat and Harmonic Ace devices, which involved the activation phase 
(Thunderbeat – 43.4%, Harmonic Ace – 46.1%).  The second most common phase of 
failure associated with the Thunderbeat was the transition phase (36.1%), and the least 
 118 
common was the results and post-op phase (20.5%).  Conversely, the second most 
common phase of failure associated with the Harmonic Ace was the results-post-op phase 
(30.4%), and the least common was the transition phase (23.5%).  On average, the most 
severe outcomes occurred during the results and post-op phase (Thunderbeat – 3.70, 
Harmonic Ace – 3.52).  The transition and main function phases associated with the 
Thunderbeat resulted in similar average outcome severities of 2.37 and 2.36, respectively.  
The main function resulted in more severe outcomes on average than the transition phase 
for the Harmonic Ace at 2.40 and 2.08, respectively.  For both devices, the transition and 
activation phase average outcome severities fell between moderate (severity of 2) and 
severe (severity of 3) on the CTCAEv4.0 grading scale, while the results and post-op 
phase average outcome severities fell between severe (severity of 3) and  life-threatening 
(severity of 4).  Adverse event outcomes associated with the final seal (results) and those 
that occur post-operatively are more severe on average than those that occur during the 
transition and main function phases of tissue sealer operation.   
 The frequencies and severities of adverse event outcomes associated with both 
tissue sealers were combined and assessed.  Across all phases, a severe outcome (severity 
of 3) was the most common accounting for 45.4% of the outcomes assessed (transition – 
11.9%, main function – 20.0%, results/post-op – 13.5%).  The results and post-op phase 
for tissue sealers resulted in the highest overall average severity of 3.58 and accounted 
for the most outcomes graded as severity 3 or higher relative to the total number of 
failure outcomes assessed (25.4%).  Of the failures that occurred during the transition 
phase, 42.6% resulted in an outcome severity of 3 or higher.  54.2% of the failures that 
occurred during the main function resulted in an outcome severity of 3 or higher.  Of the 
 119 
failures that occurred during the results and post-op phase, 97.9% resulted in an outcome 
severity of 3 or higher.   
 The outcome severity of tissue sealer failures was significantly different per 
common phase of operation in which the failure occurred (p < 0.05).  Therefore, the 
phases of tissue sealer operation were associated with the severity of the outcomes that 
occur in each phase.  It is important to consider this association with both the frequency 
and types of failure that occur during each phase of operation.  Users must be 
knowledgeable of the risks associated with each phase of operation in addition to the 
most common types of failure that occur during each phase in order to heighten 
awareness throughout various stages of a procedure and device use.   
 
3.4.3 Surgical Device Adverse Event Outcome Severity 
 
 The failure mode outcome severity data for endoscopic staplers and tissue sealers 
was combined and analyzed per common phase of operation.  The majority of failures 
occurred during execution of the devices’ main function (51.3%).  The main function of 
both surgical devices involves securing (either via stapling or sealing) and transecting 
tissue (either via knife or thermal/mechanical energy).  The average severity of the 
outcomes that occurred during the devices’ main function was between moderate and 
severe at 2.80.  Relative to the total number of failures assessed, 37.2% of the failures 
during the main function resulted in a severity of 3 or higher.  Across both devices, 
72.4% of the number of failures that occurred during the main function resulted in a 
severity of 3 or higher.   
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The transition phase was the second most common phase of operation in which 
failure occurred, accounting for 29.8% of failures.  Transition failures vary per device 
type, but in general this phase refers to any handling of the device during the procedure 
excluding execution of the main function.   The average outcome severity of the failures 
that occurred during transition was the lowest relative to the other phases of operation 
(2.57).  Of the total number of failures, the transition phase accounted for the lowest 
number of outcomes that resulted in a severity of 3 or higher (17.1%).  Similarly, the 
transition phase accounted for the least amount of outcomes that resulted in severity of 3 
or higher relative to the number of outcomes that resulted within that phase (57.4%).  The 
least amount of life-threatening outcomes and deaths occurred during transition relative 
to the other phases of operation, which is likely due to the counteractive techniques 
available for the user to employ during these circumstances.  Relative to main function 
and post-op failures, users are typically able to resort to less severe tactics during the 
reaction to many types of transition failures.   
The least amount of failures occurred during the results and post-op phase 
(18.8%); though, the failures that occurred during this phase resulted in the highest 
average outcome severity of 3.55.  This phase included failures that occur after the main 
function was carried out (i.e. seal or staple line after activation and firing, respectively) 
and adverse event outcomes that occurred post-operatively.  Adverse events associated 
with the results of device use post-operatively mainly involved surgical ligation failure 
resulting in leakage or bleeding.  Of the total failures assessed, 18.6% of the results and 
post-op phase failures resulted in a severity grade of 3 or higher.  Further, of the failures 
that occurred during the results and post-op phase, 98.7% resulted in an outcome severity 
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of 3 or higher. Seal or staple line failure after the completion of a procedure involves 
deployment of undesirable tactics, such as reoperation, and subjects the patient to high 
risk related to leakage and blood loss. 
 The percentage of outcomes that resulted in a severity of 3 or higher were 
determined for endoscopic staplers, tissue sealers, and for both device types.  81.7% of 
endoscopic stapler failures resulted in an outcome severity of 3 or higher, and 62.2% of 
tissue sealer failures resulted in an outcome severity of 3 or higher.  Across both device 
types, 72.8% of failures resulted in an outcome severity of 3 or higher. Determining the 
number of failures that result in an outcome severity of 3 or higher was of interest 
considering these were failures that resulted in a medically significant outcome deemed 
either severe, life-threatening, or morbid.  A severe outcome indicated that either invasive 
intervention was required or the procedure was altered in some way due to the failure, 
whether requiring a conversion from laparoscopic to open surgery or a procedural delay.  
These outcomes in addition to those even more severe (severity grade of 4 and 5) are the 
most concerning due to their nature and the associated risks.  Therefore, it is essential to 
assess these occurrences per phase of operation and device type.    
The outcome severity of failures associated with both device types was 
significantly different per phase of operation in which the failure occurred (p < 0.05).  
Therefore, the phases of surgical device operation were associated with the severity of the 
outcomes that occurred in each phase based on the endoscopic stapler and tissue sealer 
data.  While many studies have assessed the types of failures associated with these 
devices, and in some cases the frequency, no study to date has incorporated a severity 
assessment of the outcomes associated with the failures and phases of device operation 
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(Tucker and Voyles 1995, Brown and Woo 2004, Fuller, Paull et al. 2014, Mansour, El-
Nashar et al. 2014, Overbey, Townsend et al. 2015, Riggs, Bohm et al. 2016).  Not only 
do designers and medical professionals need to be aware of the type and frequency of 
failures, but they also must be knowledgeable regarding the level of risk posed by each 
failure.   
Whether inherent to device design or the nature of the specific patient’s tissue, 
unanticipated and unexpected outcomes associated with device use will occur.  Despite 
the low failure rate relative to overall usage, users must not only be knowledgeable in 
proper functioning and use of the devices, but also in the potential adverse event 
outcomes related to the most common types of failure.  The more tools and methods a 
surgeon can deploy in reaction to the various potential device failures, then the less 
severe the outcome will likely be.  A surgeon’s awareness of proper device use and 
function in addition to alternative procedure methods and bleeding management 
techniques contribute to prevention of adverse events, especially those that may have 
resulted in an event of severity grade 3 or higher.   
Steps should be taken to not only reduce the severity, but also work towards 
complete prevention of an adverse event.  The method described is the first step towards 
utilizing severity grades in the assessment of adverse event outcomes retrieved from the 
FDA MAUDE associated with minimally invasive surgical devices.  This work initiated a 
new approach to enhance risk awareness and prevention techniques through assessment 
of the severity of the various failure mode outcomes derived from adverse event reports 
by applying the CTCAE grading method.  The failure mode type, frequency, and 
outcome severity data presented efficiently outlines and provides inclusive content to aid 
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designer and medical professional’s education and awareness of the risks associated with 
various device types and procedures.   
Knowledge and experience is crucial for the recognition of the onset of specific 
failures, which reiterates the importance of filling the knowledge gap related to device 
use, performance, tissue interaction, potential failure, and preventative action (Deng, 
Meng et al. 2002, McColl, Karmali et al. 2009, Feldman, Fuchshuber et al. 2012, 
Feldman, Brunt et al. 2013, Madani, Watanabe et al. 2014, Riggs, Bohm et al. 2016).  
The application of an outcome severity grading method serves as a contribution to filling 
the knowledge gap regarding device use and failure in addition to bridging the gap 
between manufacturers and users.  A collaborative effort is required among various 
disciplines in order to make significant headway in preventing device and user induced 
errors, especially as they relate to the devices used in minimally invasive surgeries.  It is 
important for users to be aware of the types of failures that can occur with device usage 
and the corresponding general severity that can potentially result.  The information 
presented can contribute to the enhancement of a user’s approach when encountering the 
various phases of operation outlined herein.  User awareness should be heightened during 
all phases of operation, but especially in situations where the most severe types of failure 
modes are prone to occur.   
The application of severity to phases and failure modes can be applied to devices 
outside of the four in this study.  It is likely that the severities identified apply to the 
various brands of devices available within the two classes, and the insights provided by 
this work can be applicable even as the technology advances.  Manufacturers can utilize 
severity grading data as it relates to adverse events in order to determine the device 
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features that can be implemented to reduce or prevent specific failure modes that may 
tend to be the most severe.  It can also provide insight into which features may or may 
not be attributing to issues.  For instance, some staplers have a lockout mechanism that is 
intended to prevent an empty reload (staples deployed on a previous fire) from being 
fired.  However, it has been demonstrated that users are capable of overriding this lockout 
mechanism by applying excessive force and consequentially cutting tissue without 
applying staples (Deng, Meng et al. 2002).  Significant force to fire should be an 
indication of improper firing conditions, yet some users may proceed in their attempt to 
fire.  Therefore, not only is a user knowledge gap exhibited, but also a gap between the 
manufacturer and user regarding device performance, function, application, and 
instructions for use.   
The manufacturers have a responsibility to recognize improper use and the level 
of success exhibited by device safety features in order to address the current issues and 
implement countermeasure improvements in future designs.  Various tools are in place to 
assist the communication between the user and manufacturer regarding device 
performance, yet further developments are necessary based on the findings related to both 
user and device based failure modes and their corresponding severities.  The knowledge 
gaps exhibited also demonstrates the need for a comprehensive understanding of not only 
the specific types of failure modes prone to certain surgical devices, but also the 
associated outcome severities that can potentially result in the operation setting. 
 
3.5 Outcome Severity Study Limitations and Future Work 
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The limitations of this work are consistent with those of the failure mode study 
listed in Section 2.5.  Event descriptions within the reports were not all sufficient for 
determining the exact outcome.  Insight gained from the manufacturer narrative was used 
in some of these incidences to identify the nature of the adverse event outcome.  In some 
cases when the consequence was not explicitly stated, the severity grade was inferred 
based on the context provided in the event descriptions and manufacturer narrative.  All 
outcomes could not be directly linked to the user or device based failure.  In some cases, 
the terminology and descriptions provided were not easily interpretable, and best 
judgement in the severity of the outcome was used given the information provided as it 
relates to the CTCAE grading criteria.  Therefore, it is possible that misclassification of 
failure mode outcome severity could have occurred leading to an improper overall 
assessment of outcome severity. Terminology associated with specific failure modes and 
adverse event outcomes (including patient consequence) needs to be more consistent, and 
the current terminology suggestioned in literature should be utilized by user and facility 
administration when submitting reports to the FDA MAUDE (Brown and Woo 2004, 
Fuller, Paull et al. 2014, Overbey, Townsend et al. 2015, Riggs, Bohm et al. 2016). 
The severity grades applied to the adverse event outcomes were carried out by 
one investigator.  This is a limitation of this work as best practice involves multiple 
investigators who demonstrate a satisfactory inter-rater reliability.   Future work should 
involve multiple investigators in the application and consensus of severity grades. 
It has been demonstrated that applying severity grading methods to the adverse 
event reports in the FDA MAUDE is useful for users and manufacturers as one way to 
help bridge the knowledge gap.  Though, resource and budget limitations did not allow 
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for the assessment of additional devices that were necessary for other components of the 
overall research goals.  Not only should other brands of tissue sealers and endoscopic 
staplers be investigated, but also additional device classes.  The application of the 
CTCAE to the FDA MAUDE database reports should be expanded in order to bring 
awareness regarding the severity associated with medical device failure modes in various 
procedural settings.   
The CTCAE grading was the most appropriate grading method for the 
intraoperative surgical complications associated with medical device adverse events.  
However, the all of the criteria outlined for this method was not directly applicable in all 
cases (i.e. criteria referencing how the adverse outcome affects activities of daily living).  
Proper grading classification was inferred based on the general criteria outlined for each 
severity grade in the CTCAE v4.0.  This work assessed the severity of each adverse event 
as it relates to failure mode consequence.  While this work alludes to the severity that 
would likely be associated with specific failure modes, the predictability of severity 
grades per various failure modes should be analyzed more in depth with applicable 
statistical analyses.  Such analyses would likely require a larger sample size.  Further 
investigation could also be valuable that assesses the severity of outcomes due to failures 






DEVICE DESIGN COMPLEXITY SCORE 
 
4.1 Complexity Study Overview 
 
    The use of medical devices designed specifically for MIS is increasing along 
with their application to more wide-ranging procedures due to rapid technological and 
design evolution (Deng, Meng et al. 2002, Janetschek, Bagheri et al. 2003, Swanstrom, 
Kozarek et al. 2005, Feldman, Fuchshuber et al. 2012, Feldman, Brunt et al. 2013, Lyons 
and Law 2013, Chekan and Whelan 2014).  Design and development of new and 
modified surgical devices is vital to the enhancement of procedural outcomes, patient 
safety and wellbeing, and surgeons’ capabilities in the operation room.  Investigation into 
a method to accurately assess product complexity in particular will enable optimal design 
and manufacture of various classes of medical devices through design variable 
modifications.  Such investigation can also provide a better understanding of the design 
aspects that can affect product performance.  Therefore, identifying the complexity of 
minimally invasive surgical devices is crucial in the early design stages in order to ensure 
the effectiveness and safety of a device’s final design.  The design variables associated 
with surgical devices are of heightened interest considering they are increasingly relied 
upon to function properly during the execution of intricate minimally invasive procedures  
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(Deng, Meng et al. 2002, Janetschek, Bagheri et al. 2003, Johnson, Couture et al. 2007, 
Feldman, Fuchshuber et al. 2012, Kwazneski, Six et al. 2012). 
Specific Aim 3 is addressed in this chapter, and the purpose of this aim was to 
characterize the design complexity of endoscopic staplers and energy-based tissue sealers 
used in MIS using device component decomposition and functional modeling.  Two 
endoscopic staplers and two energy-based tissue sealers and were reverse engineered and 
a Design Structure Matrix (DSM) was constructed for each.  The DSMs were used in 
order to generate a complexity score for each device using the connectivity algorithm 
developed by Summers and Ameri (Summers and Ameri 2008).  The connectivity 
algorithm was also applied to generate a complexity score for the functional model that 
represents each device type.  The functional aspects, design features, and complexity 
scores of each device were compared and discussed. 
The nature of various aspects of device use potentially affect procedural 
outcomes, such as the instructions for use, the procedural tasks and requirements, the 
clinical environment, and the device design.  A multi-domain approach involving the 
intersection of medical and engineering design knowledge is necessary in order to 
quantify the complexity of each of these aspects and begin addressing how they relate to 
the outcomes of surgical device use and performance.  This study is the first to apply an 
existing method of quantifying design complexity to minimally invasive surgical devices 
and investigate the feasibility of the application in this domain. 
 
4.2 Complexity Scoring Methods 
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4.2.1 MIS Devices Obtained for the Complexity Analysis 
 
4.2.1.1 Endoscopic Staplers 
Two endoscopic staplers were obtained for the complexity analysis:  the Covidien 
Endo GIATM Universal Stapler with the Covidien Endo GIATM Universal RoticulatorTM 
Reload (referred to as Covidien Endo GIA in sections hereafter) and the Ethicon Endo-
Surgery ENDOPATH® ETS Endoscopic Articulating Linear Cutter (hereafter referred to 
as Ethicon ETS).  The Ethicon ETS expired in 2014 and was purchased in the original 
packaging and box on eBay for $69.99 plus $12.99 shipping.  The Covidien Universal 
handle had an expiration date of 02/2017 and was purchased in the original packaging on 
eBay for $50.00 plus $11.00 shipping. The Covidien Reload expired in 2014 and was 
purchased in the original packaging on eBay for $29.99 plus $10.00 shipping. The 
Covidien and Ethicon stapling devices were purchased from eBay in February 2016 and 
are shown removed from the original packaging in Figures 9 and 10, respectively.   
 
 
Figure 9.  The Covidien Endo GIATM Universal stapler and the Covidien Endo GIATM 




Figure 10.  Ethicon Endo-Surgery Endopath® ETS Endoscopic Articulating Linear 
Cutter. 
 
Each device was fired on a double layer of tissue paper prior to deconstruction 
and the user experience was noted during each step of use. The devices were 
disassembled in order to develop a list of components and determine their 
interconnectivity.   
 
4.2.1.2 Energy-Based Tissue Sealers 
The following energy-based tissue sealers were purchased for the analysis: 
Olympus Thunderbeat Surgical Tissue Management System (referred to hereafter as 
Olympus Thunderbeat) and the Ethicon Endo-Surgery Harmonic Ace Tissue Sealing 
Device (referred to hereafter as Ethicon Harmonic Ace).  The Olympus Thunderbeat 
shown in Figure 11 had an expiration year of 2017 and was purchased on eBay in March 
2016 for $175.  The Ethicon Harmonic Ace shown in Figure 12 expired in 2013 and was 




Figure 11. Olympus Thunderbeat Surgical Tissue Management System. 
 
 
Figure 12. Ethicon Harmonic Ace tissue sealer. 
 
 The devices were reverse engineered in order to develop a list of components and 
determine their interconnectivity.  Component decomposability was obtained in order to 
construct a DSM for each device.   
 
4.2.2 Connectivity Algorithm 
 
Device patents were used to assist proper reassembly and identification of 
components (Hmtema 1998, Huitema, Nalagatla et al. 1998, IV, Setser et al. 2005, 
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Marczyk 2006, Scirica 2010, Hall, Tanguay et al. 2011, Soltz and Broom 2012).   A DSM 
was created for each device, and a complexity score was calculated using coupling 
complexity, which accounts for a measure derived from the connections between 
variables at multiple levels represented in a graph-based format (Carrascosa, Eppinger et 
al. 1998, Eppinger and Browning 2012).  A connectivity algorithm was proposed in the 
literature to measure the connectivity of an entity-relationship graph via removal of 
relationships between entities until the graph is decomposed into individual entities 
(Summers and Ameri 2008).  Graphs are repeatedly separated into sub-graphs until single 
nodes remain.  Once the algorithm has been applied, a decomposability score results, 
which measures how difficult it is to take the product or system apart piece by piece.  
Complexity increases with the more steps, relationship sets, or relationships per separated 
element that are required to decompose the product or system entirely.  The connectivity 
algorithm was outlined in Table 5 in Section 1.2.7.3.   
The DSM for each device was converted into a bipartite graph in order to apply 
the connectivity algorithm.  Additionally, a bipartite graph was derived from each device 
functional model.  An example of a bipartite graph is shown in Figure 13.  Components 




Figure 13. Bipartite graph (entity relationship graph) (Summers and Ameri 2008). 
 
 A Matlab program was coded by the developers of the connectivity algorithm at 
Clemson University given that manual calculation of complexity scores from bi-partite 
graphs can be cumbersome for systems and products that involve many components and 
connections.  The developers permitted use of the program in this study in order to obtain 
complexity scores based upon connectivity.  The program reads each device DSM from 
an excel file, converts it into a bipartite graph, and calculates the complexity score.  
Summers and Ameri provide step-by-step instructions and examples regarding 
application of the connectivity algorithm to the bipartite graph in order to obtain a 
complexity score as executed by the program (Summers and Ameri 2008).  The 
functional aspect of a device contributes to overall design complexity.  Therefore, the 




4.3 Complexity Results 
 
4.3.1 Functionality, Reverse Engineering, and DSMs 
 
Endoscopic staplers and energy-based tissue sealers share a common functional 
requirement to secure and separate tissue.  However, each device executes the function 
utilizing dissimilar mechanisms.  The two classes of devices are applicable to different 
tissue types and procedures.   The differing mechanisms between device types and device 
brands involved in executing the main function are discussed. 
 
4.3.1.1 Endoscopic Stapler Function and DSM 
The overall function and objective of each endoscopic stapler is identical, yet 
different manufacturers’ staplers vary in terms of their components, attachments, 
features, and overall design.  Ethicon Endo-Surgery generally supplies a full stapler that 
requires reloading of individual stapler cartridges into the elongate channel of the device 
jaw.  After an Ethicon stapler is fired, it requires a new staple cartridge in order to be 
used again in the same procedure.  The device can then be reloaded and fired in the same 
patient, meaning the same jaws, articulation components, and knife can be utilized in a 
single procedure.  Covidien generally supplies a handle with a shaft portion that connects 
to a separate reload.  The reload is packaged and sold separately.  Replacing a Covidien 
reload involves new jaws, distal articulation components, and knife for the next fire 





Figure 14. Ethicon ETS loaded jaw. 
 
 
Figure 15. Distal Covidien Endo GIA reload. 
 
The firing mechanism varies between Ethicon and Covidien devices (Covidien 
2017, Ethicon 2017).  To fire the Ethicon stapler, a clamping trigger is pulled and locked 
closed.  After waiting for the tissue to compress, the firing trigger is squeezed until the 
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firing sequence is complete.  To release the clamping trigger (and jaws), a button on the 
back of the handle is pressed.  The Covidien stapler has one trigger, which is used to 
clamp and fire.  Once tissue is clamped, the user must press a button on the side of the 
device to allow stapling.  The same handle is squeezed and released multiple times to 
advance the knife through the tissue.  Once the firing sequence is complete, the return 
knobs are pulled back to retract the knife and open the jaws.  The handles and triggers for 








Figure 17. Covidien Endo GIA handle with trigger and return knobs. 
 
The type of components and mechanisms for shaft rotation, articulation, and 
safety features vary per device brand as well.  Each endoscopic stapler brand offers 
options for shaft lengths, staple line lengths, and staple heights to suit various 
applications and tissue types (Covidien 2017, Ethicon 2017).  The functional model for 




Figure 18.  Endoscopic stapler functional model. 
 
The endoscopic stapler functionality involves 25 functions and 23 connections 
between them.  The DSM derived from the functional model is included as an electronic 
attachment.  The devices were reverse engineered to assess connectivity.  The Ethicon 
ETS had 38 total components identified for the DSM, and an exploded view of the device 
is shown in Figure 19.  The Covidien Universal handle and reload were comprised of 47 
components and 42 components, respectively, resulting in a total of 89 components.  An 
exploded view of the Covidien components is shown in Figure 20.  The staples were 
recognized as a single part in each device DSM, as well as the pieces that drive the 




Figure 19.  Ethicon Endo-Surgery Endopath® ETS Endoscopic Articulating Linear 




Figure 20.  Covidien Endo GIATM Universal stapler and the Covidien Endo GIATM 
Universal RoticulatorTM reload exploded view. 
 
 
A subset of the Ethicon ETS stapler DSM is shown in Figure 21.  The full DSM is 




Figure 21. Ethicon ETS stapler DSM subset. 
 
A subset of the Covidien Endo GIA stapler DSM is shown in Figure 22.  The full 
DSM is provided as an electronic attachment.  The Covidien Endo GIA consisted of the 
most components resulting in the largest DSM.  
 


















































































29 Knife 1 1 1 1 1
30 Couple closure ring 1 1
31 Elongate channel 1 1 1 1 1
32 Channel knife guide 1 1
33 Anvil 1 1 1 1
34 Staple cartridge 1 1 1 1 1
35 Staples 1 1
36 Catidge pan 1 1 1
37 Wedge sled 1 1 1 1










Figure 22.  Covidien Endo GIA stapler DSM subset. 
 
4.3.1.2 Energy-Based Tissue Sealer Function and DSM 
 The two brands of tissue sealers obtained for this analysis share a common main 
function, which involves sealing and transecting tissue by converting electrical energy 
into mechanical and thermal energy.  However, the technology and mechanisms used to 
execute the functions differs.  The Olympus Thunderbeat integrates both bipolar and 
ultrasonic technology in order to coagulate and dissect tissue.  This device offers two 
modes that are put into effect via pressing the hand switches shown in Figure 23.  In 
“Seal” mode, bipolar energy is delivered exclusively in order to create a seal without 
involving the cutting effects of ultrasonic vibrations.  “Seal & Cut” mode delivers a 




































































































































30 First rotatable member 1 1 1 1 1 1 1 1
31 Articulation lever 1 1 1
32 Housing 1 1 1
33 Stepped portion plate 1 1 1
34 Pivot member for articulation lever 1 1
35 Second rotatable member 1 1 1
36 Translation member 1 1 1
37 Translation pin 1 1
38 Outer casing 1 1
39 Sensor cylinder 1 1 1
40 Tube housing 1 1 1 1
41 End cap 1 1 1 1
…
…
Covidien Endo GIA™ 




combination of bipolar and ultrasonic energy to seal and transect.  The ultrasonic and 
bipolar probe tip of the jaw can be used to create a puncture in the tissue, and the jaw 
itself can be used as a grasper.  Olympus offers three handle types for the Thunderbeat 
including a front-actuated grip, pistol grip, and inline grip.  The device obtained for this 
analysis featured the pistol grip. 
 
 
Figure 23. Olympus Thunderbeat activation hand switches. 
 
The Ethicon Harmonic Ace utilizes ultrasonic energy, which involves the 
conversion of electrical energy to mechanical energy to thermal energy. However, 
ultrasonic devices do not pass current through tissue to achieve the desired effects.  The 
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Harmonic Ace assessed uses a pistol grip handle and delivers either “Min” or “Max” 
power when activated (see Figure 24). 
 
 
Figure 24.  Ethicon Harmonic Ace activation hand switches. 
  
Despite the differences in sealing and cutting technology, the devices share 
common features.  Both devices require a hand piece attachment and connection to an 
electrosurgical generator in order to access, deliver, and convert electrical energy.  A 
torque wrench is provided with each device to attach and detach the hand piece.  The 
hand pieces contain piezoelectric transducers and convert the drive current into the 
ultrasonic output (Van Slycke, Gillardin et al. 2016). The jaw of each device can be used 
to grasp tissue, and the active blade of the Harmonic Ace and probe tip of the 
Thunderbeat can both be used to define tissue planes (Ethicon 2017, Olympus 2017).  




Figure 25.  Ethicon Harmonic Ace ultrasonic jaw (active blade). 
 
 
Figure 26.  Olympus Thunderbeat ultrasonic and bipolar jaw (active probe tip). 
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Each shaft can be rotated via a knob located near the proximal end of the shaft; 
this allows for simple and efficient rotation of the jaw via the users’ fingers while 
maintaining a secure grip on the device.  Additionally, the general function of the devices 
are the same as shown in the functional model in Figure 27.   The cutting and sealing 
functions of a tissue sealer is represented with the following functional model 
terminology: “separate” and “secure” tissue.  The functional model provides a general 
overview of the types of energy employed by tissue sealers (Ethicon 2017, Olympus 
2017).   
 
 
Figure 27.  Energy-based tissue sealer functional model. 
 
The conversions specific to different brands and types of tissue sealing devices 
may vary slightly from this functional model, but the main feature involving utilization of 
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electrical energy is depicted.  The DSM derived from the functional model is included as 
an electronic attachment.  The devices were reverse engineered to assess connectivity.  
Exploded views of the Olympus Thunderbeat and Ethicon Harmonic Ace components are 
shown in Figures 28 and 29, respectively.  
 
 
Figure 28.  Olympus Thunderbeat exploded view. 
 
 
Figure 29.  Ethicon Harmonic Ace exploded view. 
 
A subset of the Olympus Thunderbeat DSM is shown in Figure 30.  The full DSM 




Figure 30.  Olympus Thunderbeat DSM subset. 
 
A subset of the Ethicon Harmonic Ace DSM is shown in Figure 31.  The full DSM 




Figure 31.  Ethicon Harmonic Ace DSM subset. 
 
The full DSMs were utilized in the complexity analysis as a continuous matrix.  
Relative to the endoscopic staplers, patents containing the proper part descriptions were 
not as readily available via general patent searches.  Therefore, the part names used in the 
tissue sealer DSMs are indicative of the part descriptions to assist identification versus 
adherent to manufacturers’ naming conventions.   
 
4.3.2 Complexity Scores 
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The complexity scores were based on the connectivity of the components or, in 
other words, the decomposability of the devices.  The number of components and 
complexity scores for each device are shown in Table 40.  The devices are arranged from 
lowest to highest complexity score. 
 
Table 40.  Number of components and complexity scores per device. 
Device Number of Components Complexity Score 
Ethicon Harmonic Ace 39 170 
Ethicon ETS 38 184 
Olympus Thunderbeat 48 214 
Covidien Endo GIA 89 478 
 
Complexity scores were also calculated for each functional model based on the 
connectivity between the functions.  The number of functions and the complexity scores 
for endoscopic stapler and tissue sealer functional models are shown in Table 41. 
 
Table 41.  Functional model parameters and complexity score. 
Functional Model Number of Functions Complexity Score 
Energy-based Tissue Sealer 31 58 
Endoscopic Stapler 25 48 
 
 The energy-based tissue sealer functional model contained more functions and 
was more complex than the endoscopic staplers.  The value of creating a functional 
model from a general functional requirement is demonstrated by the two devices types as 
they show the various design paths that can be taken depending on the application.  
Figure 32 displays the branching that starts from the initial functional requirement to the 
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mechanisms to satisfy the requirement and finally to designs and products that ultimately 
fulfill the goal of separating and securing tissue. 
 
 
Figure 32. Branching of mechanisms and designs from functional requirements. 
 
4.4 Complexity Discussion 
 
Complexity has been defined as “the measure of the degree of interconnections, 
the size of the composite, and how difficult it is to solve or analyze” (Summers and Shah 
2010).  The complexity scores calculated assess the degree of interconnectedness or 
decomposability.  The complexity of a system or product increases as the 
decomposability score increases given that it is a measure of the requisite steps for 
structural disassembly (Mohinder, Gill et al. 2016).  The Ethicon Harmonic Ace had the 
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lowest complexity score (170), and the Covidien Endo GIA had the highest (478).  The 
Ethicon ETS and Covidien Endo GIA consisted of the lowest and highest number of 
components, respectively (ETS – 38, Endo GIA – 89).  When comparing the number of 
components and complexity scores per device type, a higher complexity score correlates 
to a higher number of components.  However, this relationship only exists when 
assessing the values for endoscopic staplers and tissue sealers separately.  The same 
relationship does not exist when assessing the values for all four devices as a single data 
set. 
The connectivity algorithm is a systematic approach that considers the coupling 
between elements.  When assessing the complexity of design products, a lower level of 
structural complexity is more favorable given that a design that involves less coupling 
enables mass customization, serviceability, and reusability (Ameri, Summers et al. 2008, 
Summers and Ameri 2008).  This view of complexity considers the physical attachment 
of the various components that make up a product.  Summers and Shah state that 
considering independent complexity assessments is valuable in industry as it pertains to 
“correlating manufacturing and life-cycle costs with early-stage and mid-stage design” 
(Summers and Shah 2010).  Therefore, it can be inferred that from a structural 
perspective involving coupling complexity the medical devices with a lower complexity 
score embody a more simplistic and desirable design as it relates to the design process 
and product lifecycle.   
The Covidien Endo GIA had the highest complexity based on this perspective 
(478), which is intuitive given the number of components and the modular design 
features required between the handle and the reload.  The handle must facilitate 
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articulation of the device jaw and deployment of stapling and cutting mechanisms.  
Various components and inherent connections are required for each of these functions.  
The reload is attached as an extended shaft potion.  This attachment must bridge the 
components between the handle portion of the shaft and the reload portion of the shaft in 
order to seamlessly execute the required tasks.  Conversely, the Ethicon ETS shaft and 
the components connecting the handle mechanism to the device jaw are continuous.   
The Covidien Endo GIA contains a “break” in components of the shaft, which 
inevitably increases the part count, connections required, and complexity score.  It is said 
that a good design is one that “satisfies all functional requirements with minimum 
number of components and relations” (Suh 2001).  The Ethicon ETS and Covidien Endo 
GIA both satisfy the functional requirements to secure and separate tissue via mechanical 
mechanisms, yet the inner workings to execute the functions vary.  Despite the increase 
in complexity score likely caused by the modular features of the Covidien Endo GIA, 
these same features may be viewed as beneficial by certain users.  The modular features 
allow the user to introduce a new knife, jaw, and distal articulation assembly each time 
the function is carried out during the same procedure.  New components for each firing 
can be viewed as a positive feature from a surgeons’ perspective to alleviate any worries 
regarding dulling of the knife or damage to reload components that may have occurred 
during previous firings.  However, from a complexity standpoint this may not be ideal 
given that the introduction of new components each time may increase potential of 
failure, and, as mentioned, the modularity is a major contributor to the increase in the 
complexity score.   
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Of the two tissue sealers, the Olympus Thunderbeat had a higher complexity 
score (Thunderbeat – 214, Harmonic ace – 170) associated with a higher number of 
components (Thunderbeat – 48, Harmonic Ace – 39) relative to the Ethicon Harmonic 
Ace.  The Thunderbeat must incorporate components and features that enable delivery of 
both bipolar and ultrasonic energy, which could be reason for a higher complexity score.  
The Harmonic Ace solely delivers ultrasonic energy and was shown to have the lowest 
complexity score of all devices analyzed.  Due to the Thunderbeat’s integration of two 
sealing technologies, it has been shown to be highly effective in its sealing capabilities, 
and its performance has been deemed equivalent at the least and even superior in some 
cases compared to that of similar energy-based tissue sealers (Milsom, Trencheva et al. 
2012, Seehofer, Mogl et al. 2012, Aytan, Nazik et al. 2014, Liberman, Khereba et al. 
2014, Obonna and Mishra 2014, Van Slycke, Gillardin et al. 2016).  Recall typically a 
higher complexity is viewed as an unfavorable design attribute; however, that is 
debatable in this particular case.  The Thunderbeat satisfies the same functional 
requirements as the Harmonic Ace and, in fact, has been shown to have the best-in-class 
performance per specific applications addressed in the scientific literature (Olympus 
2012, Olympus 2012, Obonna and Mishra 2014) yet it has a higher complexity score and 
number of components.   
It may be argued that additional complexity based on decomposability can be 
favorable contingent upon whether the additional features provide superior results 
relative to that of a less complex device.  Though, decomposability directly relates to the 
mechanical mechanisms inherent to the devices while the electrical features play a major 
role in tissue sealers’ performance.  Further investigation into how electrical energy can 
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be accounted for in current complexity measures is necessary prior to concluding on this 
matter, especially as it relates to the electrical parameters that attribute to device 
performance.  Performance contributions inherent to an increase in design complexity 
should be carefully weighed considering an increase in the difficulty of disassembly of 
the Thunderbeat inherent to supplying two types of sealing technologies has been shown 
to be beneficial in application. 
While assessing complexity based on connectivity provides value and objective 
insight that aid design decisions (Ameri, Summers et al. 2008, Mohinder, Gill et al. 
2016), it excludes aspects of a device outside of the mechanical mechanisms that 
dominate the connectivity.  Tissue sealers require an electrical connection to an 
electrosurgical generator.  The electrical features of these devices are necessary to carry 
out the function, yet it can also be responsible for device failures.  The electrical 
mechanisms, hand piece, and generator required are not considered in the connectivity 
algorithm, but they may contribute to the complexity of a device.  As discussed, there are 
many different approaches to assessing device complexity and it should not be viewed 
singularly (Summers and Ameri 2008).  Complexity should be viewed from a structural, 
functional, and behavioral perspective (Ameri, Summers et al. 2008).  The connectivity 
algorithm provides a solid base for assessing the complexity of the devices and allows a 
direct comparison between the devices based on decomposability and component 
connectivity alone. 
The application of complexity extends beyond the product design itself and 
product lifecycle.  The graph connectivity method has been investigated as a method to 
predict information from design representations (i.e. function structures and assembly 
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times) (Mohinder, Gill et al. 2016).  Mohinder et al. concluded these design 
representations can be used to predict product assembly time and market value; however, 
this information is more applicable to the early stages of design in order to facilitate more 
informed design decisions (Mohinder, Gill et al. 2016).  The developers of the 
connectivity algorithm emphasize the necessity to aggregate various properties in their 
approach, which includes identifying metrics for size, interconnectivity, centrality, and 
decomposition.  This research investigates decomposition and provides a foundation for 
demonstrating its potential value in the medical device industry. The work herein utilizes 
the foundation by assessing association between complexity and the severity of adverse 
event outcomes, yet the application of this calculation extends beyond the scope of this 
work.  
While the data does not indicate one device type as overall more complex than the 
other, there are important aspects of each to consider as it pertains to this analysis.  
Endoscopic stapler reloads contain multiple staples, and the staples were treated as one 
component in the DSMs created in this study.  The number of staples per reload can vary 
based on the type of tissue it is intended for.  The particular reloads for the Ethicon ETS 
and Covidien Endo GIA acquired each deploy two parallel rows of 24 staples on either 
side of the cut making 48 staples total.  If each staple had been treated as an individual 
component connecting to the cartridge, sled, and driver, then the total components and 
connectivity would significantly increase.  Given each endoscopic stapler contained the 
same numer of staples in the reload, it would not affect the complexity score difference 
between the Ethicon ETS and the Covidien Endo GIA; however, it would result in higher 
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complexity scores relative to both tissue sealers.  Each staple has the potential to fail and 
may need to be analyzed individually when assessing complexity in future analyses. 
The number of functions and a complexity score were derived from each device 
functional model.  The tissue sealer functional model consisted of more functions relative 
to the endoscopic stapler in order to achieve the main functions of securing and 
separating tissue (Tissue Sealer – 31, Endoscopic Stapler – 25).  Further, the tissue sealer 
functional model also resulted in a higher complexity score based on the connectivity 
algorithm (Tissue Sealer – 58, Endoscopic Stapler – 48).  Therefore, the tissue sealer is 
more functionally complex than the endoscopic stapler based on these models which is 
likely due to the differences in mechanisms and operation.  The particular endoscopic 
staplers analyzed herein deploy strictly mechanical mechanisms in order to execute the 
main functions involving stapling and cutting tissue.  However, the tissue sealers require 
an input of electrical energy and conversion into mechanical and thermal energy in order 
to carry out the main task.   
Function is crucial to consider when assessing potential for product failure and 
failure scenarios and is most beneficial when considered early in the conceptual phases of 
the design process.  A relationship has been demonstrated between product function and 
risk likelihood and consequence (Tumer and Stone 2003, Lough, Stone et al. 2008). The 
consideration of function has been deemed useful in particular for the Function-Failure 
and Risk in Early Design (RED) methods (Lough, Stone et al. 2008).  
It is important to reiterate that despite the similarity in the main functional 
requirement of securing and separating tissue, the two devices types are typically used for 
different types of procedures and tissue types.  Tissue sealers, such as the Thunderbeat 
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and Harmonic Ace, can be used to seal and cut vessels that are up to between 5-7mm in 
size (Ethicon 2017, Olympus 2017), whereas the endoscopic staplers can be applied on 
relatively larger tissue types such as lung and bowel tissue.  An endoscopic stapler is not 
meant for dissecting small vessels just as a tissue sealer (indicated for up to 5mm or 7mm 
vessels) is not suited for removing large portions of the stomach.  Therefore, while they 
both are well suited for laparoscopic surgeries and MIS, their specific applications must 
be well understood and considered when assessing design and functional model 
complexity.  The four devices demonstrate the important role functional modeling can 
play in brainstorming various mechanisms and design approaches to fulfill the same 
functional requirement depending on the application.   
 
4.5 Complexity Study Limitations and Future Work 
 
The limitations to consider relate to the connectivity algorithm and the specific 
devices chosen for the analysis.  The connectivity algorithm produces a complexity score 
based on decomposability and does not take into account the electrical features of the 
tissue sealers.  It is recommended to assess the contribution of the electrical features to 
the complexity measure and, if necessary, how it could be incorporated into a final 
complexity score for a medical device.  Complexity of the medical devices must be 
viewed from various perspectives as discussed in the scientific literature (Hölttä and Otto 
2005, Ameri, Summers et al. 2008, Hagedorn, Grosse et al. 2015).  Additionally, the 
staples of the reloads were considered one part in the DSMs entered in the connectivity 
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algorithm code.  It may be necessary to consider each staple as an individual part in 
future analysis considering each staple has the potential to fail.  
The methods outlined for determining complexity should be implemented in the 
early stages of design.  The approach utilized assessed the complexity of a final product.  
If the various perspectives of complexity are considered at the very early stages in 
conceptual design, the comparisons between features (as it relates to concepts, designs, 
components, assembly, etc.) would be more valuable given the flexibility at these steps.  
This also provides the opportunity to assess potential failure prior to the finalization of 
design and manufacture of a product.  Both structural and functional complexity are more 
useful if applied earlier; though this work demonstrated the application of complexity to 
current products and its potential uses and feasibility. 
Additional devices and device classes should be investigated when measuring and 
comparing complexity.  Herein, two staplers were reverse engineered that operate via 
mechanical mechanisms to carry out the same function.  However, the two tissue sealers 
investigated are not identical in the mechanisms deployed to carry out the function.  
While they both utilize ultrasonic energy, the Thunderbeat also deploys bipolar energy 
and was the only device offering this combination during the study period.  Given this 
was a relatively recent innovation, it was deemed important to include.  However, for 
complexity score comparison it would also be beneficial to compare tissue sealers that 
utilize the exact same energy deliver methods, such as comparing the Ethicon Harmonic 
Ace to the Covidien SonicisionTM.  The number and types of devices chosen for this 
analysis were limited by the resources available to acquire such types of products.    
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Future work should also involve mapping the components to the specific 
function(s) they carry out.  Such mapping would assist the tracing of historical failure 
modes; however, this technique is best utilized early in the design process (Stock, Stone 






OUTCOME SEVERITY AND DEVICE DESIGN COMPLEXITY 
 
5.1 Outcome Severity and Design Complexity Study Overview 
 
Users and manufacturers of minimally invasive surgical devices require a 
comprehensive understanding of the factors that potentially affect device performance, 
failure modes, and the severity of adverse event outcomes.  Currently there are few 
methods to integrate knowledge of clinical outcomes and device use with the engineering 
design process in order to investigate related factors.  A new approach was presented to 
integrate the clinical and design domains via assessing severity of adverse event 
outcomes and the complexity of the associated device design.  The approach provides a 
foundation for aiding in prevention of adverse clinical outcomes and bridging the gap 
between device users and designers.  
The overall goal of Specific Aim 5 was to describe the relationship between 
minimally invasive surgical device design complexity and the severity of adverse event 
outcomes associated with endoscopic staplers and energy-based tissue sealers, which is 
carried out in this chapter.  It was hypothesized that as minimally invasive surgical device 
design complexity increases, the severity of adverse event outcomes associated with the 
device also increases.  In addition, the goal of Specific Aim 5 was to develop a tool to 
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predict the likelihood of severe adverse events associated with minimally invasive 
surgical devices based on design complexity. 
 
5.2 Severity and Complexity Methods 
 
The goal of determining the relationship between outcome severity and device 
design complexity based on connectivity and an outcome severity predictive tool based 
on the complexity was explored by performing ordinal regression.  The outcome severity 
assigned to each adverse event report in Chapter III was grouped per device and 
corresponding complexity score from Chapter IV.  The severity of the adverse event 
outcomes was the ordinal, dependent variable.  The independent design complexity score 
should be deemed a continuous variable; however, due to the lack of devices obtained 
and corresponding complexity scores calculated, not enough samples were collected to 
classify complexity as a continuous variable for a robust statistical output (i.e. the ordinal 
model failed to improve indicating a poor fit and resulted in a very low standard error).  
In order for complexity to be assessed statistically as a continuous variable, more data 
points and corresponding standard deviations are necessary.  Therefore, the ordinal 
severity data was grouped under categorical data consisting of each complexity score.   
The average severity of the outcomes was reported for each design and functional 
model complexity score.  The total sample of severity data included outcomes severities 
from 383 reports.  100 severity outcomes were matched to each complexity score except 
for the Thunderbeat device.  The severities assigned to the total population of reports (83) 
were matched to the complexity score for the Thunderbeat device.  By default, the 
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statistical software SPSS used the highest value as the reference variable for ordinal 
regression.  The parameter estimates from the output were used to calculate the odds 
ratios and to assess the statistical significance of the effect with respect to each 
complexity value (p = 0.05).  The odds ratios were calculated by taking the exponential 
of the estimates.     
 
5.3 Severity and Complexity Results 
 
Sample information for the dependent variable, severity, and the independent 
variable, complexity, is shown in Table 42.   
 






1.00 37 9.7% 
2.00 67 17.5% 
3.00 205 53.5% 
4.00 56 14.6% 
5.00 18 4.7% 
Complexity 
170.00 100 26.1% 
184.00 100 26.1% 
214.00 83 21.7% 
478.00 100 26.1% 
Valid 383 100.0% 
Missing 0  
Total 383  
 
The overall average severity was 2.87.  The average severity per complexity score 
is shown in Table 43 in addition to the device type. 
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Table 43. Design complexity scores and average severities per device type. 
Device Type Complexity Score Average Severity 
Tissue Sealer 170  2.65 
Endoscopic Stapler 184 3.17 
Tissue Sealer 214 2.63 
Endoscopic Stapler 478 2.99 
 
The average severity per device type and corresponding complexity score of the 
functional model is shown in Table 44.  
 





Tissue Sealer 58 2.64 
Endoscopic Stapler 48 3.08 
 
An ordinal regression was performed in SPSS statistical software to determine 
whether the complexity score had a statistically significant effect on outcome severity.  
The model fitting information is shown in Table 45.  The abbreviation “df” stands for 
degrees of freedom. 
 







Intercept Only 140.889    
Final 118.445 22.444 3 <0.01 
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The model improved the ability to predict the severity of the outcome based on 
complexity.  Though, the test of parallel lines was statistically significant (p < 0.05) 
indicating the odds were different between thresholds.  The parameter estimates are 
shown in Table 46.  The estimates were in reference to the severity associated with a 
complexity of 478 (Covidien Endo GIA complexity score).   
 
Table 46.  Ordinal regression parameter estimates with respect to a complexity score of 
478. 
 Estimate Std. Error Wald df P-value 
Threshold 
[Severity = 1.00] -2.534 0.247 105.310 1 <0.01 
[Severity = 2.00] -1.233 0.206 35.679 1 <0.01 
[Severity = 3.00] 1.292 0.208 38.668 1 <0.01 
[Severity = 4.00] 2.886 0.292 97.512 1 <0.01 
Location 
[Complexity=170.00] -0.585 0.271 4.659 1 0.03 
[Complexity=184.00] 0.371 0.271 1.873 1 0.17 
[Complexity=214.00] -0.827 0.284 8.451 1 <0.01 
[Complexity=478.00] - - - - - 
 
The odds ratio and significance of the effect with respect to each complexity score 








Table 47.  Outcome severity odds ratios and significance with respect to each complexity 
score. 
Complexity Odds Ratio (eEstimate) Significance 
With Respect to Complexity = 478 
Complexity = 170 0.56 Significant 
Complexity = 184 1.44 Not Significant 
Complexity = 214 0.44 Significant 
With Respect to Complexity = 184 
Complexity = 214 0.30 Significant 
Complexity = 170 0.38 Significant 
Complexity = 478 0.69 Not Significant 
With Respect to Complexity = 214 
Complexity = 478 2.29 Significant 
Complexity = 184 3.31 Significant 
Complexity = 170 1.27 Not Significant 
With Respect to Complexity = 170 
Complexity = 478 1.79 Significant 
Complexity = 184 2.60 Significant 
Complexity = 214 0.79 Not Significant 
 
5.4 Severity and Complexity Discussion 
 
The goal of this research was to determine the relationship between outcome 
severity and device design complexity based on connectivity.  Based on this data sample 
and assessing the average severities per complexity score, a relationship was not shown 
to exist between the outcome severity and device design complexity.  Specifically, the 
severity of adverse event outcomes did not increase as minimally invasive surgical device 
design complexity increased.  Therefore, the null hypothesis stating there is no statistical 
significance between outcome severity and design complexity could not be rejected.   
 The majority of adverse events resulted in a severe outcome (53.5%), and a 
moderate outcome was the second most common result (17.5%).  The average outcome 
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severity was 2.87, which is between a moderate and a severe outcome.  The Ethicon ETS 
stapler had a complexity score of 184 and resulted in the highest average outcome 
severity of the adverse event reports assessed (3.17).  This device resulted in the only 
average outcome severity above severity grade 3.  The second highest average outcome 
severity was 2.99, which was associated with a complexity score of 478 and the Covidien 
Endo GIA stapler.  The Covidien Endo GIA stapler resulted in the highest complexity 
score, but this device was not associated with the highest average outcome severity of the 
devices assessed.   
 The lowest average outcome severity was 2.63 and was associated with a 
complexity score of 214 and the Olympus Thunderbeat.  The Thunderbeat was associated 
with the lowest average outcome severity, but this device did not result in the lowest 
complexity score.  The lowest complexity score of 170 for the Ethicon Harmonic Ace 
resulted in an average outcome severity of 2.65.  Despite the lack of evidence to show a 
relationship between the complexity scores and the average outcome severity of the 
associated adverse events, a trend existed in the outcomes severities across the device 
types.  The endoscopic staplers assessed resulted in higher average outcome severities 
relative to that of the tissue sealers.  Yet, the energy-based tissue sealer functional model 
contained more functions and was more complex than that of the endoscopic stapler.   
The development of a predictive tool for outcome severity based on complexity 
was explored by performing ordinal regression.  The Pearson and Deviance goodness-of-
fit tests both indicated that the model was not a good fit to the observed data, χ2(9) = 
60.041 and 61.757, p < 0.01 and p < 0.01.  Further, the assumption of proportional odds 
was not met based on the test of parallel lines, p < 0.01.  However, the final model 
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statistically predicted the dependent variable over and above the intercept-only model, 
χ2(3) = 22.444, p < 0.01.  6.2% of the variance was explained by the model per 
Nagelkerke Pseudo R-squared.  Considering the violations, the findings should be 
interpreted with caution as the model may not provide a proper prediction of outcome 
severity.   
Per the ordinal regression analysis, the odds ratios indicated that the severity 
associated with tissue sealer complexity scores 170 and 214 are likely to be lower than 
that of both endoscopic stapler complexity scores of 184 and 478 (odds ratios < 1), a 
statistically significant effect (p < 0.05).  Conversely, the odds ratios indicated that the 
outcome severity associated with endoscopic stapler complexity scores 184 and 478 are 
likely to be higher than that of tissue sealer complexity scores 170 and 214 (odds ratios > 
1), also a statistically significant effect (p < 0.05).  The odds ratios predicting the 
outcome severities associated with tissue sealer complexity scores 170 and 214 relative to 
each other did not have a statistically significant effect (p > 0.05).  Similarly, the odds 
ratios predicting the outcome severities associated with endoscopic stapler complexity 
scores 184 and 478 relative to each other did not have a statistically significant effect (p > 
0.05).       
While a severity predictive tool could not be developed from this particular data 
set for complexity based on a continuous variable, the ordinal regression analysis 
provides relative insight for the outcome severities that result specifically in association 
with the devices and corresponding complexity scores assessed herein.  Development of a 
robust predictive tool requires assessment of the severity of adverse event outcomes and 
design complexity scores of additional minimally invasive surgical devices.  
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The integration of clinical and design based assessments should take into account 
the various approaches that are employed for analysis.   Medical based studies utilize 
statistics in the research methods in order to draw accurate and unbiased inferences 
regarding the topic of study (Novack, Jotkowitz et al. 2006).  A robust study design is 
mandatory in order to make proper conclusions regarding patient treatment, procedural 
outcomes, medical adverse events, etc.  Conversely, various product design approaches 
utilize design heuristics in order to maximize creativity and diversity in design, promote 
variation in the concepts generated, and to provide alternate solutions to existing design 
problems (Yilmaz and Seifert 2011).  The use of design heuristics assists the 
development of novel product concepts and design approaches (Yilmaz, Daly et al. 
2016).  Module heuristics in particular has been defined as “a method of examination in 
which the designer uses a set of steps, empirical in nature, yet proven scientifically valid, 
to identify modules in a design problem” (Stone, Wood et al. 2000).  Therefore, heuristics 
can be viewed as an acceptable basis for assessing methodology particularly in the field 
of design.   
A combination of statistical and design heuristic approaches was employed in 
order to investigate the relationship between design complexity and outcome severity.  
While statistical conclusions regarding the overall research goal could not be drawn from 
the analysis, heuristic methods support development of the approach presented.  The 
work herein should be viewed as an essential step towards development and validation of 
a novel approach to assess the aspects of a device’s design that may contribute to adverse 
minimally invasive device failure outcomes.  
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This work provides one approach to quantifying complexity of minimally 
invasive surgical devices based on decomposability.  However, confliction between the 
work system and the operator/user capabilities (or lack thereof) can also contribute to 
errors within complex systems (van Det, Meijerink et al. 2009).  Dankelman and 
Grimbergen indicate five strategies aimed at the reduction of errors in minimally invasive 
surgery, one of which is to reduce complexity (Dankelman and Grimbergen 2005).  
Complexity in this context is relevant to the entire system of the device including its 
design, use, instructions, and procedural applications.  The strategies are aimed at 
eliminations of unnecessary and inefficient interactions and processes, the standardization 
of procedures and equipment, and training (Flin, O'Connor et al. 2008).   
The reduction of complexity in addition to implementing methods for the 
remaining strategies has been suggested to reduce minimally invasive surgical errors and, 
therefore, would likely mitigate the potential for severe adverse event outcomes.  
Provided the prevalence of both user and device-based failures outlined in Chapter II, a 
separate approach may be necessary targeted at reducing human errors.  This approach 
would involve a system analysis to identify the root cause of user errors in addition to the 
implementation of defenses within the system to prevent adverse event outcomes from 
being induced by such errors (Dankelman and Grimbergen 2005).      
The decomposability approach can aid identification of specific variables that 
contribute to design complexity, such as connectivity and number of components.  
Though, analysis of the adverse event reports indicates both user and device-based 
failures.  Further sorting of the adverse events based on specific failure type may be 
valuable and more applicable to the calculation of complexity based on decomposability.  
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For example, assessing the severity of outcomes that are explicitly stated to have 
occurred due to device failure may be more applicable to a complexity score based on the 
device design.  Furthermore, the outcome severity of user-based failures may be more 
applicable to a score that assesses the elements of device instructions and operation and 
user experience and knowledge.  Severity of outcomes should also be analyzed to 
determine association with procedure types that may affect aspects of device use, such as 
visibility, tissue type, application, etc. 
 
5.5 Severity and Complexity Study Limitations and Future Work 
 
The limitations of this study are consistent with those of the outcome severity 
study and complexity study discussed in Section 3.5 and Section 4.5, respectively.  
Specific to this analysis, the assumptions of proportional odds was violated indicating the 
possibility that the ordinal regression odds ratios and corresponding conclusions are 
invalid.  Complexity was not classified as a continuous variable and instead was 
classified as a categorical variable.  Therefore, conclusions regarding outcome severity 
per this analysis must be made relative only to the individual complexity scores 170, 184, 
214, and 478.  Future work should include a power analysis to determine the proper 
sample size from which an appropriate budget can be determined to obtain more devices 
and investigate the feasibility of an outcome severity prediction tool based on design 
complexity.  This study could serve as pilot data for a power analysis.     
Development of a complexity-severity prediction tool should be investigated for 
its application in the early design stages to mitigate potential design-related adverse 
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events.  Design variables assessing complexity can potentially enhance engineers’ 
abilities to prevent or reduce the severity of surgical device-based failure mode outcomes.  
Yet, a modified approach to assessing the relationship between outcome severity and 
device complexity is necessary. 
The limitation specific to the calculation of endoscopic stapler complexity should 
be reiterated.  In particular, the staples of each reload were considered as one part in the 
DSM and connectivity algorithm.  Each staple has the potential to fail and, therefore, 
staples may need to be considered as individual parts.  The inclusion of each staple 
separately would increase the part count and complexity score of each endoscopic stapler.   
Complexity was one variable related to the use of minimally invasive surgical 
devices that was considered in the investigation of the severity of adverse event 
outcomes.  While the analysis herein did not prove the existence of a relationship 
between outcome severity and device design complexity, there are additional factors to 
consider.  Various methods for calculating complexity exist, and the method used herein 
utilized a decomposability score.  As discussed in Section 5.4, investigation into 
operational and procedural factors that contribute to user-based errors, failures, and 
severe outcomes specifically could be beneficial while separately assessing design 
complexity in relation to device-based failures and the corresponding adverse event 





SUMMARY AND CONCLUSIONS 
 
The overall goals of this research were to 1) characterize the design attributes, 
failure modes, and adverse events associated with minimally invasive surgical devices 
and 2) describe the relationship between minimally invasive surgical device design 
complexity and the severity of adverse events.  A novel approach for investigating and 
evaluating minimally invasive device failures was presented, which involved assessing 
the severity of adverse event outcomes associated with the failures modes and exploring 
aspects of the devices’ design that may contribute to failure. The approach was unique in 
that medical device design, function, and failure outcomes were evaluated from a 
complexity perspective. 
Two endoscopic staplers, the Ethicon ETS and Covidien Endo GIA, were utilized 
in addition to two energy-based tissue sealers, the Olympus Thunderbeat and Ethicon 
Harmonic Ace.  The failures modes, severity of adverse event outcomes, and complexity 
associated with these four devices were identified.  The failures modes were derived from 
adverse event reports retrieved from the FDA MAUDE database.  Severity grades were 
applied to each adverse event outcome associated with the failure modes via application 
of the CTCAE v4.0 grading scale.  The connectivity algorithm was applied in order to 
generate a complexity score for each device based on decomposability.  Finally, the 
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overall outcome severity was explored for each device and corresponding complexity 
score by performing ordinal regression. 
The most common failure modes were assessed for both device types in Chapter 
II.  Failures associated with the endoscopic staplers occurred most frequently during the 
firing phase (ETS – 54.1%, Endo GIA – 51.3%).  Overall, malformed staples or a failure 
to form staples contributed to the most adverse events that occurred during endoscopic 
stapler firing (ETS – 15.3%, Endo GIA – 26.5%).  Failures associated with tissue sealers 
occurred most frequently during the activation phase of operation (Thunderbeat – 43.4%, 
Harmonic Ace – 46.1%).  The top two failures modes associated with tissue sealers were 
seal failure with bleeding or leakage (Thunderbeat – 18.5%, Harmonic Ace – 28.4%) and 
residual heat (Thunderbeat – 28.4%, Harmonic Ace – 15.7%).  Both user and device 
errors were prevalent in the assessment of surgical device failure modes.  Despite the 
presence of user error, the recall reasons that were consistent with the adverse event 
outcomes and the corresponding number of units recalled indicated that device based 
failures also share responsibility.  The failure modes identified and the phases in which 
they occurred were consistent with those outlined in scientific literature (Deng, Meng et 
al. 2002, Champion and Williams 2003, Hamilton, Sims et al. 2003, Marshall, Srivastava 
et al. 2003, Brown and Woo 2004, Govekar, Robinson et al. 2011, Noble, Smart et al. 
2011, Hassouna and Manikandan 2012, Lyons and Law 2013, Mansour, El-Nashar et al. 
2014, Overbey, Townsend et al. 2015).   
The severity of failure outcomes was assessed in Chapter III.  The phases of 
operation associated with each device type were regrouped into common phases of 
operation: transition, main function, and results and post-op.  The outcome severity of 
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failures associated with the surgical devices was significantly different per common 
phase of operation (p < 0.05), indicating an association between the phases of surgical 
device operation and the severity of outcomes that occurred in each phase.  Across both 
device types, the majority of failure occurred during execution of the devices’ main 
function (51.3%), which involves securing the tissue (either via stapling or sealing) and 
transecting tissue (either via knife or thermal/mechanical energy).  The average severity 
of the outcomes that occurred during the main function was 2.80, which is between 
moderate and severe on the CTCAEv4.0 grading scale.  The least amount of failures 
occurred during the results and post-op phase of operation (18.8%); however, the failures 
that occurred during this phase resulted in the highest average outcome severity of 3.55, 
which falls between severe and life-threatening on the CTCAE v4.0 grading scale.  The 
results and post-op phase involved the seal or staple line after activation or firing, 
respectively, and adverse events that occurred post-operatively.   
Various failures modes were uncommon, yet resulted in severe outcomes when 
they did occur.  Therefore, assessing both the frequency of failure modes and the 
corresponding outcome severity was necessary to provide a more comprehensive 
assessment of adverse event outcomes.  Overall, 72.8% of failures resulted in an average 
outcome severity of 3 or higher, which involved a medically significant outcome deemed 
either severe, life-threatening, or morbid based on the CTCAE v4.0 grading scale. 
In Chapter IV, the complexity scores of the surgical devices were determined 
based on a measure of the requisite steps for structural disassembly, i.e. decomposability.  
The complexity scores were further utilized in Chapter V, in which the relationship 
between outcome severity and device design complexity was explored.  The Covidien 
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Endo GIA had the highest complexity score (478) in addition to the highest number of 
components (89) and resulted in an average outcome severity of 2.99.  The Ethicon 
Harmonic Ace had the lowest complexity score (170) and resulted in an average outcome 
severity of 2.65.   The Ethicon ETS resulted in a complexity score of 184 and the highest 
average outcome severity of 3.17.  The Thunderbeat resulted in the lowest average 
outcome severity of 2.63 and a complexity score of 214.  The average outcome severity 
per device did not increase as the corresponding complexity scores per device increased.  
While there was not sufficient evidence to prove a relationship between 
complexity scores and the average outcome severity of the associated adverse events, a 
trend in outcome severity existed in the severities per the device types.  The endoscopic 
staplers assessed resulted in higher average outcome severities relative to that of the 
tissue sealer.  Though, the tissue sealer functional model consisted of more functions and 
resulted in a higher complexity score relative to the endoscopic stapler in order to achieve 
the main function of securing and separating tissue. 
Development of an outcome severity predictive tool based on complexity was 
explored by performing ordinal regression.  Recall from the discussion in Section 5.4, the 
odds ratios indicated that the outcome severity associated with tissue sealer complexities 
scores 170 and 214 are likely to be lower than that of both endoscopic stapler 
complexities of 184 and 478 (odds ratios < 1), a statistically significant effect (p < 0.05).  
Conversely, the odds ratios indicated that the outcome severity associated with 
endoscopic stapler complexities 184 and 478 are likely to be higher than that of tissue 
sealer complexities 170 and 214 (odds ratios > 1), also a statistically significant effect (p 
< 0.05).   
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While a severity predictive tool could not be developed from this particular data 
set for complexity based on a continuous variable, the ordinal regression analysis 
provided relative insight for the outcome severities specifically in association with the 
devices and corresponding complexity scores assessed.  Development of a robust 
predictive tool requires assessment of the severity of adverse event outcomes and design 
complexity scores of additional minimally invasive surgical devices.  Statistical 
conclusions regarding the overall research goal could not be drawn; however, heuristic 
methods support the development of the approach to investigating adverse event 
outcomes from a design complexity perspective.  
Evaluating the complexity of surgical devices can provide valuable insight into 
specific mechanisms of failure and a means to implement countermeasures against 
undesired outcomes in the surgical setting.  The enhancement and modification of current 
medical devices can be weighed via quantifying the complexity; specifically, the changes 
in device performance generated by the addition or modification of various features 
should be weighed in relation to the potential corresponding changes in design 
complexity. The decomposability approach used herein can aid identification of specific 
variables that contribute to design complexity, such as connectivity and number of 
components.  Though, analysis of the adverse event reports indicates both user and 
device-based failures.  Further sorting of the adverse events based on device-based 
failures specifically may be valuable and more applicable to the calculation of complexity 
based on decomposability.  Furthermore, the outcome severity of user-based failures may 
be more applicable to a score that assesses the elements of device instructions and 
operation in addition to user experience and knowledge.   
 177 
The failure modes and the recalls associated with the surgical devices indicated 
prevalence of both user and device-related issues.  The root cause of failure, whether due 
to user error or device malfunction, could not be explicitly derived from the adverse 
event report descriptions in every case.   Insufficient descriptions likely trace back to the 
knowledge gap in user’s understanding of surgical device performance and use as 
demonstrated by the inconsistencies in terminology and narratives associated with 
adverse event reporting.  Though, such findings support an investigation into adverse 
events from both a clinical and design perspective.  All challenges associated with 
surgical device use and failure must be determined and addressed; the multi-domain 
approach presented encompasses pertinent techniques to aid this task. 
By investigating devices that utilize available and advancing technologies from 
various manufacturers, this research examined a broad range of operationally diverse 
classes of surgical devices.  As a result, the work is relevant to an array of surgical 
applications and contributes knowledge to a widespread audience that encompasses users 
and designers.  The approach presented is applicable to the various brands of endoscopic 
staplers and tissue sealers used in MIS.  Also, assessing the adverse event outcome 
severity and the complexity associated with other classifications of surgical device types 
using this approach is necessary and appropriate.  An essential component of this 
research involved integrating clinical and design aspects to assist the successful 
implementation and evaluation of new and modified surgical device technology in the 
operating room. 
It has been estimated that over one million serious injuries to Americans are 
caused by medical devices each year (Rados 2003).  Each year more than 2,000 device-
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related deaths and more than 200,000 reports of device-related injuries and malfunctions 
are reported to the FDA (Mouzoon and Carome 2012).  An investigation of adverse event 
outcomes that utilizes a severity grading method and a means to quantify and assess 
complexity is applicable to a broad range of medical devices and corresponding 
applications.  The method described for investigating adverse events is valid for all such 
products that have the potential for failure and catastrophic outcomes.   
Knowledge and experience is crucial for the recognition of the onset of specific 
failures, which reiterates the importance of filling the knowledge gap encompassing 
issues related to device use, performance, tissue interaction, potential failure, and 
preventative action (Deng, Meng et al. 2002, McColl, Karmali et al. 2009, Feldman, 
Fuchshuber et al. 2012, Feldman, Brunt et al. 2013, Madani, Watanabe et al. 2014, Riggs, 
Bohm et al. 2016).  This study laid a foundation for utilizing severity grades in the 
assessment of adverse event outcomes retrieved from the FDA MAUDE associated with 
minimally invasive surgical devices.  A novel approach was presented that utilizes a 
complexity metric to assess design and functional elements of the devices in order to 
investigate the effect on adverse event outcomes.  The new approach initiated by this 
work enhances risk awareness and prevention techniques via application of the CTCAE 
v4.0 grading method to adverse event outcomes.  The failure mode type, frequency, and 
outcome severity data presented efficiently outlined and provided more comprehensive 
content to aid designer and medical professional’s education and understanding of the 
risks associated with various device types that are applicable to a range of procedures.   
Development of new methods that integrate clinical and design perspectives is 
imperative to enhance the safety of a device’s final design and improve patient outcomes.  
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While the incidence of device failures has been shown to be relatively low compared to 
overall device usage, it is essential to continuously work towards prevention of adverse 
event outcomes due to the potential for catastrophic patient consequences (Chan, Bishoff 
et al. 2000, Deng, Meng et al. 2002).  The work from this study serves as a contribution 
to filling the knowledge gap regarding device use and failure in addition to bridging the 
gap between users and manufacturers of minimally invasive surgical devices.  Thorough 
and on-going investigation into device complexity and adverse event outcomes as 
outlined by the approach herein is vital to ensuring patient safety and preventing serious 
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